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This thesis describes electrophysiological studies of rat medial vestibular
nucleus (MVN) in vitro in which the actions of opioids and the opioid receptor like-1
agonist, nociceptin (orphanin FQ) were characterised. In addition the changes in the
intrinsic membrane properties of the MVN neurones during behavioural recovery after
unilateral vestibular deafferentation ("vestibular compensation", a model of lesion-
induced plasticity in the adult brain), were investigated.
In the first part of this thesis, using agonists and antagonists selective for opioid
receptor subtypes, the presence of 8- but not p.- or K-opioid receptors was
demonstrated on spontaneously active MVN neurones in vitro. The majority (80%) of
spontaneously active MVN neurones were inhibited in dose-dependent manner by the
S-opioid receptor agonist [D-Ala2,D-Leu5]-enkephalin (DADLE) but not the ju-opioid
receptor agonists, morphine and K-opioid receptor agonist, U50 488H. The inhibitory
actions of DADLE persisted after the blockade of synaptic transmission and were
effectively antagonised by naloxone and naltrindole. In whole-cell current-clamp
recordings, the DADLE-induced inhibition was accompanied by a membrane
hyperpolarisation and a decreased cell input resistance. In voltage clamp experiments,
DADLE induced an outward current that was reduced but not abolished by
tetraethylammonium bromide (TEA). The degree of DADLE-induced inhibition was
dependent on post-natal age, such that the responses to DADLE were smaller in
younger animals and increased significantly with age. These findings resolved an
earlier conflict in the literature and clarified the actions of opioids on vestibular function.
In the second part, the effect of nociceptin / orphanin FQ (N/OFQ), the recently
discovered endogenous ligand for the opioid receptor like-1 (ORL1) receptor was
examined on spontaneously active MVN neurones. It was demonstrated that N/OFQ
potently inhibited the spontaneous discharge of the majority (86%) of MVN neurones.
This inhibition was dose-dependent, persisted in low Ca2+, Co2+ aCSF, and was
insensitive to antagonism by naloxone but was effectively antagonised by the selective
v
ORL1 receptor antagonist [PheV(CH2-NH)Gly2]nociceptin(1-13)NH2. Whole-cell
recordings showed that N/OFQ caused membrane hyperpolarisation and decreased in
input resistance in the MVN neurones. Both N/OFQ and DADLE inhibited the
spontaneous discharge of the majority of MVN neurones, while a minority of neurones
were selectively responsive either to N/OFQ or to DADLE, but not both. In addition, co¬
administration of N/OFQ and DADLE to neurones that were responsive to both
agonists, resulted in an inhibitory response that was the same as or smaller than the
inhibition induced by either agonist alone, indicating occlusion in the MVN neurones in
response to the activation of the 5- and ORL1 receptors by the agonists.
In the final part of this thesis, the changes in intrinsic membrane properties and
the action potential firing characteristics of identified "Type A" and "Type B" MVN
neurones in the rostral region of the MVN were studied during the early stage of
vestibular compensation (4h after unilateral labyrinthectomy, UL). It was shown that the
electrophysiological properties of Type A MVN neurones were unchanged following UL.
By contrast, marked changes occurred in the membrane excitability and action
potential firing characteristics of a specific sub-population of rostral Type B MVN
neurones, indicating that changes in the intrinsic membrane properties of this sub-
population of MVN neurones may be important cellular mechanism during behavioural
recovery after vestibular lesions.
vi
INTRODUCTION
In recent years, with the development of in vitro electrophysiological
techniques individual neurones in the mammalian central nervous system (CNS)
have been demonstrated to possess many different intrinsic membrane properties
as well as receptors for numerous transmitter and neuromodulator substances,
which endow them with complex integrative functions (Llinas, 1988). The vestibular
system has been used for several decades as a good model to investigate the
organisation and physiology of sensorimotor networks. The adoption of in vitro
electrophysiological methods by vestibular neuroscientists has led to insights into
the intrinsic properties, neurotransmitter receptors and the mechanisms of vestibular
plasticity (Darlington et al., 1995).
The vestibular system is a sensorimotor system that plays a major role in the
control of posture and movement by the generation of vestibulo-ocular reflexes
(VOR) and vestibulo-collic reflexes (VCRs). The VORs serve to stabilise the visual
field on the surface of retina during locomotion through command signals to the eye
muscles which result in eye movements that are equal and opposite to head
movements (Wilson and Melvili-Jones, 1979; Dutia, 1989; Berthoz et al., 1992;
Dieterich and Brandt, 1995), while VCRs give rise to the reflex excitation of the
appropriate group of neck muscles to resist and counteract the head displacement,
thus stabilising the head on the trunk (Wilson and Melvill-Jones, 1979; Dutia, 1989;
Berthoz et al.,., 1992; Wilson et al., 1995). These reflexes are initiated in the
peripheral vestibular organs where information about head movements and the
orientation of the head with regard to gravity is transduced into neural signals in the
vestibular VIIIth nerve. These signals are transmitted into the vestibular nuclei in the
brainstem and then to the oculomotor and abducens nuclei which control eye
movements, as well as to the neck motoneurone pools. Therefore, these reflexes
are critical for the stabilisation of gaze during head movement and maintenance of
the head posture in relation to the trunk.
The vestibular nuclei, sometimes collectively called the vestibular complex,
consist of four main nuclei namely medial (MVN), lateral (LVN), superior (SVN) and
inferior (IVN) nuclei. Anatomical studies have demonstrated that most of the primary
afferent input from different peripheral vestibular organs terminates in distinct areas
1
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of the four vestibular nuclei and each of these nuclei is connected with other areas
of the CNS. Afferent input from the semicircular canals projects mainly to the MVN,
SVN and IVN, while the afferent inputs from the utriculus and sacculus terminate
mainly in the LVN and IVN. The SVN and the MVN are part of the VOR circuitry and
play an important role in co-ordination of the head, neck and eye movements. They
project to cervical motoneurone pools, abducens nuclei, inferior olivary complex,
reticular formation as well as cerebellum. The IVN is a relay nucleus of the spino-
vestibular pathway and projects primarily to the cerebellum. The LVN plays a major
part for the vestibulo-spinal reflexes and projects extensively to all segments of the
spinal cord. In addition, these nuclei are interconnected bilaterally and ipsilaterally
(Wilson and Melvill-Jones, 1979; Carpenter, 1988; Buttner-Ennerver, 1992, Shinoda
eta!., 1993).
Among the four principal vestibular nuclei, the MVN is the largest and the
most easily distinguished in freshly dissected brainstem by its colour and shape on
the dorsal floor of the brainstem. The MVN therefore has recently proven to be an
attractive target for the in vitro electrophysiological studies of vestibular neurones.
Here, in this thesis, I describe electrophysiological studies of rat MVN neurones in
vitro using extracellular and intracellular whole cell patch recording techniques, in
which the action of opioids and N/OFQ were studied, and the electrophysiological
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1.1.1 THE MEDIAL VESTIBULAR NUCLEUS AND ITS CONNECTIONS
Afferent innervation of the MVN
Labyrinthine innervations
Early in vivo electrophysiological studies in the cat demonstrated that the
MVN neurones were mono-synaptically and poly-synaptically activated by
electrically stimulating the vestibular afferent fibres originating from the ipsilateral
vestibular labyrinth (Precht and Shimazu, 1965; Shinoda and Yoshida, 1974).
Subsequently, Wilson et al., (1967) showed that neurones which were mono-
synaptically activated by vestibular nerve stimulation were concentrated mainly in
the rostral third of the MVN. Anatomical studies have demonstrated that innervation
of primary afferents from the ipsilateral semicircular canals, primarily the horizontal
canal, appeared particularly dense at the rostral area of the MVN (Stein and
Carpenter, 1967; Gacek, 1969; Korte and Friedrich, 1979; Carleton and Carpenter,
1984; Sato et al., 1989), consistent with the findings that neurones in the rostral
region of the MVN respond to angular acceleration of the head in both the horizontal
and vertical planes (Shimazu and Precht, 1965; Markham, 1968; Jones and Milsum,
1970; Curthoys and Markham, 1971).
Studies in the MVN of normal monkeys, cats, guinea pigs, gerbils and rats
have identified two types of horizontal semicircular canal related neurones, Type I
and Type II neurones, with Type I neurones outnumbering Type II neurones (Precht
and Shimazu, 1965; Shimazu and Precht, 1965, 1966; Precht et al., 1966; Shimazu,
1983; Hamann and Lannou, 1988; Smith and Curthoys, 1988a, 1988b; Newlands
and Perachio, 1990a, 1990b). Both types of MVN neurones discharge
spontaneously even with the head absolutely stationary, at frequency sometimes
greater than 80 impulses/sec, and show a bi-directional response. Type I MVN
neurones increase their discharge frequency with acceleration of the head around
an earth-vertical axis in the ipsilateral direction (i.e., toward the side of the neurone
being recorded). Their discharge frequency decreases when the head is accelerated
in the opposite direction (contralateral direction). Other neurones, Type II MVN
neurones, respond in exactly the opposite pattern to Type I MVN neurones (i.e.,
decreased their discharge frequency with ipsilateral acceleration and show an
4
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increase with contralateral acceleration) because Type I neurones are excited
directly by ipsilateral horizontal canal primary afferents, whereas Type II neurones
are excited by contralateral horizontal canal afferents via commissural pathways
between the VN. Type II neurones are inhibitory neurones and act to silence Type I
neurones (Fig. 1.1.1.1). MVN neurones also receive projections from otolith organs
(Stein and Carpenter, 1967; Gacek, 1969), with neurones responded to stimulation
of the utricular nerve and to forward and backward tilting. Otolith-responsive
neurones are distributed throughout the MVN (Peterson, 1970). The afferent inputs
from semicircular canals to the MVN are functionally excitatory and mediated by
excitatory amino acid neurotransmitters, glutamate and/or aspartate acting on
mainly non-NMDA receptors (Raymond et al., 1984; de Waele et a/., 1990; Doi et
ai, 1990; Capocchi et al., 1992; Carpenter and Hori, 1992; Yamanaka etal., 1997).
Intrinsic and commissural connections
The Golgi studies of Ramon y Cajal (1909) and Lorente de No R (1933)
suggested the presence of ipsilateral intrinsic vestibular connections, which were
later experimentally demonstrated by use of the axonal degeneration technique
(Ladpli and Brodal, 1968). Recent studies using anterograde and retrograde
labelling techniques have demonstrated extensive internuclear connectivity within
the VN, with the SVN topographically and reciprocally connected to the IVN and
MVN, and LVN reciprocally connected to MVN. Apart from the connections between
the individual subnuclei, it has also been demonstrated the rostral and caudal MVN
are reciprocally connected (Pompeiano et al., 1978; Epema et al., 1988).
Using HRP retrograde labelling techniques a commissural connection
between the MVN and contralateral MVN, SVN and IVN has been demonstrated,
mostly dense between the MVNs of the two sides (Rubertone et al., 1983; Ito et al.,
1985; Epema et al., 1988). Shimazu and Precht (1966) showed that when the
contralateral vestibular nerve is electrically stimulated, field potentials could be
recorded in the ipsilateral VN. This response could be abolished following a midline
incision that interrupted the commissural fibres, thus confirming that the labyrinth
influences the activity of the contralateral VN through the commissural fibres. In
mammals, stimulation of the contralateral vestibular nerve is predominantly
inhibitory on the ipsilateral side (Shimazu and Precht, 1966; Precht et al., 1973;
5
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Figure1.1.1.1;Simplifiedschematicdiagramosomneu on letworksfthm di lves ibu arnucle s(MVN). ThetypIMVNneurones(O)incr asth irdis hargefrequencyohorizontalangularac eleratiothips l t l side,andtypeIIMVNneuron s(Q)incr asth rdisch rgefreque cyohorizontalangul rac eleratioth contralateralside.LRM,later lr ctusmuscl ;M ,medi lre tususcl ;OMN,oculomo ornucle ;AB ,abd c nucleus;Vllln,vestibulo-cochlearn rve.[□excitat ry;■inhibit] (AdaptedfromSmithandDarli g on,1996)
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Kasahara and Uchino, 1974), whereas in amphibians it is mainly excitatory
(Cochran etal., 1987; Knopfel, 1987; Dieringer, 1995).
Cerebellar, brainstem and other afferent innervations
The MVN receives extensive afferent projections from the cerebellum. The
area of the cerebellum that projects to MVN is known as the vestibulo-cerebellum,
and consists of the flocculus, nodulus, uvula, paraflocculus and fastigial nuclei.
Immunohistochemical tracing studies showed that floccular fibres terminate mainly
in the rostral area of the ipsilateral MVN (Langer et ai, 1985; Umetani, 1992), while
the nodulus fibers terminate in the caudal area of the ipsilateral MVN (Brodal, 1974,
(Langer et al., 1985). The fastigial nuclei project to the MVN on both sides, the
rostral part projecting to the ipsilateral MVN and caudal to the contralateral MVN (Ito
et al., 1985). The Purkinje neurones of the flocculus and nodulus have an inhibitory
action on MVN neurones (Baker et al., 1972; Fukuda et al., 1972). The rostral MVN
neurones that receive inhibitory fibres from the flocculus have been termed floccular
target neurones (FTN), and are involved in the three-neurone arc of the VOR (Sato
et al., 1988; Lisberger et al., 1994; Stahl and Simpson, 1995). In contrast, the
fastigial nucleus has a facilitatory influence on MVN neurones (Ito et al., 1970;
Shimazu and Smith, 1971). Through these connections the floccular cortex, which
receives convergent vestibular, visual and oculomotor information, is involved in
controlling vestibular related motor activities. It has also been suggested to play an
important role in long term plasticity of the VOR gain as well as lesion-induced
plasticity in vestibular neurones (Lisberger et al., 1994; Kitahara et al., 1997).
A number of brainstem nuclei are known to send their projections to the
MVN. Anatomical studies using horseradish peroxidase (HRP) labelling techniques
demonstrated that the MVN received afferent projections from the interstitial nucleus
of Cajal (Pompeiano and Walberg, 1957; Carpenter et al., 1970) and from the
nucleus prepositus hypoglossi (Pompeiano et al., 1978). Pontine and medullary
reticular formation also sends descending fibres to the MVN (Grottel and Jakielska-
Bukowska, 1993). Immunohistochemical studies have demonstrated that MVN
neurones also receive innervation from the caudal part of the dorsal nucleus of the
raphe (Kawasaki and Sato, 1981), from inferior olive (Balaban, 1984) and a
nonadrenergic input from locus coeruleus (Schuerger and Balaban, 1993).
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Efferent projections from the MVN
Vestibulo-ocular projections
Physiological and anatomical studies have indicated that the vestibular
nuclei particularly MVN and SVN provide the largest efferent projections to the
oculomotor nuclei, which ascend in the medial longitudinal fasciculus (MLF).
(Fig. 1.1.1.2; Tarlov, 1970a, 1970b; Gacek, 1974, 1977; Furuya and Markham* 1981;
Babalian et al., 1997). The six extraocular muscles of each eye are innervated by
motoneurones in the oculomotor, trochlear and abducens nuclei via IIIrd, IVth and VIth
cranial nerves (Fig.1.1.1.2.1; Tarlov and Tarlov, 1971; Gacek, 1974; Graf and Ezure,
1986).
The motoneurones of the abducens and the trochlear nucleus innervate the
ipsilateral rectus muscle and the contralateral superior oblique respectively. The
remaining four muscles, the superior, inferior, inferior oblique and medial rectus are
innervated by the oculomotor nucleus. The MVN projects to the abducens and
oculomotor nuclei bilaterally, but only ipsilaterally to the trochlear nucleus
(Fig. 1.2.1.2; Wilson and Melvill Jones, 1989). It has been shown that electrical
stimulation of the vestibular nerve evokes a disynaptic excitatory post-synaptic
potentials (e.p.s.p) in the contralateral abducens motoneurones, and a disynaptic
inhibitory postsynaptic potentials (i.p.s.p) is evoked in ipsilateral abducens
motoneurones. Stimulation of the rostral region of the MVN evokes similar but
monosynaptic potentials in the abducens nucleus. Thus, the anatomical and
electrophysiological results indicate that the vestibulo-ocular pathway originating in
the semicircular canal relays in the rostral region of the MVN, which then projects to
the oculomotor nuclei (Buttner-Ennever, 1992; Buttner-Ennever and Buttner, 1992).
Spino-vestibular projections
The lateral (LVST) and medial vestibulospinal tracts (MVST) provide the
major descending outflows from the vestibular nuclei to the spinal cord. The LVST
originates in the LVN and IVN and projects to all segments of the spinal cord,
terminating mainly in the extensor muscle motoneurone pools (Brodal et al., 1962;
Brodal, 1974). The MVN is the main source of the MVST and projects primarily to
the ventral horn of the cervical spinal cord from C1 to C6 (Nyberg-Hensen, 1964;
7
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Wilson et al., 1967). Peterson et al., (1978) reported that the caudal vestibulospinal
tract originates in the LVN and parts of the MVN and IVN.
Vestibulo-cerebellar projections
Anatomical studies using HRP labelling techniques demonstrated that
primary vestibular nerve afferents terminate as mossy fibres in the flocculus,
nodulus and uvula, particularly in the ipsilateral half of the cerebellum (Carleton and
Carpenter, 1984) and in the fastigial nucleus (Kotchabhakdi and Walberg, >1978).
Secondary vestibular axons originating mainly from the caudal part of the MVN,
project to the floculli in both sides, uvula and nodulus (Rubertone et al., 1983;
Barmack et al., 1992; Kitahara et al., 1997). In agreement with the anatomical
studies, monosynaptic evoked field potentials are recorded in the nodulus and
flocculus following electrical stimulation of the vestibular nerve and vestibular
nuclear afferents (Shinoda and Yoshida, 1975). These authors also demonstrated
that afferents from the rostral area of the MVN reach the vestibulocerebellum.
Other efferent projections originating from the MVN include projections to the
contralateral MVN and to other vestibular nuclei (Rubertone et al., 1983; Ito et al.,
1985; Epema et al., 1988), to the contralateral inferior olive (Balaban and Beryozkin,
1994), to the pontine and medullary recticular formation (Ladpli and Brodal, 1968;
Tarlov, 1969) and to the thalamus (Doi et al., 1997)
8
Figure 1.1.1.2 : Schematic illustration of the main projections arising
from the vestibular nuclei
The origins of the descending projections are illustrated on the left side
of the diagram and the origins of the ascending projections on the right
side. Only the connections to the medial (MR) and lateral (LR) rectus
muscles which control horizontal gaze are shown. Ill, oculomotor
nucleus; SC, superior colliculus; IV, trochlear nucleus; IC, inferior
colliculus; MFL, medial longitudinal fasciculus; VI, abducens nucleus;
S, superior vestibular nucleus; L. lateral vestibular nucleus; I, inferior
vestibular nucleus; M, medial vestibular nucleus; LVST., lateral
vestibulo-spinal tract.
(Adapted from Gilman and Newman, 1992)
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1.1.2 IN VITRO ELECTROPHYSIOLOGICAL STUDIES OF MEDIAL VESTIBULAR
NUCLEUS NEURONES
The 'brainstem slice' preparation, first used by Joel Gallagher and his
colleagues (1985), has become a widely used in vitro electrophysiological
preparation to study the brainstem vestibular nucleus complex (VNC) particularly
the medial vestibular nucleus (MVN). Considering the large number of slice studies
;
that have been conducted, the similarities in the in vitro MVN neurone resting
activity are remarkable. In all cases, with no input from the peripheral vestibular
apparatus or other areas of the CNS that are active in the intact animal, the MVN
neurones recorded in the brainstem slices of rats and guinea pigs display regular
spontaneous discharge rates (Gallagher et at., 1985; Ujihara et al., 1988; Darlington
and Smith, 1989; Ujihara et al., 1989; Darlington et al., 1990; Phelan et al., 1990;
Serafin et al., 1990, 1991a, 1991b, 1992, 1993; Smith et al., 1990; Darlington et al.,
1992; Dutia et al., 1992; Gallagher et al., 1992; Phelan and Gallagher, 1992;
Johnston et al., 1993, 1994; Dutia et al., 1995; Johnston and Dutia, 1996; Cameron
and Dutia, 1997; Ris and Godaux, 1998). In rat brainstem slices, the spontaneous
discharge rates of MVN neurones range from 0.5 - 60 spikes/sec, on average
between 10 and 20 spikes/sec, similar to those observed in vivo (Hamann and
Lannou, 1988).
It has been established by a number of in vitro studies that this regular
spontaneous neuronal discharges persist even when synaptic transmission is
blocked by perfusion with low Ca2+/ high Mg2+ or low Ca2+ / Co2+ aCSF (Gallagher et
al., 1985, 1992; Gacek et al., 1988; Ujihara et al., 1988; Doi et al., 1990; Carpenter
and Hori, 1992; Dutia et al., 1992; Lin and Carpenter, 1993, 1994), and that these
MVN neurones have intrinsic, pacemaker-like ionic conductances which are highly
sensitive to membrane potential, and generate their spontaneous discharges
independently from synaptic inputs (Serafin et al., 1990, 1991a, 1991b; Johnston et
al., 1994). This characteristic known as "autorhythmicity" has also been observed in
many other CNS neurones such as inferior olive and thalamus (Llinas, 1988).
However, the exact ionic conductances that contribute to the autorhythmicity of
MVN neurones in vitro is still unclear. Some components of the spontaneous
discharge activity observed in these neurones in vitro may be due to synaptic input
9
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within the slice, since spontaneous e.p.s.ps have been observed in some
preparations (Lewis et al., 1989; Kinney et al., 1994).
The membrane properties of MVN neurones were first examined by
Gallagher et al., (1985) in a transverse slice preparation of a rat brainstem, and at
least two subtypes of neurone were identified within the MVN, characterised on the
J
basis of the after-hyperpolarisation potential (AHPs) profiles following their
l
spontaneous action potentials. One group showed a single AHP, which was
possibly due to a Q-type current, while the other group showed a double AHP and a
voltage-dependent rectification, which may be due to a K+ rectifier (Gallagher et al.,
1985, 1992).
Serafin and colleagues (1991a,b) subsequently identified and divided guinea
pig MVN neurones into three types based on their action potential shapes and
intrinsic membrane properties in vitro (Serafin et al., 1990, 1991a, 1991b). Type A
neurones (about 30% of the neurones sampled) were characterised by a broad
action potential, a single deep AHP, an A-type rectification and small, high threshold
Ca2+ spikes, while type B neurones (about 50% of the neurones sampled) were
characterised by a narrower action potentials, an early fast AHP and delayed slow
AHP, large, high-threshold Ca2+ spikes and Ca2+ plateau potentials. The majority of
type B neurones had Na+ plateau potentials and some had low-threshold Ca2+
spikes. Type C neurones (about 20% of the neurones sampled) were
heterogeneous group with intermediate action potential shapes and therefore could
not be readily included into the other two types.
Johnston and colleagues (1994) confirmed the classification of rat MVN neurones
using intracellular recordings from horizontal brainstem slice preparations. The
neurones were classified as either type A or type B neurones based on their
averaged action potential shape profiles. Type A neurones (33% of the 123
neurones sampled) had a single deep AHP that appeared to be mediated by a
tetraethylammonium (TEA)-sensitive K+ conductance (presumably /«) and an
apamin-insensitive Ca2+-activated K+ conductance (presumably lc). Type B neurones
(67% of the neurones sampled) had an early fast AHP and delayed slow AHP. The
early fast AHP was mediated by a TEA-sensitive K+ conductance while the delayed
10
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slow AHP was mediated by apamin-sensitive K+ conductance (/AHP). The
spontaneous discharge activity of type B neurones appeared to be regulated mainly
by interactions between a persistent Na+ conductance and the hyperpolarisation
mediated by /AHP. About 30% of type B neurones also had an additional inward Ca2+
conductance. The two types of MVN neurones were distributed throughout the
rostrocaudal extent of the MVN and no Type C neurones were found (Johnston et
a/., 1994).
11
CHAPTER 1: LITERATURE REVIEWS
1.1.3 PHARMACOLOGY OF THE CENTRAL VESTIBULAR SYSTEM
The pharmacological properties of vestibular neurones have begun to
emerge only in the past decade. Different approaches including behavioural,
biochemical and electrophysiological methods have been employed to study the
pharmacology of the vestibular system. Numerous neurotransmitters, neuropeptides
and receptors have been identified in this system. '
Glutamate
Immunohistochemical and receptor binding studies have shown that all main
types of glutaminergic receptors, namely ionotropic glutamate receptors (NMDA,
kainate, AMPA) and metabotropic glutamate receptors (mGluRs) and their subtypes
were densely present in the vestibular nuclei (for reviews see Raymond et al., 1988;
de Waele et al., 1995). These studies are in accordance with in vitro
electrophysiological studies, which consistently demonstrated that MVN neurones
were highly sensitive to the glutaminergic receptor agonists and antagonists. It has
been shown that majority of MVN neurones in the rat (Gallagher et al., 1985; Lewis
et al., 1989), guinea pig (Smith et al., 1990; Carpenter and Hori, 1992; Serafin et al.,
1992; Smith and Darlington, 1992) and frog (Cochran et al., 1987) were depolarised
by NMDA receptor agonists and that this response can be blocked by NMDA
receptor antagonists.
Using intracellular recordings, Vibert et al., (1992) demonstrated that bath
application of the ionotropic glutamate receptor agonists, NMDA, kainate, AMPA
and the metabotropic glutamate receptor agonist, trans-ACPD caused excitation
and membrane depolarisation in all MVN neurones tested. These effects persisted
when synaptic transmission was blocked in a high Mg2+, low Ca2+ solution,
suggesting that these effects were mediated via postsynaptic receptors. The
existence of postsynaptic metabothropic glutamate receptors on MVN neurones
was then confirmed by Darlington and Smith (1995). Recently, using whole-cell
patch-clamp recording from rat MVN neurones, in vitro, Kinney et al., (1993) have
reported that a metabotropic-receptor antagonist blocked e.p.s.ps evoked by
stimulation of vestibular VIIIth nerve or the medial longitudinal fasciculus.
12
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Gaba and Glycine
Immmunohistochemical and In situ hybridisation studies have shown the
existence of receptors for the inhibitory amino acids y-amino-butyric acid (GABA)
and glycine on MVN neurones (Holstein et al., 1992; Li et al., 1994; Zanni et al.,
1995). Existence of these receptors was consistent with the results of in vivo and in
vitro electrophysiological experiments. Using in vivo electrophysiological recordings,
Precht et al., (1973) first demonstrated that the brainstem commissural inhibition
between the bilateral MVN could be blocked by either GABAa or glycine receptor
antagonists, indicating that both GABAa and glycine receptors mediate commissural
inhibition of type I MVN neurones. In contrast, Furuya et al., (1992) also using in
vivo recordings, indicated that commissural inhibition between the bilateral MVN
was mediated by GABAa receptors rather than by GABAb or glycine receptors.
Extracellular recordings from guinea pig (Smith et al., 1991) and rat (Dutia et
al., 1992) brainstem slices, in vitro demonstrated that most MVN neurones were
inhibited by GABA through both GABAa and GABAb receptors. The effect of GABA
on MVN neurones was further assessed by intracellular studies. Vibert et al.,
(1995a,c) using intracellular recording from guinea pig brainstem slices
demonstrated that spontaneously active MVN neurones were inhibited and
hyperpolarised both by GABAa and GABAb agonists in the presence of high Mg2+
low Ca2+ solution or in presence of TTX indicating the presence of postsynaptic
GABAa and GABAb receptors on MVN neurones. Similarly, Lapeyre and de Waele
(1995) showed that bath application of glycine caused dose-dependent inhibition of
spontaneously active MVN neurones. This action was blocked by strychnine and
persisted in high Mg2+, low Ca2+ medium, indicating postsynaptic strychnine-
sensitive glycinergic receptors.
Dopamine
Gallagher et al., (1992) have demonstrated that microdrop application of
dopamine results in excitation and membrane depolarisation of rat MVN neurones,
in vitro. Subsequently, using intracellular recording technique in vitro, Vibert et al.,
(1995) indicated the presence of D2 receptors on guinea pig MVN neurones. They
showed that both dopamine and the selective dopamine D2 agonists, piribedil and
13
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quinpirole caused depolarisation of MVN neurones, while a selective D, receptor
agonist SKF 38393 had no effect. However, when synaptic transmission was
blocked using low Ca2+, high Mg2+ aCSF, the depolarisation effect of the D2 agonist
was reversed to hyperpolarisation, indicating that the activation of postsynaptic D2
receptors may induce hyperpolarisation but D2 receptor agonist may induce




The hypothesis that histamine may be involved in regulating vestibular
function results in fact from the development of antihistamine agents that have been
used in humans for clinical treatment of motion sickness and vertigo. Anatomical
studies in the rat (Panula et al., 1989; Steinbusch, 1991), guinea pig (Airaksinen
and Panula, 1988), rabbit (Iwase et al., 1993) and cat (Tighilet and Lacour, 1996;
Tighilet and Lacour, 1997) confirmed that the whole vestibular complex is
innervated by histaminergic fibres from the tuberomammilary nucleus of the
posterior hypothalamus and both H., and H2 binding sites were also detected in the
MVN (for a review see, de Waele et al., 1995). Early, in vivo electrophysiological
studies reported that histamine caused a decrease in the firing rate of the majority
of vestibular neurones (Kirsten and Sharma, 1976; Satayavivad and Kirsten, 1977).
The inhibitory action of histamine was blocked by H2 receptor antagonist, metiamide
but not by H, receptor antagonist, diphenhydramine (Satayavivad and Kirsten,
1977).
\ /
By contrast, in vitro electrophysiological recordings in rat brainstem slices
demonstrated that in most cases, application of histamine results in excitation and
membrane depolarisation (Phelan et al., 1990; Wang and Dutia, 1995). In another
study, using intracellular recording techniques, it has been indicated that 95% of
guinea pig MVN neurones were depolarised by histamine and that this response
was due to activation of postsynaptic H2 receptors (Serafin et al., 1993). However,
the excitatory actions of histamine on the rat MVN neurones could be mediated by
both H1 and H2 receptors (Wang and Dutia, 1995). This dissimilarity could be due to
species differences in either the anatomical distribution or the pharmacological
properties of H, receptors.
14
CHAPTER 1: LITERATURE REVIEWS
Acetylcholine
Recent immunocytochemical, In situ hybridisation and receptor
autoradiographic studies have indicated the localisation of the acetylcholine and
acetylcholine-related enzymes (choline acetyltransferase and
acetylcholineesterase) in neurones of the VNC and also demonstrated high density
of both muscarinic and nicotinic cholinergic receptors in the MVN (Zanni.'ef a/.,
1995). In vitro electrophysiological studies reported that both carbach'ol and
muscarine cause dose-dependent increase in the firing rates (Ujihara et a/., 1988;
Ujihara et a/., 1989; Dutia et al., 1990; Carpenter and Hori, 1992) and membrane
depolarisation (Phelan and Gallagher, 1992) of the MVN neurones, that was
blocked by atrophine, an antagonist at the muscarinic acetylcholine receptors. The
effects of carbachol and muscarine persisted during the blockade of synaptic
transmission, indicating that they were produced postsynaptically (Ujihara et al.,
1989; Phelan and Gallagher, 1992). These results are consistent with earlier in vivo
experiments which demonstrated that application of acetylcholine results in an
increase in the discharge rates of MVN neurones, an effect that was antagonised by
the muscarinic antagonist, atrophine (Kirsten and Sharma, 1976; Ito et al., 1981).
Opioid peptides
Numerous immunohistochemical studies have demonstrated the presence of
enkephalinergic neurones and terminals in the vestibular nuclei of the brainstem
with the highest density of enkephalinergic neurones found particularly in thP MVN
(Zanni et al., 1995, Nomura et al., 1984, Finley et al., 1981, Pearson et al., 1980,
Beitz et al., 1987). These findings are supported by the results of receptor
autoradiographic investigations, which demonstrated moderate levels of S-opioid
receptor mRNAs in the medial vestibular nucleus (Mansour et al., 1994). The effects
of opioids on MVN neurones have been the subjects of several electrophysiological
studies. However the present evidence relating to the physiological effects of
opioids on the firing rates and membrane properties of vestibular neurones is
conflicting. Using single unit electrophysiological recording techniques in vitro,
Kawabata et al., (1990) demonstrated that iontophoretically applied enkephalin
inhibited the resting discharge rate and response to natural vestibular stimulation of
Type I MVN neurones in the chloralose-anaesthetised cat. They also showed that
15
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Type II MVN neurones were not affected by ionthophorectically applied enkephalin
By contrast, studies by Carpenter and Hori (1992) and Lin and Carpenter (1994)
reported that the spontaneously active rat MVN neurones in a slice preparation in
vitro were excited both by morphine and ala-leu-enkephalin, implicating both p and
5 subtypes of opiate receptors in this response, respectively. The excitatory effect of
the opioid on these neurones was probably due to direct depolarisation rather than
to disinhibition, since blockade of GABAa receptors with bicuculline did not after the
t
effect of the agonists. Furthermore, the excitation persisted after blockade of
synaptic transmission in low-Ca medium, indicating that the opioid receptors are
located postsynaptically (Lin and Carpenter 1994).
Recently, in situ hybridisation and immunohistochemical studies have
demonstrated the presence of ORL1 (opioid receptor like-1) mRNA and ORL1
receptors in MVN neurones (Anton et al., 1996, Houtani et al., 1996). However the
action of nociceptin on MVN neurones is still unknown.
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1.1.4 OPIOID PEPTIDES
A brief history of opioid receptor ligands
The opiates have their basis in more than 5000 years of medicinal use of
mekonion from the leaves and fruits of the plant or opium (from "opos," the Greek
word for juice) from the liquid, which is obtained from the unripe seed capsule of
poppy, Papaver somniferum and drying exudate. The analgesic and anti-diafrhoea
properties of opium were already recognised by the Sumerians, who inhabited the
Euphrates delta, who cultivated poppies and isolated opium. They called opium "gil,"
the lord of joy, and the poppy "hul gil" plant of joy. It appears that opium spread from
Sumeria to the remainder of the Old World including Assyria, Babylonia and Egypt.
The therapeutic use of opium was discussed by Hippocrates, Dioscorides and
Galen. Thus, "opium," "laudanum," "pulvis Doveri" and "paregoric" have been used
for centuries in western medicine. The nature of the mood changes also produced
by opium has been the basis for its non-medicinal use and abuse. In particular,
opium eating and smoking replaced the consumption of alcoholic drinking in Islamic
countries, such as Arabia, Turkey and Iran. As early as the eighth century AD, Arab
traders brought opium to India and China and it was also consumed as a favourite
substance of pleasure. Between the tenth and thirteenth centuries opium has
spread from Asia Minor to all parts of Europe. Starting in the sixteenth century,
manuscripts can be found describing drug abuse and tolerance in Turkey, Egypt,
Germany and England.
\ /
A German chemist, Friedrich Serttiner in 1806, isolated the active
component in opium and called it morphine (from "Morpheus," the Greek word for
the god of dreams), which was then used in therapy. Unfortunately, morphine has
just as much potential for abuse as opium. This prompted a great deal of effort to
develop a safer, more efficacious, non-addicting. Subsequently, in 1898, heroin
(diacetylmorphine) was synthesised and claimed to be more potent than morphine
and free from abuse liability. This was the first of such claims for novel opioids.
However, to date, none has proven valid (for a review see Brownstein, 1993).
Heroin carries ten times the potency of morphine, giving a short lasting but
extremely rapid and intense euphoria. Furthermore, heroin possesses far greater
addictive potential and remains the most notorious and abused of the opiate-derived
17
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drug. Intense research over the last two decades to understand the processes
underlying opiate tolerance, dependence and addiction led to discovery of the opioid
peptides.
Opioid peptides
Evidence for the existence of endogenous ligands for opiate receptors was
first suggested by Terenius and Wahlstrom (1975) and Hughes and Kosterlitz
(1975). Subsequently, Hughes and his collaborators successfully isolated and
characterised the sequence of two endogenous opioid pentapeptides Tyr-Gly-Gly-
Phe-Met and at lower concentration Tyr-Gly-Gly-Phe-Leu from the pig brains, and
they called them methionine [Met]-enkephalin and leucine [Leu]-enkephalin,
respectively (Hughes et a/., 1975). These were the first opioid peptides isolated
from the mammalian central nervous system. Both [Met] and [Leu]-enkephalin have
been shown to have potent opiate agonist activity when tested on mouse vas
deferens and guinea pig ileum. Soon after this discovery, it became apparent that
the sequence of [Met]-enkephalin was found on the amino terminal (N-terminal) of
another molecule, beta (P)-endorphin, a fragment of beta-lipotropin that had been
isolated and sequenced from pituitary extract (Bradbury et at., 1976; Li et at.,
1976). Following these initial discoveries many other endogenous opioid peptides
were discovered, including dynorphin A (Goldstein et al., 1979, 1981) and a-neo-
endorphin (Kangawa et al., 1981) which were structurally related to enkephalin.
All these endogenous opioid peptides have in common an N-terminal
extension of either [Met]-enkephalin or [Leu]-enkephalin sequence (Fig.1.1.4.1), for
instance, p-endorphin is a N-terminal extension of [Met]-enkephalin and dynorphin
and a-neo-endorphin are N-terminal extensions of [Leu]-enkephalin. Because of the
structural similarities of these peptides, it was postulated that p-endorphin is the
precursor of [Met]-enkephalin and that dynorphin or a-neo-endorphin is the
precursor of [Leu]-enkephalin. However, neither p-endorphin nor dynorphin or a-
neo-endorphin was the precursor of [Met] or [Leu]-enkephalin, respectively. The
discovery of these opioid peptides has suggested that the opioid peptides might
make up a family of neuropeptides. Although it was appreciated that these
neuropeptides must be synthesised in precursor form, there was no clear
18




Figure1.1.4.1:Structurofendogenousopioidpe tides Alignmentofthaminocidsequenceftendogenousopioidp t d s.Ami oacidre uho l gybetw eo i peptidesarboxe . Abbreviations:ENK,enkephalin;l ,alan ne;A g,argi i ;sasparag e;p,as t te;Cyscy t nGi ,glutam e;ly, glycine;His,histidine;l e,isoleuc ;L uleuc neyslysine;M t,methio ;Phphenylala n ;r ,ro n ;S rser e;T r, threonine;Trp,tryptophan;ytyrosi e;Val,valine.
(Source,SimonE.,1986)
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consideration on the number of opioid precursors. It later become clear by a number
of distinct techniques and approaches.
Immunohistochemical studies, initiated in the 70's and completed in the 80's
revealed the extensive distribution of opioid circuits in mammalian central nervous
system (for reviews see Cuello, 1983; Khachaturian et al., 1985). From these
studies, three distinct classes of opioid circuits were identified, [Met] andi [Leu]
✓ X
circuits, [3-endorphin circuits and dynorphin A or a-neo-endorphin circuits. These
i
studies suggested that a given neurone synthesises only one class of opioid and
there were three distinct opioid precursors.
In other studies using immunoprecipitation analysis (Mains et al., 1977), cell
free translation studies (Roberts and Herbert, 1977) and peptide microsequencing
(Chretien and Seidah, 1981), several groups independently proposed that the
pituitary hormone ACTH and opioid peptide, (3-endorphin were synthesised via a
common precursor. This precursor has been referred to as proACTH/endorphin or
pro-opiomelanocortin (POMC). Nakanishi et al., (1979) using a complementary DNA
(cDNA) technique, succeeded in sequencing POMC mRNA and confirmed the
common precursor hypothesis. Following this, the proenkephalin A (PENK, (Noda et
al., 1982b), and pro-dynorphin or pro-enkephalin B mRNA and a-neo-endorphin
were sequenced (Kakidani et al., 1982). It is now known that all mammalian
endogenous opioids are derived from these large precursor polypeptides. The three
opioid precursor polypeptides are: - /
(a) Proopiomelanocortin (POMC)
(b) Proenkephalin A (PENK)
(c) Proenkephalin B or Prodynorphin (PDYN)
Structure of endogenous opioid peptide precursors
The structural organisation of mammalian opioid precursors is shown in
figure 1.1.4.2. As a group these three opioid precursors display a number of
similarities. They range in size from 256 to 267 amino acids, and, all have a signal
sequence located at the N-terminal. The opioid peptide sequences are separated
within each precursor by sets of basic amino acids. In all precursors there is
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evidence of duplication of end product sequences. For example, in pro-enkephalin
there six copies of the [Met]-enkephalin sequence; in Pro-dynorphin the opioid
peptides, a-neo-endorphin, dynorphin A and dynorphin B, each begin with the [Leu]-
enkephalin sequence. Finally, all three precursors have a cysteine-rich region
located at the N-terminal. The number and location of cysteine residues in Pro-
enkephalin and Pro-dynorphin is very similar.
Proopiomelanocortin (POMC) ,
POMC (Fig. 1.1.4.2A) is a 263 residue protein which was the first
neuropeptide precursor protein to be isolated from the mouse pituitary cells using
double-antibody immunoprecipitation procedures by Mains et a/., (1977). Following
this, using recombinant DNA techniques, the full nucleotide sequence of the POMC
precursor was characterised from the sequence of cDNA clone of POMC mRNA by
Nakanishi and his collaborators (1979).
Of the three opioid peptide precursors, POMC is unique because it contains
only one copy of the opioid-defining amino acid sequence which is identical to [Met]-
enkephalin; this sequence is found at the aminoterminal of the most potent
endogenous opioid peptide, p-endorphin (Eipper and Mains, 1980). POMC is also
unique because it also contains other biologically active hormones that are not
related to opioid peptides. These include adrenocorticotropic hormone (ACTH) and
the three melanocytes stimulating hormones (a, p. and y-MSH) which are part of the
stress hormonal system (Mains et a!., 1977; Nakanishi et al., 1979). p-endorphin is
the only POMC product with known analgesic activity.
Proenkephalin A (PENK)
Human (Comb et al., 1982), rat (Howells et al., 1984; Yoshikawa et al.,
1984) and bovine (Mizuno et al., 1980b; Gubler et al., 1982; Noda et al., 1982a)
pro-enkephalin cDNA were cloned and sequenced in the early 80s and they appear
to be functionally identical. In contrast to the POMC precursor that contains only
one opioid peptide (p-endorphin), all of known PENK active peptides are opioid in
nature.
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The mammalian proenkephalin contains within its structure seven peptides
with methionine [Met]- or leucine [Leu]-enkephalin active core (Figure 1.1.4.2B). It is
apparent that each precursor polypeptide can be processed to generate four copies
of [Met]-enkephalin, a single copy of [Leu]-enkephalin, one copy of carboxyl
extended heptapeptide [Met]-enkephalin-Arg6-Phe7 (ENK-7) and one of the
octapeptide [Met]-enkephalin-Arg6-Gly7-Leu8 (ENK-8); each internal opioid peptide
sequence is flanked by pairs of basic amino acids that are the usual processing
signal in polyhormone precursors (Douglass et al., 1984; Loh et al., .1984).
Extended enkephalin-like peptides, such as peptides E (Kilpatrick et al., 1981;
Rossier, 1981), BAM-22P and BAM-12P (Mizuno et al., 1980a, 1980b), are also
derived from this precursor by incomplete or alternative processing.
Pro-dynorphin or Pro-neoendorphin-dynorphin (PDYN)
Kakidani et al., 1982 were the first to demonstrate that pro-dynorphin has a
mRNA sequence containing the sequence of three opioid peptides with
aminoterminal extension of [Leu]-enkephalin. The opioid peptides that derive from
pro-dynorphin include dynorphin A (Minamino et al., 1980) a-neo-endorphin
(Kangawa et al., 1981), (3-neo-endorphin (Minamino et al., 1981), and dynorphin B
(Fischli et al., 1982; Kilpatrick etai, 1982).
Biosynthesis and multiple forms of endogenous opioid peptides
Endogenous opioid peptides and other transmitters or hormones are
synthesised as a large molecular protein precursors, which are processed .within a
given cell (neural and non-neural) to produce smaller active fragments. This
process depends not only on the genetic code for the precursor, but also on the
program that directs the cellular enzymes to cut out or cleave the peptide from their
respective precursor. As will be discussed in brief, the separations of the peptides
from its large precursor by proteolytic cleavage are called post-translational
processing events, i.e. events following the translation of messenger RNA into a
protein precursor. These post-translational events are capable of determining the
exact mixture of peptides in a given cell. Nevertheless, the processing is not
uniform, depending on the tissue examined and the physiological status of the cell.
Most endogenous opioid peptides are produced from their precursor by proteolytic
cleavage at double basic amino acid residues (Lys-Arg, Lys-Lys, Arg-Arg, Arg-Lys,
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although there are at least two opioid peptides, dynorphin A and dynorphin B that
deviate from this classical pathway in that they are produced by processing
mechanism that involves cleavage at a single basic arginine residue (Fig. 1.1.4.2C;
Docherty and Steiner, 1982; Weber et a/., 1983).
Anatomy of opioid system in the CNS
Most known endogenous opioid peptides are generated from the three
precursor polypeptides which are widely distributed throughout the central nervous
system (CNS). Immunocytochemical techniques and in situ hybridisation analysis
have been used extensively to visualise and map the distribution of opioid peptides
in particular neuronal pathways (Bloom et at., 1978; Khachaturian et at., 1982,
1985; Watson et at., 1982a, 1982b, 1983; Lewis et al., 1983; Merchenthaler et al.,
1986; Lantos et al., 1995). Distribution maps comparing the localisation of the three
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Figure 1.1.4.2 : Schematic representation of the structure of the
mammalian opioid precursors.
Note that the [Met]-enkephalin appears in both POMC and PENK, while
[Leu]-enkephalin is common to both PENK and prodynorphin. The paired
and single basic amino acids that serve as processing sites are indicated
as vertical line(s). MSH, melanotropin; ACTH, adrenocorticotropic LPH,
lipotropin; CLIP, corticotropin-like intermediate-lobe peptide.
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Figure 1.1.4.3 : Schematic representation of the distribution of POMC, PENK and
prodvnorphin derived peptides in the rat CNS.
(After Khachaturian H., 1985)
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1.1.5 OPIOID RECEPTORS
Endogenous opioid peptides and opiates like morphine exert their
pharmacological and physiological effects on the target tissues by specifically
binding to membrane-bound receptors called opioid receptors. The opioid receptors
can be classified into three distinct receptor types namely mu (p), delta (8) and
kappa (k), which are unevenly distributed throughout central and peripheral nervous
system. Each of these receptors has specific pharmacological effects and h^s been
associated with specific functions (Simon, 1991; Lutz and Pfister, 1992; Mansour et
al., 1995; Dhawan et a!., 1996).
Opioid Receptors Multiplicity
The existence of multiple types of opioid receptor was suggested in 1965 by
Portoghese based on the relationship between the molecular structure of opiate
drugs and their analgesic activity. Subsequently, opioid receptors were
demonstrated in the brain by radioligand binding studies showing that radiolabeled
opioid drugs, selected for their high potencies, bound to brain tissues with high
affinity and that this binding was stereoselective (Pert et al., 1973; Simon et al.,
1973; Terenius, 1973; Gilbert and Martin, 1976; Martin et al., 1976).
On the basis of various pharmacological effects of morphine and its
derivatives (ketocyclazocine and SKF-10047) in experiments carried out in chronic
spinal dog, Martin and his colleagues (1976), systematically showed the first
definitive evidence supporting three opioid drug syndromes into which opioids could
be divided. Furthermore, this study showed that the dependence produced by these
drugs was suppressed by drugs within the same group but that abstinence
symptoms would develop or might even be participated by administration of drugs
from outside this group. In the light of these results, they defined the existence of
three opioid receptor types, mu (p), kappa (k) and sigma (a) associated with three
prototypic agonists morphine, ketocylazocine and SKF 10047 (N-
ailynormetazocine), respectively. However, the a receptor is no longer considered
part of the opioid family since subsequent study demonstrated that the a syndrome
associated with SKF 10047 is not blocked by the general opioid antagonist naloxone
(Quirion et al., 1987).
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After the discovery of enkephalin, Lord et al., (1977) postulated another type
of opioid receptor since enkephalin seemed to bind to another type of opioid
receptor. Using an in vitro bioassay system, they found that morphine showed high
potency compared to enkephalin in inhibiting the electrically induced contractions of
the myentric plexus of the guinea pig illeum while in the isolated mouse vas
deferens, enkephalin exhibited greater potency than morphine. This reversal in the
order of agonist potency observed between the two tissues indicates that different
types of opioid receptors predominate in the two systems. The major receptor
present in the guinea pig ileum was then called p to resemble Martin's p- receptor,
while the receptor in the mouse vas deferens was called delta (8) (for deferens).
The occurrence of multiple types of opioid receptor (p, 5, k) is now generally
acknowledged, although there is some evidence to suggest that additional opioid
receptors may exist. In particular, the epsilon receptor (e, Wuster et al., 1979), the
zeta (£, Zagon et al., 1991) and a high affinity binding site, lambda (A, Grevel et al.,
1985), may also be parts of the opioid receptor system. The actual number of
different opioid receptors is one of the major controversies of opioid receptor
pharmacology. The p-, 5- and K-opioid receptors have been identified by their
different selectivity for various naturally occurring opioid peptide and alkaloid opioid
ligands, and this subdivision has been substantially supported by the development
of increasingly selective synthetic ligands (for a review see Goldstein et al., 1989).
Some of the opioid receptor ligand agonists and antagonists are presented in 1.2.5.
In addition, pharmacological studies have suggested the existence of different
subtypes of the classical p-, 8- and K-opioid receptors (for reviews see, I_lutz and
Pfister, 1992; Traynorand Elliott, 1993; Dhawan et al., 1996; Zaki etai, 1996).
Molecular Basis of the Structure of Opioid Receptors.
Early studies suggesting the existence of multiple opioid receptor types have
been extended by numerous anatomical, pharmacological, biochemical, and
behavioural studies demonstrating distinct opioid receptor types in the central and
peripheral nervous system.
These findings have led several investigators to isolate and purify opioid
receptor proteins from cell membranes. Vigorous work in several laboratories
resulted in the purification to homogeneity of p-, 8- and K-opioid receptor proteins
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(for reviews, see Simon, 1986; Loh and Smith, 1990). However, none of these
attempts revealed the structures of the proteins that were pharmacologically defined
as opioid receptors primarily because of the low density of opioid receptors in
tissues. Ultimately, two independent groups, Kieffer et al., (1992) and Evans et al.,
(1992) succeeded in identifying the structure of the 8-opioid receptor without
purifying the protein. They cloned the cDNA encoding mouse 5-opioid receptor form
NG108-15 cells by expression cloning with radiolabeled 8-opioid ligands (Evans et
al., 1992; Kieffer et al., 1992). Subsequently, p- (rat: Chen et al., 1993; Fukuda et
r -
al., 1993; Thompson et al., 1993; Wang et al., 1993; Minami et al., 1994; mouse:
Min et al., 1994) and K-opioid receptor cDNAs (rat: Li et al., 1993; Meng et al., 1993;
Minami et al., 1993; Nishi et al., 1993; mouse: Yasuda et al., 1993) were cloned
based on their homology to the clone 8-opioid receptor. Other receptor cDNAs
thought to belong to this gene family have also been cloned including isolation of a
novel cDNA encoding a putative membrane receptor with high homology to the
cloned classical jla, 8 and k opioid receptors (Bunzow et al., 1994; Chen et al., 1994;
Fukuda et al., 1994; Wang et al., 1994; Wick et al., 1994).
They revealed that the three cloned opioid receptors are members of the
ever-growing family of seven transmembrane G-protein-coupled receptors, which
includes other peptide receptors such as somatostatin, substance P and
vasopressin as well as nonpeptide receptors. The amino acid sequences of the |i-,
8- and K-opioid receptors are extremely homologous (approximately 70% homology)
to one another at both amino acid and the nucleic acid levels, and that these
similarities are highly conserved across species («90%). Highest homology between
the receptor protein is found in regions spanning the transmembrane domains and
intracellular loops. The most pronounced divergent regions of these three receptors
are found at the amino (N-) and carboxyl (COOH-) termini, at the transmembrane 4
as well as extracellular loops 2 and 3. Transfection of the cloned receptors in
heterologous cell lines suggests that they are negatively coupled to adenylate
cyclase via Gi.
Well before the cloning of the opioid receptors, it was known that the opioid
receptors are couple to G proteins and have seven transmembrane segments
(Dohlman et al., 1987). The evidence that the opioid receptors belong to the family
of G-protein-coupled receptors includes; the binding of opioid receptor agonists, but
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not the opioid receptors antagonists, is regulated by guanine nucleotides (Childers,
1991). Secondly, hydrolysis of guanine nucleotides is stimulated by opioid receptor
agonists; this was originally shown in neuronal membranes, but has also been
observed with purified and reconstituted p-opioid receptor protein and G-protein
(Ueda et al., 1991). Finally, cellular responses to opioid receptor agonists (example,
opening of K+ channels, inhibition of adenylyl cyclase) require GTP and are blocked
by pertussis toxin (Aghajanian and Wang, 1986; North et al., 1987; Louie,>'ef al.,
1990), which ribosylates a cysteine residue in certain G proteins. '
Anatomical distribution of opioid receptors
Opioid receptors consist of three distinct types namely p-, 5- and x-opioid
receptors. Each of these receptors has a characteristic distribution in the central
nervous system. Numerous autoradigraphic and in situ hybridisation studies have
been performed to map the localisation of p-, 5- and x-opioid receptor binding sites
and mRNAs in the central nervous system (McLean et al., 1986; Mansour et al.,
1987; Tempel and Zukin, 1987; Mansour et al., 1988, 1994, 1995). Both techniques
demonstrate a distinct anatomical distribution that corresponds well to one another.
These studies not only provide insight into the cellular localisation but also
demonstrate the neuronal circuits they may modulate. Figure 1.1.5.1 shows
schematic distribution of p-, 8- and x-opioid receptor mRNA expression and binding
in the rat CNS (Mansour et al., 1995).
Functional roles of the opioid receptors
Despite various studies of opioid actions in the brain, it is still difficult*to draw
a strong conclusion regarding the functional roles of the different types of opioid
receptors in any neuronal system. However, significant progress has been made in
several systems. Briefly, p-opioid receptors, which are particularly enriched in the
striatum, thalamus, hippocampus, the nucleus of the solitary tract, locus coeruleus
and spinal cord, have been associated with analgesia, respiratory and
cardiovascular functions, as well as a number of hormonal actions. 5-opioid
receptors, which are expressed at high levels in many forebrain areas, including the
olfactory bulb, neocortex, striatum, hippocampus and amygdala, in addition to the
midbrain pontine nuclei and dorsal horns of the spinal cord, have been primarily
associated with analgesia, gastrointestinal motility and thermoregulation. While the
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nucleus accumbens, hypothalamus, amygdala, and parallel the p- distribution in the
brainstem and spinal cord, have been strongly associated with analgesia and
maintaining water balance as well as other neuroendocrine functions and
behaviours (for a review see, Akil et al., 1993).
Opioid peptides-receptors relationship
The three opioid receptor systems in the central nervous system can be
stimulated by one or more of the endogenous and exogenous opioid peptides, (table
1.1.5.1). Endogenous opioid peptides are derived from three separate precursor
molecules as a result of post-translational enzymatic processing. POMC is the
precursor from which p-endorphin is derived; PENK gives rise to [Met]- and [Leu]-
enkephalin; and PDYN serves as the precursor for dynorphin and its related
peptides. This multiplicity in both systems raises questions as to the relationship
between the various opioid peptides and opioid receptors. A great deal of work has
been carried out to demonstrate and to analyse actions of opioids with respect to the
particular receptors and ligands involved (for a review see Corbett et al., 1993).
p-endorphin, a POMC-derived peptide product, binds equally well to p- and
5-receptors and possibly to s-receptor (Shook et al., 1988). Likewise, PENK
products, [Met]- and [Leu]-enkephalin have the highest affinity for 8-opioid receptors,
but can also bind to p-opioid receptors (Davis et al., 1985). Prodynorphin products,
such as p-neoendorphin and dynorphin A, have high affinity for K-opioid receptors
(Chavkin et al., 1982). However shorter prodynorphin products (dynorphin A(l-8), a-
neoendorphin) appear to bind well to other opioid receptors, particularly in the rat
brain where there is predominance of p and 8-opioid receptors (Quirion and Pert,
1981; Wuster et al., 1981;Schulz et al., 1982).
The three opioid receptor subtypes also represent targets for exogenous
opioid peptides. Many peptides and alkaloid like compounds showed high affinity
and selectivity for the various opioid receptors, and have become available in recent
years. As indicated in table 1.1.5.1, morphine and synthetic peptides, DAGO and
DAMGO have a high affinity and selectivity for the p-opioid receptor (Handa et al.,
1981), thus representing exogenous p-opioid receptor ligands. On the other hand,
synthetic peptides such as DPDPE and U69593 are highly selective for 8- and k-
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opioid receptors, respectively (Mosberg et al., 1983; Lahti et al., 1985). In addition,
several opioid receptor antagonists have been synthesised. Naloxone, naltrexone
and nalmefene are "non-selective" antagonists in that they interact not only with p-
opioid receptors, but also interact with 8- and K-opioid receptors, despite with lower
affinity in case of naloxone and naltrexone (DeHaven-Hudkins et al., 1990). Other




PEPTIDELIGAN SFOROPIORECE TO S
OPIOIDRECEPTORTY EENDOG NOUSEX GENOUSANTAGONISTS LIGANDSLIGANDS
NON-SELECTIVESELECTIVE
p-endorphin Enkephalins Dynorphin
Morphine DAGO DAMGO DPLPE DPDPE DELTROPHIN U50488H U69593
CTOP CTAP
Naloxone Naltrexone Nalmefene
ICI174864 Naltrindole p-Funaltrexamine Nor-binaltrophimine
CTOP:D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NHi;CTAP:D-Phe- ys-Tyr-D- rp- rg- hr-Pen-Thr-NhL;DAGO:Tyr-D-Ala Gl -MePh -Gly-ol;DAMGOTry-D-Ala G y-MePhe-NHfCH^OH DELTROPHIN:Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NHj;DP PE:Try- -Al Gly-Phe D-Leu;DP E:Try- - en-G y-Phe-D-Pen;(Pen-pencillamine) IC1174864:N,N-dially-Tyr-Aib-Aib-Phe-Leu;(Aib:Aminoiso utyrate)Naltrindol :^-cyclopropylmethyl-eT-dehydro^.S-epoxy-S.M-dihydroxy-eT^'.S'-indolmorphinan; Nor-binaltrophimine:17,17'-i>/s(cyclopropylmethyl)-6,6'l7,7'-tetradehydro-4,4',5,5'-diepoxy-6l6'-(imino)(7,7'-bimorphinan)-3,3'l14,14'-tetrolhydro lorideyd t ; U50488H:frans-(+)-3,4-dichloro-A/-methyl-[2-(1-pyrrolidinyl)cyclohexyl].benzeneacetamidemethan sulp o t ;U69593:5a,7a,8|T(-)-A/-methyl-N-[7-(1-pyrrolidinyl)-1- xaspiro(4l5)dec-8^yl]-benzen ac tamide;
(AdaptedfromHerz.,1997)
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1.1.6 CELLULAR MECHANISMS OF ACTION OF OPIOIDS
The biological effects of opioids begin with the binding of agonist to their
endogenous receptors and end with series of cellular responses. Within this, a
series of complex transduction steps takes place, which translates the action of
receptor binding into biological responses. It has now been shown that all three
opioid receptor types are coupled to G-proteins, and many of these transductions
utilise this coupling protein to activate all three of the well recognised effector
systems; i.e. adenylate cyclase, calcium channels and potassium channels. >
Adenylate cyclase
Coupling of the opioid receptors to the inhibitory system of adenylate cyclase
has been studied in transformed cell lines and in brain membranes (for a review
see, Childers, 1993). The hybridoma cell line NG108-15, consisting of mouse
neuroblastoma N18TG-2 and rat glioma C6Bu-1, has been an excellent model
system to study the mechanisms of opioid receptor coupling to adenylate cyclase
(Sharma et al., 1975,1977; Traber et al., 1975). The pharmacological characteristics
of these opioid sites correspond to 8-opioid receptor types (Chang et al., 1978,
1981). Other transformed cell types, including N4TG1, N1E-115 and N18TG2 cells,
also have been identified as expressing the 8-opioid receptor type as well as 8-
inhibited adenylyl cyclase (Gilbert and Richelson, 1983). In all of these cell lines,
opioids inhibit both basal and prostagladin ETStimulated adenylate cyclase activity.
Incubation of NG108-15 cells with pertussis toxin abolishes the inhibition of
adenylate cyclase by opioids (Burns et al., 1983; Hsia et al., 1984), suggesting that
Gi (or G0) protein is coupled to these opioid receptors to exert their inhibitory activity.
The coupling of p and 8 opioid receptors to the inhibitory system of adenylate
cyclase has been demonstrated also in the brain using membrane preparations
derived from several brain regions including striatum (Collier and Roy, 1974),
thalamus (Childers, 1993) and preaqueductal gray (Fedynyshyn and Lee, 1989).
The inhibition of adenylate cyclase activity by K-opioid receptor agonists has been
demonstrated in membranes from rat spinal cord neurones (Attali et al., 1989) and
in the guinea pig cerebellum (Konkoy and Childers, 1989).
The cloned p-, 8- and K-opioid receptors expressed in COS or CHO cell lines
are also coupled to the inhibitory system of adenylate cyclase (Evans et al., 1992;
Chen et al., 1993; Meng et al., 1993; Wang et al., 1993; Yasuda et al., 1993). The
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inhibitory effects of opioid agonists on this system in the CHO cells expressing p-, 5-
and K-opioid receptors are blocked by pertusis toxin, indicating that Gi (0) were
required for the inhibitory effect.
Calcium (Ca2+) channels
One of the cellular events that underlies the effect of opioids in reducing
cellular excitability and neurotransmitter release is the inhibition of voltage-
dependent Ca2+ channels (for reviews see, North, 1986, 1987; Grudt and Williams,
1995). It has been shown that opioid receptor agonists for p.-, 8- and K-opioid
receptors can inhibit Ca2+ currents in various preparations, including a human
neuroblastoma cell line (Seward et al., 1991), dorsal root ganglion cells (Macdonald
and Werz, 1986; Gross and Macdonald, 1987; Schroeder et al., 1991), and guinea
pig submucosal neurones (Shen and Surprenant, 1990; Surprenant et al., 1990).
This inhibition of Ca2+ currents by opioid receptors is blocked by pertussis toxin
(Surprenant et al., 1990; Seward et al., 1991), indicating the involvement of Gr
and/or G0-proteins. Hescheler et al., (1987) revealed that G0 is more effective than
Gi in reconstituting the inhibitory actions on Ca2+ channels in the cells pretreated
with pertussis toxin.
The cloned K-opioid receptor expressed in PC12 cells couples with the Ca2+
channel system to inhibit Ca2+ conductance through N-type channels (Tallent et al.,
1994). Functional coupling between the cloned K-opioid receptor and N-type
channels has been identified in Xenopus oocyte system. The K-opioid agonist
U50488H inhibited Ca2+ channels in Xenopus oocytes co-injected with in vitro
transcribed mRNAs encoding the K-opioid receptor and a1-and p-subunife of the
Ca2+ channel (Kaneko et al., 1994).
Potassium (K+) channels
Another cellular event, which is thought to be an important effect of opioids in
reducing cellular excitability and neurotransmitter release is the membrane
hyperpolarisation caused by an increase in K+ conductance (for reviews see, North,
1986, 1993; Grudt and Williams, 1995). Activation of p-, 5- and K-opioid receptors
leading to an increase in K+ conductance has been observed in neurones from
various regions of the mammalian nervous system such as locus coeruleus and
submucosal plexus (North et al., 1987), hippocampus (Wimpey and Chavkin, 1991)
as well as substantia gelatinosa neurones (Grudt and Williams, 1993). The K+
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channels that are activated have many properties of the inward rectifier family of
channels. This increased in inwardly rectifying K+ conductance caused by activation
of opioid receptors are sensitive to pertussis toxin, indicating mediation through Gr
and /or G0-proteins (Tatsumi et al., 1990). Opioid receptors are also commonly
coexpressed on cells with other G-protein coupled receptors, such as a2-
adrenoceptors, muscarinic acetylcholine M2, somatostatin and GABAb receptors,
whose activation also opens K+ channels. Indeed, Shen et al., (1992) demonstrated
that all three opioid receptors could couple to a single K+ channel in an excised
f >'
patch of membrane.
The increased in K+ conductance by the activation of opioid receptors has
been confirmed using Xenopus oocytes system, in which the cloned n-, 8- and k-
opioid receptor and G-protein-activated K+ channel are co-expressed (Chen and Yu,
1994; Ikeda et al., 1995; Kovoor et al., 1995). They showed that these increases of
K+ conductance were also blocked by pertussis toxin.
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1.2 AIMS OF STUDY
Electrophysiological studies in various areas of the mammalian central
nervous system have shown that activation of opioid receptors predominantly
results in an inhibition of the neuronal firing of action potentials. The inhibitory
actions of opioids occur either directly through membrane hyperpolarisation which is
associated with the potentiation of potassium conductances in the post-synaptic
neurones (for reviews see, Duggan and North, 1983; McFadzean, 1988; Grudt and
Williams, 1995) or through activation of presynaptic opioid receptors which, when
activated result in a reduction of excitatory neurotransmitter release from pre¬
synaptic nerve terminals (Bixby and Spitzer, 1983; Von Kugelgen et al., 1985; Pan
et al., 1990). The particular opioid receptor subtype associated with the inhibition
mediated by an increase in membrane potassium conductances has been reported
elsewhere as a p-opioid receptor in rat locus coeruleus neurones (Williams and
North, 1984; Wimpey and Chavkin, 1991) and neurones of the dorsomotor vagal
nucleus (Travagli et al., 1995), 8-opioid receptor in rat dentate gyrus of the
hipocampus (Piguet and North, 1993) and K-opioid receptor in guinea-pig
substantial gelatinosa neurones (Grudt and Williams, 1993).
Numerous immunohistochemical studies have demonstrated the presence of
enkephalinergic neurones and terminals in the vestibular nuclei of the brainstem
with the highest density of enkephalinergic neurones found particularly in the medial
vestibular nucleus (MVN; Pearson et al., 1980; Finley et al., 1981; Nomuta et al.,
1984; Beitz et al., 1987; Zanni et al., 1995). Together with these findings is the
result of receptor autoradiographic investigations, which demonstrated the presence
of opioid receptor sites in the vestibular nuclei complex (Pearson et al., 1980;
Wamsley, 1983; Zanni et al., 1995) and moderate levels of 8-opioid receptor
mRNAs have been observed in the medial vestibular nucleus (Mansour et al., 1994;
Mansour et al., 1995).
The effects of opioids on MVN neurones have been the subject of several
electrophysiological studies. However the present evidence relating to the
physiological effects of opioids on the firing rates and membrane properties of
vestibular neurones is conflicting. Using single unit extracellular recording
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techniques in vivo, Kawabata et a!., (1990) demonstrated that iontophoretically
applied enkephalin inhibited the resting discharge rate and response to natural
vestibular stimulation of Type I MVN neurones. By contrast, Carpenter and Hori
(1992) and Lin and Carpenter (1994) reported that the majority (30% of neurones
sampled) of tonically active rat MVN neurones recorded in a slice preparation in
vitro were excited both by morphine and ala-leu-enkephalin, implicating a role for
both p. and 8 subtypes of opiate receptors in this response. A minority of MVN cells
were inhibited by morphine and enkephalin, while other cells showed b'iphasic
responses to these agonists where the brief excitatory effects were followed by a
longer-lasting inhibition more typical of that seen in other neuronal cell types. These
effects were obtained in response to 1-sec iontophoretic application of the agonists
to the slice, and persisted after blockade of synaptic transmission in low-Ca medium
and during blockade of GABAa receptors using bicucullin, indicating that the opioid
receptors were postsynaptic and that the excitation produced by opioid agonists,
morphine and enkephalin was due to direct depolarisation rather than to
disinhibition (Lin and Carpenter, 1994).
While the actions of opioids in the mammalian central nervous system are
predominantly inhibitory, the physiological evidence thus disagrees as to the
functional effects of opioids in the mammalian MVN neurones as to whether their
effect are inhibitory or excitatory. However, an excitatory neuronal response to
opioids has been reported in the Renshaw cells of the spinal cord (Duggan et al.,
1976; Hill et al., 1976) and in the cerebral cortex (Satoh et al., 1974). Mbreover,
none of these findings have shown that the opioid-induced response was a direct
excitation of the neuronal membranes or whether it was not due to disinhibition. An
important objective of the experiments described here was therefore to clarify the
opioid actions on MVN neurones and to determine their mechanisms of action using




Preparation of the Horizontal Slices of the Dorsal Brainstem In Vitro
Experimental animals.
Animal care and experimental procedures were carried out in accordance
with the UK legislation for the humane care and the use of laboratory animals. Male
Sprague-Dawley rats (Bantin and Kingman, Hull, UK) weighing between 60 t6 180g
were used throughout the study. They were housed with littermates of 10-15 per
cage in an environmentally controlled animal facility: - constant room temperature of
21-23°C, relative humidity of 50-60%, 12 hours light/12 hours dark cycle, with food
and water available ad libitium. The rats were kept for at least 2-3 days upon arrival,
before being used for experiment, in order to accustom them to handling and to
minimise the effects of non-specific stress.
Slice preparations.
Prior to decapitation, animals were anaesthetised with halothane (Fluothane,
May and Baker Ltd., UK) by inhalation. The anaesthetic was administered by
placing the animal in a small Perspex box containing a piece of halothane-soaked
cotton wool. A sufficient level of anaesthesia was determined by a lack of reflex
responses to a paw or tail-tip pinch. While under anaesthesia, the animal was
decapitated using a small animal guillotine and rapid craniotomy was performed:
With a pair of scissors the scalp was removed, including the external ears
and the neck muscles. With fine bone ronguers the occipital bone was then
removed, exposing the cerebellum. The parietal and frontal bone were divided by a
cut in the midline and the cranium was lifted away from the brain by carefully
inserting blunt-ended forceps or scissors. The dura was cut and peeled to the edges
of the skull with fine scissors. The head was then tilted sideways, and the intact
brain was gently lifted up with a fine spatula, hence exposing the cranial nerves.
These were also cut close to their point of exit from the brain. Finally, the whole
brain was gently rolled into a beaker containing approximately 100ml of ice-cold
(4°C), oxygenated (95% 02 / 5% C02) artificial-cerebrospinal fluid (aCSF; for
composition see solutions and chemicals). After about a minute in the beaker, the
brain was then placed on its rostral surface on a cold dissecting stage which
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comprised of a piece of filter paper moistened in ice-cold oxygenated aCSF placed
on the surface of an upturned petri dish on ice.
The cerebrum was removed and the brainstem extending from the inferior
colliculi to the obex was blocked with a sharp razor blade. The cerebellum was then
removed by gently lifting it away from the brainstem with the blunt edge of scalpel
blade and cutting through the cerebral penduncles, consequently exposing the
MVN. The MVN were easily recognised from surrounding structures by their'darker
grey area and oval shape on the dorsal floor of the brainstem, symmetrically located
on the floor of the fourth ventricle. During these procedures, the brain tissue was
kept moist by periodic bathing with aCSF, which was also kept on ice and
continuously oxygenated. Slices were cut on a motorised vibrating tissue chopper,
Vibroslice made by Campden Instruments, London, UK.
The block of brainstem containing the MVN was cemented on the stage of
the Vibroslice stage with cynoacrylate glue. The stage was positioned in the
Vibroslice reservoir and filled with ice-cold oxygenated aCSF. Horizontal slices
containing entire rostro-caudal length of the MVN were cut by advancing the
reservoir in the horizontal direction. After removal of superficial layers of the dorsal
brainstem about 100-200 pm, 1-2 slices were cut through the MVN at 300-400pm
thickness. They were immediately removed to a small petri dish of ice-cold
oxygenated aCSF. Finally, the slice was bisected along the midline to obtain 2
preparations containing the individual nucleus of the left and right side.
\ I
Maintenance of the Slice in the Chamber.
Following the slicing procedure, a single slice containing the MVN was
quickly transferred to a Haas type interface recording chamber (Haas et al., 1979)
as illustrated in figure 1.3.1, which located in a Faraday cage and supported on an
optical table isolator (Intracel, UK). The slice was positioned on the fine nylon mesh
on the ramp surface of the recording chamber which sat above a thermostatically
controlled water reservoir at the temperature of 33 ± 0.2 °C. The water bath was
gently bubbled with 95% 02 / 5% C02 to produce a continuous stream of gas
saturated with water vapour which flowed over the slice through a small port at the
head of the recording chamber.
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A peristaltic pump (Miniplus 2, Gilson) was used to drive the oxygenated
aCSF through the water bath to the recording chamber at the rate of approximately
1.8ml/min via PVC tubing (Bore: 1.5mm; WalM.Omm). Hence, the slice was
maintained at the interface between a thin layer of flowing pre-warmed oxygenated
aCSF and a layer of flowing 95% 02 / 5% C02 gas saturated with water vapour. It
took about one and half minutes for the aCSF flow into the recording chamber to
exchange completely. The whole procedure from decapitation to the placerhent of
the slice in the recording chamber lasted about 15 minutes and the slice was
incubated for at least an hour prior to recording.
Solutions and Chemicals.
The following solutions and chemicals were used in this study: -
Artificial cerebrospinal fluid (aCSF) and modified low Ca2+/high Mg2+ aCSF.
The normal physiological artificial cerebrospinal fluid (aCSF) (Llinas and
Sugimori, 1980) used for preparing the brain slices and initial filling of the recording
chamber was prepared fresh at the beginning of experiment and had the following
composition (in mM); Sodium Chloride (NaCI) 124, Potassium Chloride (KCI) 5,
Potassium dihydrogen orthophosphate (KH2P04) 1.2, Magnesium sulphate (MgS04)
1.3, Calcium Chloride (CaCI2) 2.4, Sodium bicarbonate (NaHC03) 26, D-glucose 10,
and continuously bubbled with 95% 02 / 5% C02.
i
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A modified low Ca2+/high Mg2+ aCSF (Lin and Carpenter, 1994; Lu et al.,
1995) was used in series of experiments to eliminate chemical synaptic
transmission by reducing the concentration of Ca2+ and increasing the concentration
of Mg2+ to 0.1 mM and 6.3mM respectively.
Opioid agonists and antagonists
For the pharmacological experiments on opioids, 1.0 mM stock solution of
opioid agonists and antagonists were made in distilled water, divided into small
aliquots of 1.0ml and frozen at -20 °C until required. Opioid agonists and
antagonists used in this experiment were obtained from various sources. The
selective 5-opioid receptor agonists, [D-Ala2, D-leu5]-enkephalin (DADLE) and [D-
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Figure 1.3.1 : Haas-type interface recording chamber
300 pm thick MVN slice (S) is placed on the nylon mesh on the ramp
surface of the chamber and superfused with prewarmed (33 ± 0.2°C)
oxygenated (95% 02, 5% C02) aCSF supplied via the inlet PVC tubing
(1) and entering the chamber at 2. The water bath (3), filled witf}
distilled water to the level indicated by the dashed line, is heated by
thermoplate (4) and maintained at 33 ± 0.2°C by probe (5) connected
to themoregulator. The heated distilled water is bubbled with a gas
mixture (95% 02, 5% C02) through water bath at E, and the water
vapour produced enter the slice through an outlet in the ceiling of the
chamber (6). aCSF is drained from the chamber by the cotton wick (7)
and enter the collecting beaker at 8 and sucked out by the outlet
PVC tubing to the waste reservoir.
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Pen2,Pen5]-enkephalin (DPLPE); the selective k-opioid receptor agonist, U50.488H
and the highly selective p-opioid receptor agonist, [D-Ala2 ,N-Me-Phe4, Gly5-ol]-
enkephalin (DAGO) were purchased from Sigma (UK). The p-opioid receptor
agonist, morphine was obtained from The Royal Infirmary, Edinburgh, UK. The non¬
selective opioid receptor antagonist, naloxone and the highly selective S-opioid




DADLE is known to be a selective agonist at the 8-opioid receptor, having a
K, of 2.1 nM at 8 receptors compared to a K; of 14 nM at p-receptors and 16000 nM
at k receptors (James and Goldstein 1984, Corbett et al., 1993). The highly
selective S-opioid receptor, DPLPE has K| value of 2.8 nM at 8-receptors compared
to Kj of 710 nM at p-receptors and >15000 nM at k-receptors (Mosberg et al., 1983;
Corbett et al., 1993). The arylacetamide U50.488H is a highly selective k-opioid
receptor agonist synthesized by the Upjohn Company and has a K; of 0.69 nM at k-
receptors compared to a K, of 435 nM at p-receptors and 9200 nM at 8-receptors
(Lahti et al., 1982; Corbett et al., 1993). The alkaloid morphine has approximately
50-fold higher affinity for p-opioid receptors than for 8-opioid receptors with Ki of 1.8
nM at p-receptors compared to 90 nM at 8-receptors and 317 nM at k-receptors.
The enkephalin analogue DAGO which is commonly used selective p-opioid
receptor agonist has the Kj of 1.9 nM at p-opioid receptors compared to 345 nM at
8-receptors and 6090 nM at k-receptors (Handa et al., 1981; Corbett et al., 1993).
Ion channel blockers
Two different ion channel blockers purchased from Sigma, UK, were used in
this study: -
(1) Tetrodotoxin (TTX) was used at the concentration of 0.5 - 1.0 pM to block
voltage-gated sodium channels, and
(2) Tetraethylammonium bromide (TEA) was used at the concentration of 20 mM to
block voltage-gated potassium channels.
Both TTX and TEA were dissolved in distilled water to give a stock solution of




Aliquot of opioids and ion channel blockers were thawed and diluted to their
final concentration in the appropriate volume of oxygenated aCSF immediately prior
to use, placed in the 10ml or 20ml syringes connected to the inflow of the interface
chamber and applied to the slice by switching the perfusion inlet tube to the desired
solution by means of 3-way taps so that the perfusion rate did not change. All opioid
agonists were applied to the slice for a period of 60 seconds whereas opioid
I
antagonists and ion channel blockers were applied continuously for at least 5-20
minutes before the next application of agonists.
Electrophysiological Recordings
There were two kinds of electrophysiological recording techniques
conducted throughout this study. Extracellular recording technique was performed
in the first part of the study in order to clarify the normal physiological actions of
different type of opioid peptides on the spontaneously active MVN neurones as well
as to determine the subtype of opioid receptor involved. In the second part of the
study, current and voltage clamp experiments were conducted using whole-cell
patch-clamp recording technique to investigate the mechanism of action of opioid
peptides on the membrane currents of rat MVN neurones.
Recording set-up.
Conventional electrophysiological equipment was used for recprding,
storage and analysis of electrophysiological data. The electrophysiological s^tem is
illustrated diagrammatically in figure 1.3.2. A high input impedence amplifier,
Axoclamp 2A (Axon Instruments, Foster City, CA City, USA), amplified the signals
from the electrodes with an output bandwidth filter upper limit set at 3 or 10kHz. The
currents and voltage (x10 gain) outputs from the Axoclamp 2A amplifier were
simultaneously displayed on a 20 MHz digital storage oscilloscope (HM 205-3,
Hameg, German) and monitored continuously. The voltage output was also sent to
a NeuroLog system (Digitimer, UK) and to a CED 1401 Plus interface and a













Figure1.3.2:Schematicrepresent tionoftelectro hysiologicalequi m tfoextracellu arandwhole-cellr c rd ng
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The NeuroLog system consisted of a filter module (low frequency cut-off
500Hz and high frequency cut-off 5000Hz), an audio amplifier module, a high gain
AC amplifier set at a gain of 1000 and a spike discriminator/triggering module. Prior
to entering the DigiData 1200 interface, both current and voltage signals were
amplified with a gain of x10 and x2 respectively by a conditioning amplifier to
optimise digitisation of the signals. In intracellular whole-cell patch clamp
experiments, current commands were generated either by the computer using
pCLAMP 6.0.2 software from Axon instruments (Foster city, CA, USA) ,dr by a
Digitimer D4030 pulse generator (Digitimer, UK). All experimental data were stored
for off-line analysis on the computer hard disk and also recorded on VHS video
cassettes using a VR-10B digital recorder (Instrutech Corp, USA) and as a
hardcopy on Gould TA 240 (GOULD instrument systems ltd, UK) chart recorder.
Recording electrodes and electrode-filling solutions
Extracellular and intracellular whole-cell patch-clamp recordings of
spontaneously active MVN neurones were made using filamented standard-wall
borosilicate glass microelectrodes (1.5mm outer, 0.86mm inner diameter; Clark
Electromedical Instruments, UK). They were fabricated in three stages on a Flaming
/ Brown horizontal programmable microelectrode puller, Model-P87 (Sutter
Instruments, UK) and had tips that were 1-2 pM in diameter. The extracellular
microelectrodes were back-filled with 2M sodium gluconate (resistance 10-20 MQ),
while for the intracellular whole-cell patch-clamp microelectrodes, they were, back¬
filled with filling solution that is different from extracellular filling solutiqn and
containing (mM) 145 potassium gluconate, 2 MgCI2, 5 K2ATP, 0.1 ethylene glycol-
bis (p-amino-ethyl-ether)-A/,A/,A/,'A/'-tetraacetic acid (EGTA), and 5 A/-2-
hydroxyethylpiperazine-A/'-2-ethanesulfonic acid (HEPES; pH 7.2, osmolarity
adjusted to 290 mosmol, after Kinney et al., 1994) immediately before being used.
The intracellular filling solution used through out this study was designed such a
way to mimic the intracellular milieu of the MVN neurones. An important
consideration in this regard is Ca2+ concentration, although it is generally known that
the free Ca2+ concentration is low inside the cells. EGTA is the most widely used
buffer for Ca2+. K2ATP is used in the filling solution in order to prevent channel
'rundown' due to dialysis of intracellular ATP (Forscher and Oxford, 1985). The
filling solution was also buffered at a pH between 7.1 -7.3 with HEPES and stored
39
CHAPTER 1: METHODS
frozen in 1 ml aliquots. The microelectrode resistance ranged from 5 to 20 MQ
when filled with internal filling solution.
The microelectrode was then inserted into a Perspex microelectrode holder
and the solution was contacted by a silver/silver chloride wire in the holder that was
linked to the unity gain headstage of the Axoclamp 2A amplifier. The slice was
illuminated with fibre optics and location of MVN was visualised using a binocular-
dissecting microscope (Carl Zeiss, Germany). The microelectrode was first Jowered
and advanced with 3-axis coarse manipulator until it was positioned under visual
guidance over the MVN slice and then was further advanced into the slice in 2 pM
steps with a Burleigh inchworm controller, PZ-550 (Burleigh Instruments
Incorporated, USA).
Extracellular Recordings.
Single extracellular action potentials of the tonic discharge of MVN neurones
were made using 2M sodium gluconate containing microelectrodes. The
microelectrode was advanced into the MVN tissue as described in above and
monitored continuously on the oscilloscope for the appearance of spontaneous
extracellular action potentials. The spontaneous extracellular action potentials
normally appeared over and above the background noise and increased in
amplitude as the microelectrode approached the neurone. Figure 1.3.3 shows an
example of extracellular action potentials recorded from a tonically activq MVN
neurone. \ f
In order to prevent neurone injury or excitation of neurone by the
microelectrode and at the same time to obtain a high signal-to-noise ratio with an
extracellular action potential, the microelectrode tip position was carefully adjusted
backward or forward using manipulator control so that sufficient amplitude of
extracellular action potentials could be discriminated and digitised. The amplified
and filtered extracellular action potentials were fed to a spike discriminator/triggering
module of the NeuroLog System and continuously monitored on the oscilloscope.
Proper triggering of the extracellular action potentials were obtained by setting the
discriminator level greater than that of the background noise but below than that of
the peak of the extracellular action potentials. The pulses that were triggered each
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time an extracellular action potential crossed the triggering level were fed to a CED
1401 interface linked to a IBM-compatible. The spontaneous discharge rate of MVN
neurones was displayed on-line in the form of frequency histogram (spikes/sec) with
the histogram bin width of 1000ms. The program (SCAP 90) was written by Dr. MB
Dutia.
The effect of opioid peptides on neuronal activity of medial vestibular
nucleus were assessed as follows; After obtaining a stable recording from a single
neurone for at least 5 minutes, opioid peptides were applied to the slice arid the
responses were assessed by observing the changes in discharge rate. Neurones
were considered as having been excited or inhibited when their discharge rate
showed either an increase or decrease of more than 10% compared with that
recorded during 5 minutes control period.
Intracellular Whole-Cell Patch-Clamp Recordings
The effect of opioid peptides on medial vestibular neurones was also studied
with the use of the "blind" whole cell recording technique (Blanton et ai, 1989;
Coleman and Miller 1989). The electrophysiological recordings were carried out in
the whole cell current-clamp configuration using recording equipment set up as
described above except that the output signals from the high input impedence
amplifier, Axoclamp 2A were not delivered to the filter, high gain AC amplifier and
the spike discriminator/triggering module of the NeuroLog System. In addition, the
side port of Perspex microelectrode holder was connected to 1.0 m PV(^ tubing
(Altec, UK; Bore: 1.5mm, Wall: 1.0mm) for mouth pressure application.
The techniques for establishing a gigaOhm (GQ) seal in the blind technique
is described below and illustrated schematically in figure 1.3.4. Positive pressure
was applied to the back of microelectrode by gentle blowing into the PVC tubing
that was connected to the side port of the microelectrode holder and closed by
means of three-ways tap to retain the positive pressure. This was done in order to
prevent clogging of the microelectrode tip during movement through the tissue. The
microelectrode was then slowly lowered into the MVN tissue. Offset potential
between the reference electrode (Ag/AgCI wire) and the microelectrode was zeroed
using the calibrated offset potentiometer control on the Axoclamp 2A amplifier when
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the microelectrode touched the tissue. The bridge balance was compensated using
a calibrated potentiometer. This gave a measurement of electrode resistance, and
this was monitored on the oscilloscope throughout the recording by injecting
intermittent 100 ms, -1.5nA DC current pulses using the DC current command
control of the amplifier. The microelectrode was then slowly advanced into the
tissue in 2 pM steps.
The presence of a cell was indicated by the presence of extracellular. action
potentials and an increase in resistance by 20-40% of its original amplitude. The
positive pressure was then released, thus resulting in a further increase in the
resistance if the electrode was indeed contacting a cell. The distance of
microelectrode tip to the cell can be gauged by the speed of rebound decrease in
the resistance following repeated positive pressure applications by gently blowing
into the side-port tube. The closer the cell the faster the rebound. Gentle suction
frequently results in the formation of a cell-attached patch. The GQ seal (1-3 GQ)
usually formed rapidly, within 15 seconds and took a few minutes to improve and
stabilise. After formation of GQ seal between the electrode and the cell membrane,
whole cell recording configuration was then achieved by application of additional
suction to rupture the membrane patch.
Data Analysis and Presentation
All experimental data from extracellular recordings were continuously
displayed on a storage oscilloscope, analysed on-line using Scap90 program and
stored on the computer hard disk for off-line analysis. Current command protocols
and membrane voltage during whole-cell recordings were continuously observed on
a storage oscilloscope and were plotted directly on a Gould TA 240 chart recorder
paper (GOULD Instrument Systems Ltd. UK) as well as being digitised and stored
for later analyses using pCLAMP software ver. 6.0.2 (Axon Instruments, Inc, USA).
Neurones obtained from whole-cell recording were accepted for analysis if they had
a stable resting membrane potential, an overshooting action potential of greater
than 40 mV amplitude and input membrane resistance of greater than 100 MQ.
Discharge rate histograms of extracellular firing rate and figures of whole-cell
recordings were constructed for publication from selected data files using
CorelDraw version 5.0 software (Corel Inc, Canada). Numerical results in this study
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are expressed as mean values ± S.E of mean. Student's t test was used for
statistical comparison between groups based on the estimation of the mean and
standard deviation of the samples, after confirming that the samples were drawn
from normally distributed populations (Sigmastat, Jandel Scientific, Germany), with
P < 0.05 being the criterion for statistical significance.
The experimental protocol involved measuring the following parameters: -
The resting membrane potential
Since most neurones of MVN are tonically active, it was not possible to
record a "resting" membrane potential (RMP) of these neurones. However, the
measurement for the RMP was taken as the membrane potential value displayed on
the digital voltmeter display of the Axoclamp amplifier. This was the time-averaged
value of the cell membrane potential (Johnston et al., 1994). The resting membrane
potential was corrected by subtracting the offset value read directly from the
voltmeter display of the Axoclamp 2A amplifier after withdrawing the microelectrode
from the neurone at the end of the recording. The RMP value during whole cell
configuration was taken when there was no depolarising or hyperpolarising DC
current injected through recording electrode.
The spontaneous discharge rate
The measurement of spontaneous discharge rate of tonically active MVN
neurones was made by recording the spontaneous action potentials at \'resting'
membrane potential (i.e with no current being injected into the cell) for 15 seconds
using the Fetchex program and was calculated automatically using Fetchan
program, of the PCLAMP software suite.
The membrane input resistance
The membrane input resistance before, during and after drug responses
was determined from the current-voltage (l-V) curves. The l-V relationships were
obtained by injecting a series of constant depolarising and hyperpolarising current
step commands of 40 pA increments from - 460 pA that were applied for 200 ms
duration. In all measurements the membrane potential of the spontaneously active
MVN neurones was hyperpolarised 10 or 20 mV below the threshold for action
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potential generation by applying continuous negative current through the recording
microelectrode, in order to stop the spontaneous resting discharge.
The averaged action potential shape
These procedures were adapted from the previous study of MVN neurones
in vitro by Johnston et al 1994. The action potential shape of the spontaneously
active MVN neurone was obtained by digitising the intracellular^ recorded
membrane potential at 40 kHz for a period of two seconds while the ceU at its
'resting' membrane potential (i.e. when neither positive nor negative DC current was
injected through recording microelectrode). The time of occurrence of the peak of
each spontaneous action potential was located in the digitised data, and the
membrane potential over a 20 ms window around each of these times was
averaged to give an action potential shape synchronised to the peak of the spike
(Fig. 1.3.5).
Since the membrane potential in spontaneously active MVN neurones was
always gradually depolarising before the discharge of an action potential, it was not
possible to make an objective measurement of the firing threshold from the
averaged spike shape itself. Instead the averaged action potential shape was
differentiated twice and the firing threshold was taken to be the membrane potential
at the point when the second derivative became greater than 2 times its own noise
level (Johnston et al., 1994). The action potential rise time was measured as the
time from the firing threshold to the peak of the averaged action potential and the
fall time was measured as the time to return from the peak to the thresh6(d level
(see fig. 1.3.5). The amplitudes of the after-hyperpolarisation were also measured
with respect to the firing threshold. The action potential width was measured both as
the width at threshold (WT) and as the width at half-height (WH).
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200 |iiV, 500 ms
Figure 1.3.3 : An example of an extracellular recording of the
action potentials fired by a spontaneously active MVN neurone in
a dorsal brainstem slice preparation.
Legend 1.3.4 : Whole-cell patch-clamp techniques (blind patch)
Schematic representation of procedures for obtaining whole-cell
recordings. (A and B) Neurones are detected by monitoring the
microelectrode resistance as its lowered through the slice. Cell
contact occludes the microelectrode tip, causing an increase in
microelectrode resistance. The application of gentle pressure
removes the obstruction, restoring the microelectrode resistance. (C)
If the microelectrode is against a cell, then the resistance will increase
when the pressure is released because of elastic recoil of the cell.
The speed of recoil is used to gauge the closeness of the
microelectrode's tip and cell membrane. (D) Application of gentle
suction at this stage results in the formation of gigaOhm seal. (E)







Figure 1.3.4 : Schematic diagram of procedure for obtaining whole-cell patch-clamp
Peak
Figure 1.3.5 : Analysis of the average action potential shape
Upper trace, Averaged action potential shape (E) obtained by averaging, the
membrane potential over a 20ms window synchronised to the peak of each
successive spike in the resting discharge of one MVN neurone, with 1.25 ms pre-
trigger period (see text). Middle and lower traces, first (E) and second (E)
differentials of the averaged spike shape, calculated by taking simple differences
between successive points. Horizontal dashed lines in the lower panel indicate the
level corresponding to twice the noise amplitude in the last 5 ms of this trace. The
vertical dashed line indicates where the second differential becomes greater than
this level, and the corresponding points in the averaged spike shape (upper trace)
which is taken as the onset of the rising phase of the action potential (firing
threshold). WT, spike width at firing threshold; WH, spike width midway between
firing threshold and peak; Aahp, amplitude of AHP with reference to firing threshold;
Asp, spike amplitude. Rise time was measured as the time from firing threshold to
peak, and fall time as the time from peak to firing threshold.
(Adapted from Johnston et al., 1994)
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1.4 RESULTS
Stable extracellular recordings lasting up to 3 hours were obtained from a
total of 127 spontaneously active neurones within the medial vestibular nuclei in
horizontal slices of the dorsal brainstem from 45 rats. Consistent with the previous
studies (Dutia et a!., 1992, Wang and Dutia, 1995), all neurones recorded in this
study showed steady and regular resting discharge rates ranging from 7.0 to 41.4
spikes/sec, with a mean discharge rate of 21.3 ± 0.6 spikes/sec (mean ± S.E.tyi).
Opioid inhibition and opioid receptor subtypes on MVN neurones
The response of the MVN neurones to bath application of the selective 8-
opioid receptor agonist [D-Ala2, D-leu5]-enkephalin (DADLE, 1-100 jaM), the pi-opioid
receptor agonist morphine (1-100 |u.M), and the selective K-opioid receptor agonist,
U50,488H (1-100 |iM) were examined systematically. The results are summarised
in table 1.4.
Bath application of DADLE produced a dose-dependent, long-lasting
inhibition, seen as a decrease in the spontaneous discharge rate of 102/127 (80%)
of the MVN neurones, the remaining 25 neurones (20%) being unresponsive to
DADLE at doses up to 100 |iM. The maximum inhibitory effect of DADLE was seen
within 1-2 min of the peptide reaching the recording chamber, and complete
recovery of the firing rate to the control level was normally seen within 15-30 min
after washing out of DADLE with normal aCSF medium, (Figs. 1.4.1.1 - 1 ;4.1.6).
The inhibitory effects evoked by DADLE were reproducible with repeated application
of the peptide. Figures 1.4.1.1 and 1.4.1.2A show representative examples of the
effect of successively increasing concentrations of the peptide.
To determine whether DADLE affects the MVN neurones directly or through
presynaptic actions, modified low Ca2+, high Mg2+ aCSF medium was used. This
medium is essentially known to eliminate all synaptic transmission through blockade
of transmitter release at the presynaptic terminal (Lu et a!., 1995, Lin and Carpenter
1994). If the inhibitory effect of DADLE is mediated by activation of postsynaptic
receptors on medial vestibular neurones, rather than through presynaptic actions,
the inhibitory effect of DADLE should therefore be maintained even when synaptic
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transmission is completely blocked. In five experiments, the inhibitory responses of
MVN cells to DADLE were recorded first in normal aCSF medium and repeated
subsequently in modified low Ca2+, high Mg2+ aCSF medium (0.1 mM Ca2+, 6.3 mM
Mg2+). Two of these experiments are illustrated in figure 1.4.1.3. In all 5 MVN
neurones tested in this way, the inhibitory response to DADLE persisted in low Ca2+,
high Mg2+ aCSF, and remained similar to the control response in normal aCSF,
indicating that the effects of DADLE are mediated by its actions on postsynaptic
opioid receptors on the MVN cells, in vitro. >
As illustrated for two different MVN neurones in Figures 1.4.1.4 to 1.4.1.6,
the inhibitory effects of DADLE were mimicked by the highly-selective S-opioid
receptor agonist [D-Pen2, Pen5]-enkephalin (DPLPE, 1-10 pM, n = 10 cells). As
illustrated for two representative neurones in figures 1.4.1.5 and 1.4.1.6, perfusion
with non-selective opioid antagonist, naloxone (10 mM, Fig. 1.4.1.5B) and highly
selective 8-opioid receptor antagonist, naltrindole (10-100 nM, Fig. 1.4.1.6B), which
themselves had no direct effect on the discharge rate of MVN neurones, effectively
antagonised the inhibitory effects of DADLE and DPLPE in all 6 MVN cells where
this was tested.
By contrast, as illustrated in figures 1.4.1.2C and 1.4.1.4B the p-opioid
receptor agonist morphine (up to 100 pM) had no effect on the discharge rate of any
of the 33 MVN neurones tested. In addition, the highly selective p-opioid receptor
agonist, [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAGO, 1-10 pM), also had no
effect on the discharge rate of any of the six MVN cells tested (Fig. 1.4.1.4B). The
K-opioid receptor agonist U50488H (up to 100 pM) also had no effect on the tonic
discharge rate of all 30 MVN cells tested (e.g. Fig. 1.4.1.2B and 1.4.1.4B). These
results strongly indicate the presence of 8-opioid receptors and not p and K-opioid
receptors on rat MVN neurones.
Excitatory effects of opioids on MVN neurones
Weak excitatory responses were seen at high concentrations (30 and 100
pM) of the DADLE in only two MVN neurones, which are illustrated in figure 1.4.1.7.
Neither of these MVN cells responded to lower doses of DADLE. Since these
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Figure1.4.1.7:Weak,excitatoryr sponsestohighdosefDADLEintwdiffer ntMVNneuron s.
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excitatory effects were too small to be considered significant (less than 5% change
relative to the control resting discharge rate); they were not investigated further. It is
likely that these small excitations are secondary to the inhibitory effect of DADLE on
other cells, which are synaptically connected to them.
Effects of DADLE on membrane properties of MVN neurones
In 19 further experiments, intracellular whole-cell patch recordings were
obtained from MVN neurones and the effects of DADLE on the membrane potential
and intrinsic conductances were investigated. The 19 MVN neurones had a mean
resting membrane potential of -45 ± 0.6 mV, steady resting spontaneous activity of
23.5 ± 0.9 spikes/sec, spontaneous action potentials of greater than 40 mV in
amplitude and the membrane input resistance was in the range 100 to 250 MQ.
From the averaged action potential shapes taken from tonically active MVN
neurones over a period of 2-secs, two main distinct neuronal cell types were
identified, namely Type A and Type B MVN neurones (Johnston et at., 1994). Figure
1.4.1.8 shows examples of average action potential shapes in 2 different types of
spontaneously active MVN neurones. Of the 19 MVN neurones, 6 (32%) cells had a
single deep after-hyperpolarisation (AHP) following their spontaneous action
potential and were characterised as Type A cells, while the remaining 13 (68%)
neurones were characterised as Type B cells as they showed an early fast AHP and
a delayed slow AHP (Serafin et at., 1991, Johnston et a!., 1994). The membrane
properties of both Type A and Type B MVN neurones are summarised in figure
1.4.1.9. Except for the properties of AHP described, there were no other differences
in the membrane properties of type A and type B neither in their resting membrane
potential, input resistance nor their steady resting spontaneous activity.
Bath perfusion of DADLE (3-100 |iM) caused a membrane hyperpolarisation
and inhibition of the tonic discharge in 18/19 (95%) of the MVN neurones tested.
Five of these neurones are illustrated in figures 1.4.2 to 1.4.2.3 In some of these
experiments the extracellular K+ concentration was reduced to 2.0 mM ("low-K+
aCSF"), in order to increase the prominence of K+ mediated effects on membrane
conductance. In low-K+ medium, the neurone shown in figure 1.4.2 showed a
marked membrane hyperpolarisation (arrow) and cessation of its tonic firing
following the application of DADLE. The membrane hyperpolarisation gradually
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reversed with the return of resting activity over the following seven minutes. As
indicated by the smaller voltage responses to the hyperpolarising current pulses
applied every 10-sec (downward deflections in Fig. 1.4.2), the DADLE induced
inhibition was accompanied by a decreased input membrane resistance or an
increase in the cell membrane conductance. A decreased in input membrane
resistance is more clearly seen in the neurones illustrated in figures 1.4.2.1 and
1.4.2.2, where depolarising and hyperpolarising current pulses were applied before
the application of DADLE (control) and during the maximal DADLE-induced
inhibition, at a manually-clamped holding potential of -60 mV. From the slopes of
the regression lines fitted to the steady-state membrane current/voltage
relationships the apparent input resistance of these cells were seen to decrease in
the presence of DADLE (Figs. 1.4.2.1C and 1.4.2.2C).
In 4 MVN neurones the membrane current evoked by DADLE was recorded
under voltage-clamp configurations, also in low-K+ aCSF and in the presence of
TTX (1pM, Figs. 1.4.2.3), in order to eliminate the spontaneous Na2+ spikes. Bath
application of DADLE for 60-seconds induced a dose-dependent outward current in
all 4 neurones tested in this way. Each of these neurones was then exposed to 20
mM potassium channel antagonist, TEA in order to determine if voltage-activated
potassium currents contributed to this outward current. As illustrated for 2 neurones
in figure 1.4.2.3, the outward current evoked by DADLE after 15 minutes exposure
to TEA became smaller in amplitude but was not abolished, indicating that the
inhibition and membrane hyperpolarisation of MVN neurones evoked byiDADLE
involves the potentiation of TEA-sensitive potassium conductances in the cell
membrane.
Age-related effects of DADLE on MVN neurones
In the course of these experiments it became apparent that the degree of
inhibition of the tonic discharge of the MVN neurones evoked by DADLE tended to
be greater in slices prepared from older animals. This was quantified by expressing
the frequency of discharge during the maximal inhibitory effect of DADLE as a
percentage of the control (pre-DADLE) resting discharge rate, for each neurone.
Figure 1.4.2.4A shows the mean percentage inhibition (± S.E.M) induced by a
standard dose of 30 pM DADLE in all the MVN cells tested, as a function of the
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body weight of the animal which was recorded before the preparation of the slice.
The inhibitory effects of DADLE were relatively small in the youngest animals used
here, and increased significantly with age. As shown in figure 1.4.2.4B, there was
no systematic change in the mean in vitro resting discharge rates of the MVN cells
over the age range used in these experiments. Figure 1.4.2.5 illustrating the
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Figure 1.4.1.8 : Averaged action potential shapes of Type A and Type B
MVN neurones
Two main distinct neuronal types from two different spontaneously
active MVN neurones, Type A and Type B.
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Legend 1.4.2.1 : Effect of DADLE on membrane input resistance of
MVN neurone.
Voltage-current relationships (raw data) of an MVN neurone tested
with DADLE. Left figure (A) was sampled first in normal aCSF
(control) and the right figure (B) during the maximum inhibitory effect
of DADLE. Graded series of constant depolarising and
hyperpolarising current pulses (0.04 nA increments from -0.46 nA)
were applied for 200 ms (as shown in the figures) to the recording
electrode at a manually clamped holding potential of -60 mV.
Decreased in membrane input resistance was indicated by smaller
voltage responses at all potential tested during maximum inhibitory
effect of DADLE. (C) The change in slope of the regression lines of
the steady-state current-voltage (l-V) relationship obtained from (A)
and (B) snowed that the siope of the l-V curve decreased significantly
from 175 Mfi in normal aCSF to 63 M Q in the presence of DADLE,
indicating a decreased in input resistance. Arrow head indicates
where measurements were made.
(A) control (B) DADLE 30 fiM
Figure 1.4.2.1 : Effect of DADLE on membrane input resistance.
Legend 1.4.2.2 : Effect of DADLE on membrane input resistance of
MVN neurone.
Another example of voltage-current relationships (raw data) of MVN
neurone to DADLE. Response of membrane voltage to a graded
series of a constant depolarising and hyperpolarising current pulses
(bottom) in normal aCSF (A) and during (B) maximum effect of
DADLE. (C) l-V curves obtained from (A) and (B). The slope of the I-
V curves is reduced from 125 MQ in control to 97 MQ in the
presence of DADLE, indicating a decrease in membrane input
resistance.
(A) Control (B) DADLE 30 pM
ms
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Legend 1.4.2.4 : Age-related inhibition of DADLE
Mean (± S.E.) inhibitory responses to a dose of 30 |u,M DADLE (upper
graph), and the resting control discharge rates (lower graph), of all
the MVN neurones tested, plotted as a function of the body weight of
the animal before sacrifice. Percentage inhibition was calculated as
the maximal inhibitory effect of DADLE expressed as a fraction of the
control (pre-DADLE) resting discharge rate. The approximate age of
the animal is also indicated assuming a weight gain of 50 g per week.
Note that there is no systematic change in the intrinsic tonic
discharge rates of the MVN cells over the age range used in these
experiments, while the efficacy of the opioid-induced inhibition is
relatively small in young animals and increases with age (significant
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Figure 1.4.2.4 : Age-related inhibition of DADLE.
Figure 1.4.2.5 : Percentage of responsive neurones.
Histogram showing the percentage of responsive MVN
neurones at different ages to bath application of DADLE.
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1.5 DISCUSSION
This study examined opioidergic actions in the medial vestibular nucleus
(MVN) neurones in brainslice preparations of the dorsal brainstem. The study using
both extracellular and intracellular whole-cell patch-clamp techniques demonstrated
that activation of S-opioid receptors by [D-Ala2, D-leu5]-enkephalin (DADLE) dose-
dependently inhibited the spontaneous discharge rate of the majority (80%) of
neurones in the rat MVN. This effect was mediated by an increase in a TEA-
sensitive potassium conductance on the postsynaptic cell membrane. These
findings are in agreement with the results from other brain areas, which have found
that the functional effects of opioids on neurones are predominantly inhibitory (for
review see part 1.1.6)
DADLE-mediated postsynaptic inhibition
In contrast to its predominantly inhibitory effect on neuronal activity in many
areas of the brain, enkephalin appears to be facilitatory on rat (Madison and Nicoll,
1988) and guinea pig (Caudle and Chavkin, 1990) hippocampal pyramidal cells.
This effect might be due to inhibition of local inhibitory interneurones by enkephalin
leading to a facilitatory response at the pyramidal cell. The excitatory effect of
enkephalin on hippocampal pyramidal neurones appears to be the result of
suppression of GABAergic i.p.s.ps, which unmasks the underlying e.p.s.ps.
Excitatory opioid actions in the central nervous system may therefore be indirect
effects resulting in disinhibition. Although, there is evidence that enkephalin can
modulate presynaptic release of neurotransmitter and synaptic activity (McFadzean,
1988; Schlosser et al., 1995; Vaughan and Christie, 1997), the inhibitory effects of
DADLE on the discharge rate of MVN neurones in the present study were likely to
be due to a specific interaction through postsynaptic opioid receptors since the
inhibition was TTX-insensitive and persisted during blockade of synaptic
transmission in modified low Ca2+(2 mM), high Mg2+(6 mM) aCSF medium, which
eliminate both spontaneous and evoked postsynaptic potentials.
The inhibitory effect of DADLE was reversibly antagonised by the non¬
selective opioid antagonist, naloxone and the highly selective 5-opioid receptor
antagonist, naltrindole. However, the present study does not address the possibility
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of additional, presynaptic modulatory effects of opioids in the vestibular nuclei, as
the experiments were carried out on single medial vestibular nuclei isolated from
their normal afferent and efferent projections. It can therefore be concluded that
DADLE inhibited the discharge rate of MVN neurones directly through post-synaptic
opioid receptors.
The results of this study are consistent with the findings of Kawabata et al
(1990), who demonstrated that iontophoretically applied met-enkephalin inhibited
the discharge rate of cat MVN neurones in vivo. However, the results are in contrast
to those of Carpenter and Hori (1992) and Lin and Carpenter (1994), who observed
that the majority of spontaneously active rat MVN neurones were excited both by
morphine and enkephalin in vitro. In the experiments of the present study there
were only weak excitatory effects by opioid agonists seen in two MVN neurones in
response to high doses of DADLE. The observed responses were less than a 10%
change in the discharge rate. Although these responses were not investigate in any
detail, they are likely to be disinhibitory effects caused by the action of DADLE on
other MVN cells synaptically connected to the recorded neurones. It is possible that
the differences between the present results and those of Lin & Carpenter and
Carpenter & Hori could be due to a difference between the strains of rats used in
the two studies (Wistar vs Sprague Dawley). However, it is more likely that the
difference may arise from methodological considerations. In the present study bath
application of known concentrations of the agonists were used which were
equilibrated to the pH of the perfusing aCSF, while the study by Lin and Carpenter
drugs were applied in rather acidic solution at high concentration by brief (1 sec)
iontophoretic current injection.
Opioid receptor on MVN neurone is the 8-type
Although DADLE is known to be selective for S-opioid receptors, it also has
considerable affinity for the p-opioid receptor. Postsynaptic inhibition induced by
DADLE via S-opioid receptors has previously been reported for rat locus coeruleus
neurones (Williams et al., 1982) and through p-opioid receptors for dorsomotor
vagal nucleus neurones in slices of rat medulla oblongata (Duan et al., 1990).
However, the present study demonstrated that the inhibitory effect evoked by
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DADLE was specifically due to its direct activation on S-opioid receptors
rather than p- or k- opioid receptors.
The evidence indicating the presence of 5-opioid receptors in MVN neurones
is as follows:- First, the discharge rate of the majority (80%) of MVN neurones was
inhibited by the selective 5-opioid receptor agonist, DADLE, while the p-opioid
receptor agonist, morphine, and the k- opioid receptor agonist, U50 488H at a
concentration up to 300 pM were without effect on the discharge rate of any of the
33 and 30 neurones tested, respectively. These data indicate that p- and k-opioid
receptors were not involved in the inhibitory action of the MVN neurones. Second,
DPLPE which has previously been shown to be more highly selective opioid peptide
analogue than DADLE at the S-opioid receptor (Mosberg et al., 1983) mimicked the
inhibitory effect of DADLE in all MVN neurones tested, while DAGO, a highly
selective p-opioid receptor agonist failed to elicit a response in any MVN neurones
tested. Third, the highly selective 5-opioid receptor antagonist, naltrindole effectively
attenuated the inhibitory action of both DADLE and DPLPE. Hence, these data
confirm the presence of 5-opioid receptors but not p- or k-opioid receptors in the rat
MVN.
The results of the present study are supported by several
immunohistochemical studies that have shown the presence of enkephalinergic
neurones and fibres in the MVN (Pearson et al., 1980; Finley et al., 1981; Nomura
et al., 1984; Beitz et al., 1987; Zanni et al., 1995), together with the demonstration
of moderate levels of 5-opioid receptors and low levels of p- and k-opioid receptors
in the MVN (Fallon and Leslie, 1986; Mansour et al., 1988, 1994). Despite the
reported presence of low level of p- and k-opioid receptor in the MVN, in the present
study no effects of p- and k-opioid receptor agonists were observed in any of the
MVN cells tested. It is thus possible that any p- and k-receptor mediated effects
within the MVN may be entirely pre-synaptic, a possibility that cannot be discounted
on the basis of the present results.
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Ionic mechanisms responsible for DADLE-induced inhibition
The ionic mechanisms underlying opioid actions were first elucidated in
neurones of the rat locus coeruleus (Williams et al., 1982). It is now clear that
opioids directly inhibit the electrical activity of neurones in many regions of the
nervous system by opening of the inwardly rectifying potassium channels, thus
leading to membrane hyperpolarisation. Opioid inhibition of the neuronal firing rate
resulting from a membrane hyperpolarisation have been reported for neurones of
rat and guinea pig locus coeruleus (Pepper and Henderson, 1980; North and
Williams, 1985; Travagli et al., 1995), rat substantia gelatinosa (Yoshimura and
North, 1983), rat periaqueductal gray (Chieng and Christie, 1994), rat dorsomotor
vagal nucleus (Duan et al., 1990) and guinea pig myenteric plexus (Morita and
North, 1981).
Voltage-clamp experiments using whole-cell patch clamp recordings from
MVN neurones in the present study confirmed that the inhibitory effect of the 8-
opioid agonist, DADLE on the MVN cells was mediated via an increase in an
outward TEA-sensitive potassium conductance in the cell membrane thereby
causing membrane hyperpolarisation, similar to that reported in other regions of the
rat and guinea pig nervous systems. This is consistent with the decrease in input
resistance that was observed in current-clamp recordings of the l-V curves. Further
experiments using selective K+ channel blockers are necessary to determine which
class of TEA-sensitive K+ channels are involved. However, since the primary
purpose of this study was to classify the discrepancies in the literature about the
effects of opioids on MVN neurones, the nature of the K+ current was not further
investigated.
Age-related inhibition
The age-related increase in the opioid-induced inhibition on the MVN
neurones in this study is of interest in the context of previous work in our laboratory
on the development of the membrane properties, tonic discharge and electrical
excitability of mouse MVN neurones over the first post-natal month (Dutia et al.,
1995; Johnston and Dutia, 1996). From the present results in the rat it is clear that
the responsiveness of the MVN neurones to 5-receptor agonists is weak in young
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animals and increases significantly with age (Fig. 1.4.1.5A). In the youngest animals
used in the present experiments the mean spontaneous discharge rate of the MVN
cells had already reached its adult level, as no further increases were seen over the
following 2-3 weeks (Fig. 1.4.1.5B; Johnston and Dutia, 1996). Nevertheless the
inhibitory responses to DADLE were still immature in the youngest animals but
increased substantially over the following weeks. This may be due to continuing
post-natal growth and maturation of the MVN neurones and their dendritic arbors,
as this process occurs during the first post-natal month (Lannou, Precht and Cazin,
1983). Thus, 8-opioid receptors located on the dendrites may increasingly contribute
to the DADLE-induced inhibition.
It has been shown that the expression of 5-opioid receptors in the rat and
mouse brain begins in the first weeks after birth and gradually increases in density
over the next three to four weeks to reach the adult level (McDowell and Kitchen,
1986; Negri et al., 1997). Competitive binding study also revealed that in the rat
brain 8-opioid receptors lag in development to the other opioid receptors and are not
present until about the second postnatal week (Wohltmann et al., 1982). Although
such information is not available for the development of 8-opioid receptor
expression in the brainstem neurones, the responsiveness of the agonist in relation
to the age of the animal in the present study indicates that a similar pattern of
expression of 8-opioid receptors may occur in MVN neurones. Alternatively it may
reflect changes in the overall density of 8-opiate receptors on the MVN cells and in
the efficacy of the intracellular second-messenger systems activated by them (for
review see part 1.1.6). In either case, a fuller understanding of such age-related
post-natal changes in the neurochemical responsiveness of neurones is likely to be
important in the interpretation of results from other in vitro studies, where tissues
from young animals are often employed.
In summary, the effects of the opioid peptides for p-, 8 and K-opioid
receptors on neurones of the MVN in the rat dorsal brainstem slice preparations
were investigated with extracellular and intracellular whole-cell patch-clamp
recording techniques. The present results strongly indicate that the activity of most
MVN neurones was inhibited by activation of postsynaptically located 8-opioid
receptors and that the DADLE inhibition is mediated via potentiation of a TEA-
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sensitive potassium conductance. The present results also demonstrated that the
inhibitory effect of DADLE increased linearly with age, in that the inhibitory effects of
DADLE were smaller in young than in older animals.
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2.1.1 THE ORPHAN OPIOID RECEPTOR
The opioid receptor like-1 (ORL1) receptor
Opioid receptors were first discovered over two decades ago, and identification
of the p-, 5- and K-opioid receptor subtypes was based on pharmacological grounds.
Only in recent years has the complementary DNA (cDNA) sequences of these
receptors been cloned, sequenced, and found to encode highly homologous protein
with a primary structure typical for G protein-coupled membrane receptors (for reviews
see Chapter 1, part 1.1.5).
The first opioid receptor cloned was the mouse 5-opioid receptor by Evans et al.,
(1992) and Kieffer et al., (1992). They succeeded in cloning the cDNA of the 5-opioid
receptor and identified its amino acid sequence without purifying the protein. Both groups
simultaneously used very similar cloning techniques to identify this receptor from hybrid
NG108-15 neuroblastoma X glioma cells. Cloning of the 5-opioid receptor initiated an
intense effort in search of the remaining members or 'other' members of this potentially
large gene family. Subsequently the p.- and K-opioid receptors were cloned on the basis
of their homology to the cloned 8-opioid receptor in various species including mouse, rat
and human. The deduced amino acid sequences for these three opioid receptors were
approximately 60% identical (for reviews see Kieffer et al., 1994; Minami and Satoh,
1995; Satoh and Minami, 1995)
Along with the p-, 5- and K-opioid receptors, a cDNA clone with a very high
degree of amino acid sequence homology to the three opioid receptors has been
identified by several independent research groups in rat, mouse and human. This
"orphan" opioid receptor-like receptor is variously known as ORL1 for the human clone
(Mollereau et al., 1994), ROR-C (Fukuda et al., 1994), oprl (Chen et al., 1994), LC132
(Bunzow et al., 1994), XOR1 (Wang et al., 1994), Hyp-8-1 (Wick et al., 1994) or C3
(Lachowicz et al., 1995) from rat brain libraries and MOR-C (Nishi et al., 1994) from a
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mouse genomic library. For the purpose of this review, I shall refer to the receptor as
the opioid-like orphan receptor (ORL1).
The homology of the cDNA deduced amino acid sequence of ORL1 with the p.-,
5-, and K-opioid receptors is exceptionally high (>80% homology), particularly in the
putative transmembrane helices and cytoplasmic loops. However, the degree of
homology is much less in the N-terminus, the second and third extracellular loops.
These homologies are highly conserved among mammalian species. Overall, the ORL1
receptor is equally homologous to the three types of opioid receptors except that its
acidic second extracellular loop makes it resemble more closely the K-opioid receptor
(which binds dynorphins preferentially) than the p- or 5-opioid receptors (Mollereau et
at., 1994). This homology profile would indicate that ORL1 exhibits signalling
mechanisms similar to the opioid receptors, all of which inhibit adenyl cyclase, activate
potassium conductances, and inhibit calcium currents (for a review see Childers, 1991).
Distribution of opioid-like orphan receptor (ORL1) in mammalian central nervous
system (CNS).
An initial move to gain insight toward characterisation of the ORL1 in the CNS
has been the gross anatomical investigation of ORL1 receptor mRNA expression by
means of Northern blot and in situ hybridisation techniques (Bunzow et at., 1994;
Fukuda et at., 1994; Mollereau et al., 1994). These studies have shown that ORL1
mRNA is widely expressed throughout the brain and spinal cord. The highest levels of
ORL1 mRNA expression were observed particularly in the paraventricular and
ventromedial nuclei of the hypothalamus, in the amygdala and piriform cortex, and in
the dorsal raphe nucleus and locus coeruleus of the brainstem. Moderate expression
was observed in the cortex, thalamus, hippocampus, periaqueductal gray and in the
dorsal and ventral horns of the spinal cord. A notable feature that distinguished the
distribution of ORL1 from the p-, 8- and K-opioid receptor was the very low expression
of ORL1 receptor mRNA in the caudate-putamen and cerebellum (Fig. 2.1.1.1)
58
ppOFQ mRNA
H Very fl'Ivj Dense FTvl Moderate F^j Lightfc'X'J density density
OFQR mRNA
W2L 9 I Dense I. '-IH Moderate I I LightI r 1 density | | density
STCX
Abbreviations: I-VI, cortical layers l-VI; ABL,
basolateral amygdaloid nucleus; AC, anterior commissure; ACB, nucleus
accumbens; ACE, central amygdaloid nucleus; ACO, cortical amygdaloid
nucleus; AD, anterodorsal thalamus; AL, anterior lobe, pituitary; AMB,
nucleus ambiguus; AME, medial amygdaloid nucleus; AON, anterior
ollactory nucleus; ARC, arcuate nucleus, hypothalamus; BST, bed
nucleus, stria terminalis; CC, corpus callosum; CE, central canal; CL.
centrolateral thalamus; CM, centromedial thalamus, CPU, caudate
putamen; CRB, cerebellum; DC, dentate gyrus; DH, dorsal horn, spinal
cord; DMH, dorsomedial hypothalamus; DPC, deep gray layer, superior
colliculus; DTN. dorsal tegmental area; ENT, entorhinal cortex; EPL,
external plexilorm layer, ollactory bulb, ECX, Irontal cortex; C, nucleus
gelatinosus, thalamus; CL glomerular layer, ollactory bulb; CP, globus
pallidus; HL, lateral hobenula; HM, medial habenula; HPC, hippocampus.
IC, inferior colliculus; ICR, intermediate granular layer, ollactory bulb;
IL, intermediate lobe, pituitary; INC, intermediate gray layer, superior
colliculus; IntP, interposed cerebellar nucleus; IP, interpeduncular nucleus;
LC, locus coeruleus; LD, laterodorsal thalamus; LC, lateral geniculate
thalamus; LHA, lateral hypothalamic area; LRN, lateral reticular
nucleus; LS, lateral septum; MD, mediodorsol thalamus; ME, median
eminence; Med, medial cerebellar nucleus; MC, medial geniculate
thalamus; Mi, mitral cell layer, ollactory bulb; MM, medial mammillary
nucleus; MS, medial septum; MV, medial vestibular nucleus; NDB, nu¬
cleus diagonal band; NL, neural lobe, pituitary; NRCC, nucleus reticularis
gigantocellularis; NTS, nucleus tractus solitarii; OB, ollactory bulb; of,
optic tract; OTU, ollactory tubercle; PAC, periaqueductal gray; PBN,
parabrachial nucleus; PCX, parietal cortex; PIR, piriform cortex; PN, pons;
PnR, pontine reticular; PO, posterior nucleus thalami, POA, preoptic area,
POR, periolivary region; PrS, presubiculum; PV, paraventricular thalamus;
PVN, paraventricular hypothalamus, RD, dorsal raphe; RE, reuniens
thalami; RM, raphe magnus; RME, median raphe; SC. superior colliculus;
SCP, superior cerebellar peduncle, SC. substantia gelatmoso; SNc, sub¬
stantia nigra, pars compacta; SNr, substantia nigra, pars reticulata;
SNT, sensory trigeminal nucleus; SON, supraoptic nucleus; STCX, striate
cortex; STN, spinal trigeminal nucleus; SUC, superficial gray layer,
superior colliculus; TCX, temporal cortex; VH, ventral horn, spinal cord;
VL, ventrolateral thalamus; VM, ventromedial thalamus; VMH, ventro¬
medial hypothalamus; VP, ventral pallidus; VPL, ventroposlerolaterol
thalamus; VTA, ventral tegmental area; and Zl, zona incerta.
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Figure 2.1.1.1 : Schematic representation of N/OFQ and N/OFQ
receptor expression in the rat CNS.
(After Darland et al., 1998)
CHAPTER 2: LITERATURE REVIEWS
Using a monoclonal antibody to the N-terminus of ORL1 in order to map areas
of receptor expression in the rat CNS, Anton et al., (1996) produced distributions
similar to the earlier ORL1 mRNA distribution observed from in situ hybridisation
studies, indicating the presence of local ORL1 receptor circuitry. Following the
discovery of the endogenous ligand for ORL1 receptor, Sim et al., (1996) successfully
mapped the ORL1 receptor in the rat cortex, amygdala, hypothalamus thalamus and
brainstem that matched with the earlier studies which used agonist-induced
incorporation of [35S]GTPyS in brain slices.
Interaction of opioid ligands with the ORL1 receptor.
At the time of cloning of cDNA-deduced amino acid sequences of the ORL1 no
endogenous ligand for this receptor had been isolated. In spite of its extensive
nucleotide sequence homology to p-, 6- and K-opioid receptors, the ORL1 receptor
binds opioid ligands and antagonists with very low affinity compared with these opioid
receptors. Mollereau et al., (1994) and Lachowicz et al., (1994) have demonstrated that
in the recombinant Chinese hamster ovary (CHO) cells expressing the ORL1 protein
receptor, no specific binding of peptide or nonpeptide opioid ligands could be found.
However, the ORL1 receptor was shown to have some functional similarity to
the classical opioid receptors. In stable CHO cells expressing the ORL1 receptor, the
potent oripavine agonist, etorphine was found to inhibit forskolin-induced accumulation
of cAMP but at a concentration three orders of magnitude higher than that required to
produce the effect through the opioid receptors (Mollereau et al., 1994). On the other
hand, dynorphin A and dynorphin A (1-13) stimulate potassium currents in Xenopus
oocytes co-injected with the cRNAs to the XOR1 receptor and a G protein-activated
potassium channel, suggesting that dynorphins may be endogenous ligands for the
ORL1 receptor (Zhang and Yu, 1995).
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2.1.2 THE ENDOGENOUS LIGAND OF THE ORPHAN OPIOID RECEPTOR
A characteristic of the ORL1 receptor was that all of the known opioid receptor
ligands bound with very low affinity to it suggesting the presence of unknown
endogenous neurotransmitter as its natural ligand. This endogenous ligand was
subsequently identified by two separate groups, Meunier et al., (1995) and Reinscheid
et al., (1995), who used similar strategies and found it to be a heptadecapeptide.
Starting with crude whole rat brain in the case of the former group and porcine
hypothalamus extracts in the latter, both groups used this assay to monitor ORL1
agonist activity through a series of biochemical fractionation steps, which ultimately led
them to isolate and identify the heptadecapeptide with a sequence of amino acids that
suggested a close evolutionary relationship to the existing endogenous opioid peptides,
in particular dynorphin A. However, the most striking dissimilarity between this new
endogenous peptide and all of the other endogenous opioid peptide lies in the N-
terminal amino acid residue. While all endogenous opioid peptides derived from their
separate pro-precursors have tyrosine as their N-terminal, the N-terminal amino acid of
this new endogenous peptide is phenylalanine (Phe; Fig.2.1.2.1A).
In addition, the isolated peptide was shown to strongly inhibit forskolin-induced
accumulation of cAMP with nanomolar binding affinity in the transfected CHO cells
expressing ORL1. The maximal inhibition observed was 80-90%. When the two groups
examined this isolated peptide for activity in vivo by injecting this peptide
intracerebroventricularly (i.c.v) in the mouse brain, each group found that the peptide
did not induce analgesia as expected, but rather appeared to be hyperalgesic in the
hot-plate escape jumping latency (Meunier et al., 1995) and tail-flick latency
(Reinscheid et al., 1995) tests. Meunier and colleagues named the new peptide
"nociceptin", as indication of its in vivo pro-nociceptive properties, whereas Reinscheid
and colleagues, called it "orphanin FQ" (OFQ) to designate the fact that it was an
endogenous ligand for an orphan receptor and that its amino acid sequence begins
with phenylalanine and ends with glutamine (F and Q, in the single-letter code). The
60
CHAPTER 2: LITERATURE REVIEWS
peptide was later identified as an endogenous ligand of the mouse ROR-C receptor
and reported to induce allodynia following intrathecal administration in conscious mice
(Okuda-Ashitaka et al., 1996).
Nociceptin / orphanin FQ precursor
As is often the case for small peptide hormones and transmitters, nociceptin /
Orphanin FQ (N/OFQ) appears to be synthesised as part of a larger polyprotein
precursor. The cDNA carrying the entire coding sequence of the polyprotein precursor
for N/OFQ was subsequently isolated from rat (Nothacker et al., 1996), mouse (Houtani
et al., 1996; Pan et al., 1996; Saito et al., 1996) and from human brains (Mollereau et
al., 1996). The deduced N/OFQ precursor showed a sequence similar to the opioid
peptide precursors, preproenkephalin, preprodynorphin and preproopiomelanocortin
and shares characteristic structural features particularly with preprodynorphin,
indicating that the precursor proteins are evolutionary related. Figure 2.1.2.1B
summarises structural similarity between the N/OFQ precursor and the opioid peptide
precursors. Both N/OFQ precursor and preprodynorphin contain 6 conserved cysteine
residues in the amino-terminal (NH2) region preceded by the signal peptide. These
residues form disulfide bridges. Both N/OFQ and dynorphin A are found in the
conserved position residing near the carboxyl terminus of each precursor. The amino
acid sequence of N/OFQ is flanked by the dibasic amino acids, Lys-Arg, the recognition
site for several endopeptidase (Seidah et al., 1992). This is consistent with the idea that
the precursor of N/OFQ is proteolytically processed. There are several paired dibasic
amino acids distributed throughout the N/OFQ precursor, which suggests that this large
polyprotein precursor could be a source of several other bioactive peptides, just as the
opioid precursors are.
Distribution of nociceptin / orphanin FQ
Following the discovery of N/OFQ as a natural ligand for ORL1 receptor, a
number of groups have begun to map the detailed expression of N/OFQ in the
mammalian CNS by means of in situ hybridisation and immunohistochemical
techniques. Using in situ hybridisation analysis of N/OFQ precursor mRNA in the
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Legend 2.1.2.1 : Comparison of N/OFQ peptide sequence and
precursor structure with other opioids.
(A) Structure of N/OFQ, the endogenous agonist of the ORL1
receptor compared with those of closely related peptide agonists at
classical opioid receptors. Amino acid residue homology between
N/OFQ and other peptides is indicated in bold. (B) Schematic
representation of the structures of the N/OFQ precursor and opioid
precursors. The locations of neuropeptides as well as characteristic
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Figure 2.1.2.1 : Comparison of N/OFQ peptide sequence and precursor
structure with other opioids
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mouse CNS, Houtani et al., (1996) observed hybridisation signals in neuronal perikarya
in discrete sites of the brain and spinal cord. In the brain N/OFQ mRNA is highly
expressed in the central gray, central tegmental field, nucleus of the lateral lemniscus,
superior olive and spinal trigeminal nucleus of the brainstem but are absent in the
caudate-putamen and cerebellum. Within the spinal cord, N/OFQ mRNA precursor is
abundant in laminae l-lll of the dorsal horn and lamina X.
Riedl and colleagues (1996) raised specific antibodies against the N/OFQ
peptide and revealed high levels of N/OFQ immunoreactivity in the superficial dorsal
horn, lateral spinal nucleus and the region dorsal to the central canal. This was
subsequently confirmed by Schuligoi et al., (1997) and Lai et at., (1997). Schulz et at.,
(1996) have detected high N/OFQ immunoreactivity in the sensory trigeminal complex,
locus coeruleus, raphe nucleus, periaqueductal grey, amygdala, hypothalamic and
septal areas. Overall, the distribution of the precursor of N/OFQ and /or N/OFQ
peptides in mammalian CNS is clearly distinct from that of the classical opioid
precursors and/or peptide but matches the distribution of the ORL1 receptor mRNA
(Riedl et al., 1996; Schulz et at., 1996; Monteillet-Agius et at., 1998). Figure 2.1.1.1
shows a schematic representation of N/OFQ and ORL1 receptor distribution in the rat
CNS.
Cellular actions of nociceptin / orphanin FQ
The cellular actions of N/OFQ have received considerable attention and the
actions induced by N/OFQ are similar to those induced by agonists acting at other
receptors that are also members of the seven transmembrane domain, G-coupled
receptor superfamily, particularly the classical opioid receptors. Meunier et al., (1995)
and Reinscheid et al., (1995) have demonstrated that in CHO cells transfected with the
ORL1 receptor, N/OFQ potently inhibited forskolin-stimulated adenylate cyclase and
activated inwardly rectifying potassium currents (Matthes et al., 1996). Ikeda et al.,
(1997) reported that the ORL1 receptor is functionally coupled with a G-protein
activated potassium channel in Xenopus oocytes, and that the receptor mRNA and G-
protein-activated potassium channel mRNA co-exist in various neurones of the mouse
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CNS. In addition they found that in hippocampal pyramidal neurones, N/OFQ induced
hyperpolarising currents through activation of inwardly rectifying potassium channels.
N/OFQ inhibition of neuronal electrical activity associated with activation of an inwardly
rectifying potassium conductance has also been observed with N/OFQ, in rat dorsal
raphe neurones (Vaughan et at., 1997), rat locus coeruleus neurones (Connor et at.,
1996a), rat supraoptic (Doi et at., 1998) and ventromedial nucleus neurones (Lee et at.,
1997) of the hypothalamus, rat periaqueductal gray neurones (Vaughan et at., 1997),
rat cardiomotor neurons in the rostral ventrolateral medulla (Chu et at., 1998) and
guinea pig arcuate nucleus neurones (Wagner et at., 1998).
Apart from its ability to increase an inwardly rectifying potassium conductance,
N/OFQ also has been shown to have the potential to modulate the function of neurones
in the CNS via a number of different cellular effectors. Connor et at., (1996) reported
that N/OFQ inhibits N-type Ca2+ channel currents in SH-SY5Y human neuroblastoma
cells in vitro as well as promoting the release of Ca2+ from intracellular stores. Connor
and Christie (1998) using whole cell patch clamp technique demonstrated that N/OFQ
predominantly inhibits the N-type Ca2+ channel current but has little effect on L- and R-
type Ca2+ channel currents in acutely dissociated rat periaqueductal gray neurones.
Previously, using the same recording techniques in freshly dissociated CA1 and CA3
hippocampal neurones, Knoflach et at., (1996) demonstrated that N/OFQ modulated L-,
P/Q- as well as N-type voltage-gated Ca2+ channels. The inhibition of Ca2+ entry
through voltage-gated Ca2+ channels and the release of Ca2+ from intracellular stores
by N/OFQ were prevented with pretreatment with pertussis (Connor et at., 1996b;
Knoflach et at., 1996). In rat cerebrocortical slices (Nicol et at., 1996), N/OFQ was
shown to inhibit K+-stimulated glutamate release and Faber et at., (1996) provided
indirect evidence of N/OFQ inhibition of glutamatergic transmission on the neonatal rat
hemisected spinal cord preparation, suggesting a role for N/OFQ in the control of
glutamatergic neurotransmission.
N/OFQ also has been found to inhibit the release of dopamine in the nucleus
accumbens of the anaesthetised rat (Murphy et at., 1996), tachykinin in the guinea pig
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renal pelvis preparation (Giuliani and Maggi, 1996) and inhibition of acetylcholine
release from parasympathetic nerves of the guinea pig trachea (Patel et al., 1997) as
well as release of GABA from nerve terminals of rat periaqueductal gray neurones
(Vaughan et al., 1997). The cellular responses induced by N/OFQ are thus features this
receptor shares with the "classical" opioid receptors. However, surprisingly N/OFQ is
reported to either enhance nociception (Meunier et al., 1995; Reinscheid et al., 1995)




2.2 AIMS OF STUDY
Following the successful cloning of the complementary DNA (cDNA)
encoding G-proteins for the 8-, p- and K-opioid receptors (for a review see Chapter 1,
part 1.1.5), several independent groups have isolated and cloned a fourth novel
opioid receptor from mouse, rat and human brains (for a review, refer to part 2.1.1).
This fourth receptor, referred to hereafter as the opioid receptor-like receptor (ORL1)
has very high structural homology with the classical opioid receptors. However it did
not bind all of the known opioid ligands with the expected high affinity. This receptor
was therefore considered as an "orphan" member of the opioid receptor family.
The putative endogenous ligand for the ORL1 receptor was subsequently
identified and was discovered to be a heptadecapeptide (17-amino-acid peptide) with
a sequence of amino acids most closely related to the existing endogenous opioid
peptide, in particular dynorphin A. The peptide was termed "nociceptin" by Meunier
et al., (1995) and "orphanin FQ" by Reinscheid et al., (1995). A noticeable difference
between nociceptin/orphanin FQ (N/OFQ) and the other endogenous opioid peptides
is located on the N-terminal amino acid residue. All of the known endogenous opioid
peptides have tyrosine as their N-terminal amino acid while N/OFQ contains
phenylalanine.
At the cellular level the responses induced by N/OFQ are similar to those
induced by agonists of the classical opioid receptors including the inhibition of
neuronal activity via activation of inwardly rectifying K+ channels (Vaughan and
Christie 1996, Connor et al., 1996, Lee et at., 1997, Vaughan et al., 1997, Doi et al.,
1998, Wagner et al., 1998) and the modulation of a variety of voltage-dependent
Ca2+ currents (Connor et al., 1996a, 1996b, Knoflach et al., 1996, Connor and
Christie 1998). Surprisingly, in spite of these similarities, N/OFQ and the ORL1
receptors appear to be anatomically and pharmacologically distinctive from the
classical opioid system.
Neurones expressing N/OFQ mRNA and ORL1 receptor transcripts have
been demonstrated in many brain regions including the MVN of the brainstem
(Mollereau et al., 1994, Bunzow et al., 1994, Fukuda et al., 1994, Lachowicz 1994,
Anton et al., 1996, Houtani et al., 1996, Darland et al., 1998). While the effects of
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opioid peptides on MVN neurones have been recently demonstrated (Kawabata et
al., 1990, Lin and Carpenter 1994, Carpenter and Hori 1992, Sulaiman and Dutia
1998), the actions of nociceptin on vestibular neurones are presently unknown. The
aim of this study, therefore was to examine the actions of N/OFQ on the
spontaneously active MVN neurones in the horizontal brainslice preparation of the
rat dorsal brainstem in vitro and compare the responses produced by N/OFQ to





The horizontal MVN slices were prepared from Sprague Dawley rats weighing
between 60 - 120g. The procedures used in the preparation of the animal,
maintenance of the horizontal slices of the MVN in vitro and recording techniques
used in this study are similar to that outlined in the methods section of Chapter 1
(part 1.3).
Drugs and Chemicals
N/OFQ and its selective antagonist, [PheV(CH2-NH)Gly2] Nociceptin (1-13)
NH2 (Guerrini, et al., 1998) were obtained from Tocris Cookson (UK). Both
compounds were dissolved in distilled water to make a stock solution (0.1 mM) and
subsequently stored in small aliquots at -20°C. The 5-opioid receptor agonist, [D-
ala2, D-leu5]-enkephalin, the peptidase inhibitor bestatin, and the non selective
opioid antagonist naloxone hydrochloride were purchased from Sigma (UK). The
inactive derivative of N/OFQ, [des-phe1]-riociceptin was obtained from Phoenix
Pharmaceutical Inc. (USA). Stock solutions of these drugs were also made up in
distilled water, divided into small aliquots and stored frozen at -20°C. The aliquots
were thawed and diluted to working concentrations by using oxygenated aCSF
immediately before use. Drugs were applied to the MVN slice by changing the
perfusion medium to one that differed only in its content of drug by means of three-
way taps (Dutia, et al., 1992). Peptide agonists were applied to the slice for a period
of 60 seconds while peptide antagonists were applied continuously for at least 20




In the course of this study, stable extracellular recordings were made from a
total of 57 spontaneously active MVN neurones in horizontal slices of the dorsal
brainstem in vitro. These neurones had a mean resting discharge of 19.7 ± 0.7
spikes/sec which is similar to that of previous studies (Dutia et a!., 1992; Wang and
Dutia, 1995).
Postsynaptic inhibition of MVN neurones by N/OFQ
The effects of N/OFQ at concentration of 0.1-1.0 pM were tested on 57
spontaneously active MVN neurones. Bath application of N/OFQ resulted in an
inhibition of the discharge rate in 49 of 57 neurones (86%), while the remaining
neurones were unresponsive. The N/OFQ-induced inhibition was dose-dependent.
As illustrated for two neurones in figures. 2.4.1.1 and 2.4.1.2, the inhibitory effect of
N/OFQ was seen rapidly after the drug reached the slice and full recovery occurred
over the 5-15 minutes after the end of the 60-second exposure to the peptide.
The inhibitory effect induced by N/OFQ persisted in the presence of modified
low Ca27 Co2+ aCSF medium (n = 3 neurones) (Llinas and Sugimori, 1980), that
abolished synaptic neurotransmission. As shown in the example in figure 2.4.1.3,
the spontaneous discharge rate of the MVN neurones increased in this modified
aCSF, but the inhibitory effects of N/OFQ were similar to those in normal aCSF,
suggesting a direct action of N/OFQ on the postsynaptic receptor of the recorded
neurones.
Protease inhibitor on N/OFQ action and the effect of [des-Phe1]-nociceptin
In order to confirm that the inhibitory action of N/OFQ was due to the peptide
itself and not any possible products of its degradation following proteolysis within the
slice tissue, in three further experiments bath applications of N/OFQ were conducted
in the continuous presence of the peptidase inhibitor, bestatin (20 |aM). This
procedure did not alter the inhibitory response of the MVN neurones to N/OFQ or
alter their discharge rates in the presence of bestatin. In addition, as the example in
figure. 2.4.1.2, bath application of the inactive analogue of N/OFQ, [des-phe1]-
nociceptin (1 - 3p.M) had no effect on the spontaneous discharge rate of the MVN
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neurones, and did not interfere with the action of N/OFQ when co-applied with
N/OFQ.
N/OFQ-induced inhibition of the MVN neurones mediated via ORL1 receptors
In 18 of the 57 MVN neurones, the effects of N/OFQ and the selective 8-
opioid receptor agonist [D-Ala2, D-Leus]-enkephalin (DADLE) over a dose range of
3-30 pM were systematically tested. The effects of N/OFQ and DADLE are
summarised as in table 2.4. Of these, 11/18 neurones (61%) were inhibited both by
N/OFQ and DADLE, while 5/18 neurones (28%) were inhibited only by DADLE and
did not respond to N/OFQ up to a dose of 30 uM. Conversely, in 2/18 cells (11%)
nociceptin induced a dose-related inhibition but DADLE was ineffective (Fig.
2.4.1.4).
In 6 other neurones, which were inhibited both by N/OFQ and DADLE
application of non-selective opioid receptor antagonist, naloxone at a concentration
of 10 pM reversibly blocked the inhibitory effect of DADLE while the inhibitory effect
of nociceptin remained unaffected (Fig. 2.4.1.5). By contrast, a selective antagonist
of the ORL1 receptor, [PheV(CH2-NH)Gly2]nociceptin(1-13)NH2 at a concentration
of 30nM-100nM effectively blocked the inhibitory action of N/OFQ but not that of
DADLE (Fig. 2.4.1.6). The effect of [PheV(CH2-NH)Gly2]nociceptin(1-13)NH2 on the
action of N/OFQ was reversible.
Interaction between N/OFQ and DADLE
The similarity between the effect of ORL1 receptor agonist, N/OFQ and the
S-opioid receptor agonist, DADLE suggests that both agonists may activate the
same ionic conductance. If this were the case, it would be expected that the
maximum conductance change evoked by the agonists at the two receptors would
be the same and any combination of agonists should produce inhibition which never
exceed this maximum. In 4 further experiments on neurones that were responsive to
both agonists, concomitant application of nociceptin (1pM) and DADLE (lOpM)
produced an inhibition which was either the same as, or somewhat smaller than, the
inhibition caused by nociceptin alone (Figs. 2.4.1.5B and 2.4.1.7). This finding
indicates that occlusion rather than summation occurs between the receptor-
messenger systems activated by the two peptides in MVN cells.
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Effects of N/OFQ on membrane properties of MVN neurones
The effects of N/OFQ (1 - 3pM) were also tested on eight MVN neurones
recorded intracellular^, of which four were classified as Type A neurones and four
as Type B neurones. All neurones included in this study had apparent input
membrane resistance exceeding 100 MO and action potential amplitude larger than
60 mV. The mean RMP and spontaneous discharge rates of the two subtypes of
MVN neurones were not different (Type A: -44.5 ± 1.0 mV and 27.0 ± 1.6
spikes/sec, respectively, n = 4; Type B: -45.3 ± 0.9 mV and 25.4 ± 1.7 spikes/sec, n
= 4).
In all neurones (Type A and Type B) exposure to N/OFQ by bath perfusion
for 1 min, caused a marked decrease of the spontaneous discharge rate (a
decrease of more than 10% of control) accompanied by a detectable membrane
hyperpolarisation as shown by the example in figure 2.4.1.8. During N/OFQ-induced
hyperpolarisation, the input membrane resistance decrease from the control value
by more than 20%, measured as voltage deflections produced by injecting













Figure 2.4.1.1 : Dose-dependent inhibitory effect of N/OFQ
Discharge rate histograms from extracellular recordings
showing dose-dependent inhibition relationship of a single
spontaneously active MVN neurone to successively increasing
concentration of N/OFQ (0.1-1 pM). In this and subsequent
figures, the perfusion of solution was changed to one containing
agonists at the given dose during the duration indicated by the
solid horizontal bar above the traces.
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Legend 2.4.1.8 : Whole-cell patch-clamp recordings of MVN neurone
(A) Inhibition of the spontaneously active MVN neurones by N/OFQ (IpM). This
was accompanied by membrane hyperpolarisation (arrow). (B) Firing rate of the
same neurone as in (A).
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Figure 2.4.1.8 : Whole-cell patch-clamp recordings from MVN neurone
Legend 2.4.1.9 : Effects of N/OFQ on membrane input resistance
Example of voltage-current relationship (raw data) of MVN neurone to
N/OFQ. Response of membrane voltage to a graded series of a
constant depolarising and hyperpolarising current pulses (bottom) in
normal aCSF (A) and during maximum effect of N/OFQ (B). Arrow
indicates where measurements were made. (C) The slope of l-V
curves is reduced from 104 MQ in control to 87 MQ in the presence of
N/OFQ, indicating a decrease in membrane input resistance. The
membrane potential was held at -60 mV.
(A) Control (B) N/OFQ 1 |LXM














Figure 2.4.1.9 : Effect of N/OFQ on membrane input resistance of MVN neurone
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2.5 DISCUSSION
Postsynaptic inhibition of N/OFQ on MVN neurones
In the present study, it has been demonstrated that bath application of the
endogenous ORL1 receptor ligand, N/OFQ dose dependently inhibited the ongoing
discharge rate of over 80% of spontaneously active MVN neurones in slices of the
rat dorsal brainstem in vitro. The minimum concentration of N/OFQ required for the
inhibition in vitro was 100 nM. These results are consistent with the reported in situ
hybridisation and immunohistochemical studies indicating the presence of low to
moderate level of ORL1 receptor mRNA (Anton et al., 1996; Darland et al., 1998) in
the MVN. The inhibition of MVN neurones resulting from activation of ORL1
receptors is similar to that reported in the rat substantia gelatinosa neurones (Lai et
al., 1997), supraoptic nucleus neurones (Doi et al., 1998) and cardiomotor neurones
in the rostral ventrolateral medulla (Chu et al., 1998). It is presumed that as in those
other regions, the inhibitory effect of nociceptin seen in these study results from an
increased membrane potassium conductance.
The inhibitory effect of N/OFQ was likely to be mediated through direct
activation of receptors located on the postsynaptic neurone as the inhibition effect
persisted after blockade of synaptic transmission in modified low Ca2+/Co2+ aCSF
medium (Llinas and Sugimori, 1980). In addition, the peptidase inhibitor, bestatin did
not increase the potency of the inhibitory effect of N/OFQ indicating that the effects
were due to the peptide itself and not any possible products of its degradation. The
functional importance of phe1 moiety in the binding of N/OFQ to the ORL1 receptor
was also demonstrated, as [des-phe1]- nociceptin did not alter the discharge rate of
any MVN neurones tested and a combination of N/OFQ with [des-phe1]-nociceptin
did not interfere with the inhibitory effect of N/OFQ (Dooley and Houghton, 1996; Doi
eta!., 1998).
N/OFQ-induced inhibition of the MVN neurones mediated via ORL1 receptors
In Chapter 1, it has been demonstrated that 8- but not p-, or K-opioid
receptors are present on spontaneously active MVN neurones in vitro and that the
inhibitory action of 8-opioid receptors was due to an increase in a TEA-sensitive
potassium conductance in the cell (Sulaiman and Dutia, 1998). In the present study,
N/OFQ acts via an interaction with the ORL1 receptor to inhibit the discharge rate of
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MVN neurones and not via a 5-opioid receptor mediated mechanism, since the
majority of MVN neurones were inhibited both by nociceptin and 5-opioid receptor
agonist, DADLE, while a minority of MVN neurones were inhibited either by
nociceptin or DADLE. Furthermore bath application of the non-selective opioid
receptor antagonist, naloxone did not diminish the effect of N/OFQ but effectively
antagonised the response of DADLE. Conversely application of the selective ORL1
receptor antagonist, [PheV(CH2-NH)Gly2]nociceptin(1-13)NH2 reversibly
antagonised the effect of N/OFQ but had no effect on the responses to DADLE.
These findings are consistent therefore with an inhibitory action of N/OFQ on rat
MVN neurones through its direct activation of the ORL1 receptor. This is supported
by the fact that the potency of N/OFQ was comparable to that found by others at the
ORL1 receptor both in the CNS and also in heterologous expression systems
(Matthes et a!., 1996; Vaughan and Christie, 1996; Vaughan et at., 1997). These
results also indicate that both ORL1 and 5-opioid receptors are co-expressed on the
majority of rat MVN neurones.
Interaction between N/OFQ and DADLE
Co-existence of p-opioid receptors, somatostatin receptors, a-adrenoceptor
and ORL1 receptors have been shown for rat locus coeruleus neurones (Connor et
al., 1996). Agonists of these receptors act on their distinct receptor to activate the
same population of potassium channels. In this study, it has been found that both 5-
opioid and ORL1 receptors act on distinct receptors to affect the same conductance
(presumably a K+ conductance) because co-application of nociceptin and DADLE
produced an inhibition which was similar to the inhibition that was caused by
nociceptin or DADLE alone. This finding indicates that occlusion rather than
summation occurs between the receptor-messenger systems activated by the two
peptides in MVN neurones.
Ionic mechanisms of N/OFQ-induced inhibition
Recent studies on other neurone types have demonstrated that N/OFQ-
induced hyperpolarisation is associated with activation of a K+ conductance, through
G-proteins coupled to the ORL1 receptor (for a review, refer to part 2.1.1). In this
study the membrane hyperpolarisation and decrease in input resistance seen in
MVN neurones in response to N/OFQ is in agreement with such actions on K+
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conductances, though further voltage clamp experiments are necessary to confirm
the conductance(s) involved.
The functional importance of N/OFQ pathways in modulating vestibular
reflexes in vivo will be an interesting area of future research. In parallel experiments
to the in vitro study described in this chapter, our collaborators in Linkoping, Sweden
carried out an analysis of the effects of intracerebroventricular (i.c.v.) injection of
N/OFQ on the VOR in the alert rat (Sulaiman et al., 1999, in press). They showed
that low concentration of N/OFQ i.c.v., which did not cause general behavioural
effects, caused a significant decreased in the gain of the VOR. This was
accompanied by a significant increase in the time-constant of post-rotatory
nystagmus, indicating that the "velocity-storage" mechanism in the brainstem was
significantly potentiated by N/OFQ. Although these in vivo results probably involve
the effects of N/OFQ on many other sites in addition to MVN neurones (e.g.
cerebellar flocculus), these in vivo and in vitro results show that N/OFQ has a role in
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Vestibular compensation a model of lesion-induced plasticity
In all classes of vertebrates, surgical removal of the peripheral vestibular
receptors of one ear (unilateral labyrinthectomy, UL) or transection of the VIIIth cranial
nerve results in the loss of excitatory input to the vestibular nucleus complex ipsilateral
to the lesion, resulting in an imbalance in neuronal activity between the two sides of the
brainstem. Since many of the vestibular neurones project directly to the motoneurones
controlling the ocular and skeletal musculature, the imbalance in neuronal activity on
the lesioned and intact sides of the vestibular nuclei is believed to generate the
characteristic syndrome of severe oculomotor and postural symptoms, including
spontaneous ocular nystagmus, roll- and yaw-tilt of the head, contralateral limb
extension and ipsilateral limb flexion, barrel-rolling and circular walking, that is
consistent among all vertebrate species (for reviews see Smith and Curthoys, 1989;
Curthoys and Halmagyi, 1995; Dieringer, 1995; Vibert et al., 1997). Remarkably, over
time, many of the severe symptoms following UL gradually disappear or decrease in a
process of behavioural recovery known as "vestibular compensation" (VC). Since the
peripheral vestibular receptors do not regenerate and neurones in Scarpa's ganglion do
not undergo functional recovery following UL, the phenomenon of VC has been
attributed to plasticity in the central vestibular pathways, and is regarded as an
attractive model for studying lesioned-induced plasticity in the adult mammalian central
nervous system (CNS).
The severe symptoms following UL are divided into two categories, "static" and
"dynamic" symptoms, depending upon their relationship to head movement. Static
symptoms occur in the absence of head movement and include spontaneous ocular
nystagmus, deviation of the eyes towards the lesioned side, roll- and yaw-tilt of the
head. Dynamic symptoms such as impaired gain and phase of the vestibulo-ocular and
vestibulo-spinal reflexes occur as a result of head movement (Fisch, 1973; Maioli et al.,
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1983). Although, the exact time-course of vestibular compensation varies among
species, it is the static symptoms which undergo a remarkable degree of compensation
while the dynamic symptoms compensate more slowly and compensation is normally
incomplete (Curthoys and Halmagyi, 1995).
Behavioural changes following unilateral labyrinthectomy (UL).
Static symptoms
In mammals, the most prominent ocular motor effect immediately after UL is a
spontaneous nystagmus, with quick phases directed away from the lesioned side, and
slow phases directed toward the lesioned side (for reviews see Smith and Curthoys,
1989; Curthoys and Halmagyi, 1995; Vibert et at., 1997). In non-mammalian species
such as frogs and probably in all amphibians, the spontaneous nystagmus of the eyes
is absent. Instead the eyes undergo a tonic deviation toward the side of the lesioned
labyrinth (Precht and Dieringer, 1985; Dieringer, 1995). The recovery period of the
spontaneous nystagmus after UL varies among species, from a few hours for the rat
(Hamann and Lannou, 1988) and guinea pig (Curthoys et at., 1988), to a few days for
the cat (Maioli et at., 1983; Maioli and Precht, 1985) and monkey (Fetter and Zee,
1988), to about a week for humans (Cass et at., 1992).
UL also causes severe disturbances in maintaining the posture of the head and
eyes, which has been referred as the ocular tilt reaction. The ocular tilt reaction
consists of roll- and yaw-tilt of the head, skew deviation of the eyes, ipsilateral flexion
and contralateral extension of the forelimbs, circling and rolling toward the lesioned side
(for reviews see Halmagyi et at., 1979; Curthoys et at., 1988, 1991; Curthoys and
Halmagyi, 1995). Changes in maintained head posture after UL are more prominent in
species such as guinea pigs (Curthoys et at., 1988; De Waele et at., 1989), rats (Sirkin
et a!., 1984; Hamann and Lannou, 1988), cats (Xerri and Lacour, 1980; Cass and
Goshgarian, 1991) and monkeys (Fetter and Zee, 1988) than in human (Halmagyi et
at., 1979). In the former four species, UL results in both roll- and yaw- head tilts, while
in humans the head tilt is moderate. As mentioned earlier, recovery of postural
abnormalities induced by UL varies among species. It may take several hours in rats
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(Sirkin et al., 1984; Hamann and Lannou, 1988), days in guinea pigs (Smith et al.,
1986b; Smith et al., 1986a) weeks in monkeys (Fetter and Zee, 1988) and months in
frogs (Dieringer and Precht, 1982; Dieringer, 1995). Recovery of the postural
abnormalities occurs much faster in the presence of visual input (Putkonen et at., 1977;
Smith et al., 1986a).
UL also causes skew deviation of the eyes, in which the eye on the ipsilateral
side to the lesion is held lower in the orbit than the eye on the intact side (Halmagyi et
al., 1979; Curthoys et al., 1991; Wolfe et al., 1993). In species such as guinea pigs,
rabbits, rats and horses, the eye on the side of the lesion deviates down and the eye on
the contralateral side deviates up, while in humans the eye on the lesioned side moves
down and the eye on the opposite side remains in its normal position (Baarsma and
Collewijn, 1975; Halmagyi et al., 1979; Dieringer and Precht, 1982; Sirkin et al., 1984;
Curthoys et al., 1991).
Dynamic symptoms
The dynamic symptoms following UL include a disruption of the vestibularly
mediated ocular motor and postural reflexes, which are evoked by head movement.
While the static symptoms caused by UL and their compensation have been known for
150 years, the dynamic symptoms were first described when measures of ocular motor
and postural reflexes became available about 50 years ago (Curthoys and Halmagyi,
1995).
In mammals, UL causes severe deficits in the gain, symmetry and timing of the
horizontal vestibulo-ocular reflex (VOR). Numerous studies have shown severe and
permanent VOR gain asymmetry following UL in which the gain of the VOR is smaller
for head rotations toward the lesioned side compared to that of head rotations towards
the intact side representing an asymmetric VOR gain. Therefore, eye movements are
neither sufficient in amplitude nor phase in order to compensate for head movements
(Baarsma and Collewijn, 1975; Maioli et al., 1983; Maioli and Precht, 1985; Cass and
Goshgarian, 1991).
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The dynamic symptoms improve over a period of weeks, however
comparatively their compensation is much slower and more limited than in the case of
the static symptoms. In all species studied, the asymmetry of the VOR gain appears to
be permanent since deficits in the VOR gain can be detected many months or even
years following UL (for reviews see Smith and Curthoys, 1989; Curthoys and Halmagyi,
1995).
Neuronal changes following UL
Extensive in vivo extracellular electrophysiological studies from brainstem
vestibular relay neurones, particularly the medial vestibular nucleus (MVN) neurones
have been carried out in order to examine the changes in neural activity that occur
during VC (Precht et al., 1966; Markham et a/., 1977; Ried et at., 1984; Hamann and
Lannou, 1988; Smith and Curthoys, 1988a, 1988b; Newlands and Perachio, 1990a,
1990b; Ris et al., 1995, 1997). These studies have demonstrated the sequence of
changes in the resting activity of the vestibular neurones, which correlates well with the
sequence of changes in behaviour. It has been shown that immediately after UL or
vestibular neurorectomy, the normally high resting discharge rate of most MVN
neurones on the ipsilateral side of the lesion is largely abolished but gradually restored
over time as VC advances (Fig. 3.1.1.1).
Smith and Curthoys (1988a,b) demonstrated that immediately after UL (0-8
hours) in anaesthetised guinea pigs, there is a reduction in the number of Type I
neurones recorded from the MVN on the ipsilateral side to the lesion and the average
resting discharge of recorded neurones is very low. Studies in alert guinea pigs also
reveal that during the first 10 hours after UL, 69% of the Type I MVN neurones on
ipsilateral side are silent while the remaining active neurones have a very low average
resting discharge (Ris et al., 1995, 1997). Conversely, recordings from MVN neurones
contralateral to the lesion show an increase in the resting discharge rate of the Type I
MVN neurones. These results are consistent with the recordings of single neurone
activity in cats (Markham et al., 1977; Ried et al., 1984), gerbils (Newlands and
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Perachio, 1990a) and rats (Precht eta/., 1966; Hamann and Lannou, 1988). The loss of
neuronal activity in the Type I MVN neurones on the ipsilateral side to the lesion
appears to be caused not only by the loss of excitatory drive from the lesioned
ipsilateral primary vestibular afferents, but also due to an enhanced commissural
inhibition from the contralateral MVN neurones, which become hyperactive due to loss
of inhibitory drive from the ipsilateral side (Fig. 3.1.1.1: Smith and Curthoys, 1988a,
1988b; Curthoys and Halmagyi, 1995).
While recordings from Type 1 MVN neurones on the ipsilateral side showed an
immediate decrease in the resting discharge rate and increase on the contralateral side
at 0 - 8 hours post-UL, the resting discharge rate of Type II MVN neurones on the
ipsilateral side was reported either to increase (Shimazu and Precht, 1965; Smith and
Curthoys, 1988b) or remain the same as normal (Hamann and Lannou, 1988). On the
contralateral side, the resting discharge rate of Type II MVN neurones were reported to
be lower than that of normal animals (Smith and Curthoys, 1988b) or virtually absent
(Ried e/a/„ 1984).
Apart from these electrophysiological studies, this early imbalance in the
neuronal activity between both sides of the MVN has also been suggested by studies
using other indicators of activity including 2-deoxyglucose (Patrickson et al., 1985;
Luyten et al., 1986), c-fos expression (Kaufman et al., 1992; Cirelli et al., 1993;
Kitahara et al., 1995; Cirelli et al., 1996) and recently glial fibrillary acidic protein
(GFAP) mRNA expression (de Waele et al., 1996).
As VC progresses, the imbalance in neuronal activity of Type I MVN neurones
on both sides of the brainstem gradually improves. Recording from guinea pig MVN
neurones on the ipsilateral side to the lesion showed that the resting discharge rate of
Type I MVN neurones returned to normal, 52 hours after UL (Smith and Curthoys,
1988b) and a recent study in the alert guinea pig demonstrated that a resting discharge
rate of Type I MVN neurones on the ipsilateral side begin to recover as early as 12
hours post-UL with complete restoration within 1 week post-UL (Ris et al., 1995). The
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Figure 3.1.1.1 : The interaction between the VN and changes in resting
activity following UL
Before UL, each MVN receives excitatory input from the eight nerve and
exerts inhibition via the commissural fibers on the opposite MVN. The
average resting discharge is equal in both nuclei. Following UL (0-8h) Type
I neurones on the lesioned side (ipsilateral side) are now disfacilitated due
to the loss of their excitatory input. The resting discharge of MVN neurones
in the ipsilateral side drops to a low value, thus inhibition of the contralateral
MVN is reduced. In turn, the contralateral MVN neurones become
hyperactive and they thus exert greater inhibition on the neurones in the
ipsilateral side (thick arrow). Thus the ipsilateral MVN neurones rapidly fall
silent after UL, while the neurones on the contralateral side are hyperactive.
However, during VC (52h after UL) the vestibular neurones on the ipsilateral
side recover their resting activity, and the marked imbalance in excitability is
progressively reduced.
(Adapted from Curthoys and Halmagyi, 1995)
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restoration of normal spontaneous neuronal activity of Type I MVN on the ipsilateral
side seems to correlate with the recovery of the initial static symptoms of UL. In guinea
pigs, compensation of the static symptoms occurs within 52 hours post-UL (Smith et
al., 1986a). In the frog, compensation of the static postural symptoms occurs over a
longer time-period, approximately 40 - 70 days post-UL and is also associated with a
return of the normal resting activity to neurones in the lesioned side (Dieringer and
Precht, 1979a).
Mechanisms of vestibular compensation.
Electrophysiological changes within the vestibular nuclei induced by UL,
particularly restoration of spontaneous neuronal activity to Type I MVN neurones on the
lesioned side have been associated with the initial rapid stage of behavioural recovery.
However the mechanisms underlying the rapid restoration of spontaneous neuronal
activity in these ipsilateral Type 1 MVN neurones are still largely unknown. Since the
early study by Precht and his colleagues (1966) on the decerebrated cat, several
hypotheses have been put forward to explain VC.
Reactive synaptogenesis
Reactive synaptogenesis, the sprouting of healthy axons to form new synapses
in response to deafferentation as a possible outcome of UL in cats, was first proposed
by Precht et al., (1966), and has often been considered as a likely mechanism of VC.
Although there is evidence for reactive synaptogenesis in the frog (Dieringer et al.,
1984) and cat (Korte and Friedrich, 1979; Raymond et al., 1991) as early as 5 days
post-UL, this cellular process appears to be too slow to account for the rapid time-
course of static compensation in other mammalian species. For example, in the guinea
pig and rat, neuronal activity returns within 52 h and 24h respectively. Reactive
synaptogenesis is clearly too slow to explain the rapid restoration of resting discharge
rate of deafferented vestibular nucleus neurones, however, it may be responsible for
the long-term stability of VC (Gacek et al., 1988, 1989, 1991; Raymond et al., 1991).
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Denervation supersensitivity
Another relatively slow developing cellular process of lesion-induced synaptic
plasticity that has been suggested as a possible mechanism of VC is denervation
supersensitivity. It is suggested that neurones in the VN, which have been deprived of
afferent input by UL, become more sensitive to the transmitter normally released by the
now silent primary afferents. This process has been suggested in other neurones to be
due to either an up-regulation in the number of postsynaptic receptors or due to an
increase in receptor affinity following denervation and occurs within days rather than
hours (Sharpless, 1975; Wall and Devor, 1981; Ulas et a!., 1990). As far as the VN is
concerned, there is no convincing evidence so far to support the denervation
supersensitivity hypothesis. Although several studies have suggested that the return of
resting discharge rate in the ipsilateral MVN neurones may be associated with an up-
regulation of NMDA receptors (Smith and Darlington, 1988; Darlington and Smith,
1989; de Waele et al., 1990; Pettorossi et at., 1992; Flohr and Luneburg, 1993), neither
electrophysiological studies nor neurotransmitter binding studies clearly support this
hypothesis (for reviews see Smith and Curthoys, 1989; Darlington et al., 1991; Smith
and Darlington, 1991). Furthermore the time period of VC does not correlate with the
time period required for denervation supersensitivity and therefore does not support
this hypothesis as mechanism of VC.
Role of vestibular commissures
Participation of vestibular commissures in the compensation process has been
demonstrated in the frog. It has been demonstrated that VC in the frog is associated
with an increase in efficacy of excitatory brainstem commissural input to lesioned
vestibular neurones (Bienhold and Flohr, 1978; Dieringer and Precht, 1979a; Dieringer
and Precht, 1979b; Galiana et al., 1984; Kunkel and Dieringer, 1994; Dieringer, 1995),
however, in mammals, there is no evidence in support of this hypothesis (Smith and
Curthoys, 1988c; Newlands and Perachio, 1990a). The failure to find any
corresponding change in commissural efficacy can most easily be explained by the fact
that in mammalian species, the vestibular commissures are functionally inhibitory rather
than excitatory (see Galiana et al., 1984 for a discussion).
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Cerebellar shutdown
Because of its important role in motor co-ordination in the normal animal, the
cerebellum is believed to play a functional role in VC. Involvement of the cerebellum in
VC following UL in the cat has been suggested by McCabe and Ryu (1969). They have
suggested that the cerebellum is involved in VC by responding to a massive asymmetry
of neuronal activity following UL. During the acute stage of post-UL, the cerebellum
imposes a shutdown of the intact side in order to rebalance the asymmetry of neuronal
activity between the two vestibular nuclei. This hypothesis is called "cerebellar
shutdown". The authors also demonstrated that a cerebellectomy released this
shutdown of neuronal activity on the intact MVN, indicating that they were previously
inhibited by the cerebellum during the critical stage of compensation (McCabe and Ryu,
1969; McCabe et ai, 1972). The reduction of horizontal VOR gain for both directions of
rotation immediately after UL supports this hypothesis (Fetter and Zee, 1988).
However, cerebellar shutdown by itself is not enough to prevent spontaneous
nystagmus as it occurs soon after UL. Also, other in vivo electrophysiological
recordings in cat and other species have shown that MVN neurones in the intact side
were not silenced following UL (Markham et al., 1977; Hamann and Lannou, 1988;
Smith and Curthoys, 1988a; Ris et al., 1997)
Change in Intrinsic excitability
It has been suggested that an intrinsic capacity of the cell membrane for
repetitive firing may be responsible for the regeneration of resting activity which occurs
in the lateral cuneate nucleus following partial deafferentation (Kjerulf and Loeser,
1973). In the light of this work, Darlington and Smith (1996) have proposed that such a
mechanism may also be functioning in the deafferented VN, since recent studies have
demonstrated that the majority of MVN neurones in vitro exhibit a spontaneous resting
discharge in the absence of synaptic drive (Darlington et al., 1989, 1990; Lewis et al.,
1989; Serafin et al., 1990, 1991a; Smith et al., 1991; Dutia et al., 1992) and possess
endogenous pacemaker-type properties such as the persistent Na+ conductance and
low and high threshold Ca2+ conductances (Serafin et al., 1991b; Johnston et al., 1994).
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The first direct evidence for a change in the intrinsic excitability of MVN
neurones, which is argued may be responsible for the restoration of the resting
discharge on the lesioned side of the MVN following UL was demonstrated by Cameron
and Dutia (1997) in rat dorsal brainstem slices. They have shown that a significant
increase in the intrinsic excitability of MVN neurones on the lesioned side occurs
between 2-4 hours after UL. The increase in intrinsic excitability of these neurones
was observed as an increase in the mean spontaneous discharge rates of the MVN
neurones on the lesioned side when the MVN of the two sides are isolated in vitro.
Thus, they are removed from the influence of the commissural inhibitory system that
normally links them in vivo. In addition, the change in intrinsic properties of the MVN on
the lesioned side is restricted to the neurones located in the rostral area of the lesioned
nucleus where the vestibular nerve afferents predominantly terminate.
It has been suggested that the mechanism underlying the increase in excitability
of the deafferented MVN neurones may be due to down-regulation of GABA receptors
on these neurones, since it is known that the spontaneous discharge rate of MVN
neurones in vitro is modulated by GABAergic activity and administration of GABA
antagonists results in disinhibition (Dutia et al., 1992). The proposed mechanism is
supported by Calza et al., (1992), who observed a decrease in benzodiazapine binding
in the MVN on the side of lesion within 3 hours post-UL. In a recent in vitro
electrophysiological study, Yamanaka et at., (1998, in preparation) observed a marked
down-regulation in the efficacy of both GABAa and GABAb receptors toward their
agonists in the rostral region of the lesioned MVN after 4 hours post-UL. Hence, it is
likely that the loss of excitatory input from the primary vestibular afferents is
compensated by a decrease in responsiveness of the MVN neurones to inhibitory
synaptic input, thus causing an increase in their intrinsic excitability.
In subsequent in vitro experiments, Cameron and Dutia (1998, in preparation)
have shown that the increase in intrinsic excitability of the rostral MVN neurones after
UL in the rat is dependent on the activation of the hypothalamo-pituitary-adrenal stress
axis, particularly the activation of glucocorticoid receptors (Grs). The compensatory
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increase in intrinsic excitability of MVN neurones did not occur in labyrinthectomised
animals that were maintained under urethane anaesthesia for 4 - 6 hours after UL, so
that they did not experience the stress that normally results from UL. In these animals,
administration of the synthetic GR agonist dexamethasone at the time of UL in order to
mimick the stress response, restored the compensatory increase in intrinsic excitability
of the MVN neurones. Administration of dexamethasone in itself had no effect on the
intrinsic excitability of MVN neurones in sham-operated animals. In conjunction with this
experiment, Cameron and Dutia have also demonstrated a high level of c-Fos-like
immunoreactivity in the paraventricular nucleus of the hypothalamus 1.5-3 hours post-
UL in awake animals that experienced the oculomotor and postural symptoms of UL,
indicating a strong activation of the stress axis. In addition, administration of the GR
antagonist RU38486 at the time of UL abolished the increase in intrinsic excitability of




3.2 AIMS OF STUDY
It is well established that surgical removal of one labyrinth of the inner ear
(unilateral labyrintechtomy) or transection of vestibular nerve (neurectomy)
generates severe disturbances of the vestibulo-ocular and vestibulo-spinal reflexes
leading to a complex syndrome of ocular motor and postural symptoms (for details
refer to part 3.1.2). However, many of these symptoms recover gradually over time
in a process referred to as vestibular compensation (VC). The majority of recent
studies using in vivo extracellular recording have concentrated on vestibular
neurones in the MVN, in order to examine the changes in neural activity during VC.
It is now known that following UL, the resting activity of MVN neurones on the
lesioned side (ipsilateral) is severely depressed, due to the loss of excitatory input
from the lesioned VIIIth nerve and presumably also because of enhanced
commissural inhibition from contralateral MVN neurones, which become hyperactive
due to the loss of inhibitory drive from the lesioned side. This severe imbalance in
the excitability of the vestibular nuclei on the two sides is believed to cause the
severe ocular and postural symptoms. During the process of VC over 2-3 days the
vestibular neurones on the ipsilateral and contralateral sides restore their resting
activity, and marked imbalance in excitability is progressively reduced correlated
with the recovery of many ocular and postural symptoms.
Recently, using in vitro slices of the MVN from animals that had been
labyrinthectomised at various times beforehand, Cameron and Dutia (1997) have
demonstrated that neurones in the rostral region of the MVN develop a sustained,
significant increase in their intrinsic excitability between 2-4 hours after UL. Thus,
this rapid cellular response is likely to be an important initial step in the process of
VC. Subsequently, Yamanaka et al., (1998, in preparation) have shown that within 4
hours after UL, there is marked functional down-regulation of the efficacy of GABAa
and GABAb receptors in the rostral MVN neurones and significant up-regulation of
GABAa receptor efficacy in the contralateral MVN neurones. They have proposed
that the down-regulation of GABAergic efficacy following UL may be responsible for
the restoration of the resting activity in the ipsilateral rostral MVN neurones.
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While the changes in GABAergic inhibitory efficacy in the ipsilateral rostral
MVN neurones may contribute to their increase in intrinsic excitability after UL, it is
possible that other compensatory changes in the intrinsic properties of these
neurones also occur. In vitro electrophysiological studies of MVN neurones in the
brainstem slice preparation have identified two distinct types of MVN neurones
based on their after-hyperpolarisation (AHP). Type A exhibited a single AHP and
Type B exhibited double AHP (Johnston et al., 1994). In addition, it has been
demonstrated that these neurones possess a variety of voltage activated
conductances such as a persistent Na+ conductance, K+ conductance and Ca2+
activated K+ conductances which contribute to a regular spontaneous discharge
activity in vitro. It has also been proposed that changes in the intrinsic membrane
properties of the MVN neurones may be important in the functional recovery
following vestibular lesions (Darlington et al., 1992). However, there have been no
such studies so far of MVN neurones during VC after UL. Therefore, using whole-
cell patch clamp recordings from MVN neurones in dorsal brainstem slice
preparations taken from animals that had been labyrinthectomised 4 hours earlier,
the primary aims of this study was to determine if changes occur in the intrinsic
membrane properties and action potential firing of identified Type A and Type B
MVN neurones in the early stage of VC, over the period in which these neurones




The intrinsic membrane properties of MVN neurones in normal and left
unilateral labyrinthectomised adult rats were studied with the use of the blind whole
cell recording techniques. For the purpose of analysis the MVN slice was visually
divided into two regions, rostral part and caudal part (Fig. 3.3.0). Except for the
following, the methods used in this part of study are similar to those described in the
method sections of Chapter 1 (part 1.3). All values are presented as means ±
S.E.M. Comparisons of the mean resting discharge rates, membrane properties and
action potential properties of MVN neurones in different groups were performed
using the Student's t-test (Sigma Stat, Jandel Scientific), unless otherwise stated
and significance was assumed when p<0.05.
Anaesthesia
Avertin (tribromoethanol)
Avertin (Dyer et al., 1981), anaesthetic was prepared fresh every morning
according to the following recipe: 2.5g tribromoethanol (Sigma, UK) was added to
10ml of ethanol (Sigma, UK) and mixed until the tribromoethanol dissolved
completely. To this solution, 1.5mls of 2-methylbutan-2-ol (Sigma, UK) was added
and subsequently made up to a final volume of 125ml by the addition of normal
saline (9g/l). The solution was administered intraperitoneal^ at a dose of 1ml/100g
body weight and provided surgical anaesthesia for 30-40min.
Unilateral labyrinthectomy and behavioural observation
The procedure to perform a unilateral labyrinthectomy was as follows. Male
Sprague-Dawley rats (60-130g) were anaesthetised with Avertin. A sufficient level
of surgical anaesthesia was determined by a lack of reflex to a paw pinch. The
surgical area was then clipped, shaved and scrubbed clean with hibisol. An incision
about 4 cm long was made above the left ear with a sterile scalpel and the
connecting tissue was cut using sharp surgical scissors, the middle ear was opened
and the ossicles were removed. The muscles attached to the lambodial ridge were
cut close to the bone and reflected to expose the temporal bone. The bony duct of
the horizontal semicircular canal was then exposed by carefully drilling with a dental
drill (Precision P.C.B drill, RS Components) near the point of exit of the VIIth cranial
nerve. The area was kept clear with a needle attached to a suction pump.
87
CHAPTER 3: METHODS
The horizontal duct was followed anteriorly and opened near its ampullary
swelling. Drilling was continued in the plane of the horizontal canal to follow the
open duct into the vestibule of the inner ear. The ampulla of the anterior canal was
drilled through, and the contents of the vestibular cavity were rinsed with 100%
ethanol (Sigma U.K.), which was then aspirated. When bleeding had stopped, the
wound was sutured and animals returned to their home cage to recover. An
identical procedure was used for sham operated animals except that the horizontal
canal was not opened, and no damage was inflicted on the inner ear. Success of
the unilateral labyrinthectomy was determined by observing the animal following
recovery from anaesthesia, which was completed within 50-60 min after induction.
Unilaterally labyrinthectomised animals showed characteristic symptoms including
tonic eye deviation, spontaneous ocular nystagmus, circular walking and head
deviation toward the side of the lesion, extensor weakness in the ipsilateral limbs,
and barrel rolling. These symptoms were absent in sham-operated animals.
Horizontal slices of brainstem containing the MVN were then prepared 4 hours
following surgery (see Part 1.3 of Chapter 1).
Experimental protocols are similar to that described in methods in Chapter 1, except
for the following protocol:-
The spike frequency adaptation and steady-state gain.
Spike frequency adaptation (SFA) during constant depolarising current
injection was determined by using the Clampex program (Pclamp Software
Program, Axon Instruments) to obtain the interspike intervals (ISI) in ms. A series of
constant depolarising current steps of increasing amplitude (50 pA increments from
100 pA, 200 ms duration) were injected into an identified Type A or Type B MVN
neurone from a holding potential of RMP -20mV (below firing threshold). ISIs of
each series were extracted from the Clampex files and converted to spikes/sec (Hz)
using program written by Dr MB. Dutia with the formula 1 /ISI X 1000 = Hz. Microsoft
Excel ver 7.0 was used to plot the firing frequency Hz (y-axis) against current
injection (x-axis) and provided a graphic depiction of SFA curves.
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SFA index was measured by subtracting the first ISI (ISI,) from 14th ISI
(ISI14) of the largest current injection (8th current pulse) and the steady-state gain
was obtained from the ISI14.(Fig. 3.3.1). The SFA index and steady-state gain plot of
each neurone was achieved by plotting the SFA index and steady-state gain against
resting discharge rate. Measurements of the membrane input resistance and spike
frequency adaptation in control, sham-operated and lesioned animals were made at
membrane potential held at -20 mV below firing threshold.
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Figure 3.3.0 : Schematic representation of the MVN
Schematic representation of the horizontal slice of the left MVN showing









Figure 3.3.1 : Spike-frequency adaptation Index (SFA index) and steady-
state gain
Firing properties of typical Type A MVN neurone in response to
depolarising current injection. SFA index was measured from the
difference between the first interspike interval (ISI.,) and the 14th interspike
interval (ISI14), while the steady-state gain was obtained from the ISI14 of
the largest depolarising current injection (8th current pulse).
CHAPTER 3
3.4 RESULTS
Data in these experiments were obtained from a total of 91 spontaneously
active MVN neurones in horizontal slices of dorsal brainstem of normal, sham-
operated and 4h post-UL rats, in vitro. The spontaneously active MVN neurones
were recorded using intracellular whole cell patch clamp recording techniques and
each MVN neurone was classified as either Type A or Type B based on the work of
Johnston et al., (1994,1998). All MVN neurones included in this study displayed a
resting membrane potential (RMP) greater than -45 mV (-45.6 ± 0.5mV, mean ±
S.E.M), membrane input resistances of 139.3 ± 6.1 MQ and spontaneous action
potentials larger than 60 mV in amplitude.
Electrophysiological properties of normal and sham-operated MVN neurones
Intracellular whole cell patch clamp recordings were made from a total of 25
spontaneously active MVN neurones in slices prepared from normal adult rats.
Based on their averaged spontaneous action potential shapes, 9/25 (36%) of these
neurones were classified as Type A MVN neurones, had a single deep post spike
after-hyperpolarisation (AHP) and the remaining 16/25 (64%) were classified as
Type B MVN neurones with an early fast AHP followed by a delayed slow AHP
following their spontaneous action potentials (Fig. 3.4.1.1).
The mean values of the spontaneous action potential parameters obtained
from averaged action potential shapes of the two MVN neurone types in normal
slices are shown in Table 3.4.1. The duration of the averaged spontaneous action
potential of Type A neurones, which was measured as the width at threshold (WT)
and as the width at half-height (WH) was significantly longer than that of Type B
neurones. Correspondingly, the rate of rise (measured as the rate of change of
voltage from threshold to the peak of the action potential) and fall (measured as the
rate of change of voltage from the peak of the action potential to return to threshold)
of the action potential of Type A neurones were significantly slower than those of
the Type B neurones. The membrane input resistance of Type A and Type B MVN,
measured from the slope of l-V curve (Fig.3.4.1.2 and 3.4.1.3) and their resting
discharge rate did not show significant difference. Thus, the proportion and
averaged action potential parameters of Type A and Type B MVN neurones in this
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study are similar to those obtained in the earlier studies with sharp electrodes
(Johnston et al., 1994; Dutia and Johnston, 1998).
As reported earlier by Serafin et al., (1991) and du Lac and Lisberger
(1995), Type A and Type B MVN neurones also showed a clear difference in their
characteristic of action potential firing in response to long-lasting, constant
depolarising current steps of increasing amplitude at a holding potential of 20 mV
below RMP. As indicated in the examples in figure 3.4.1.4, Type A MVN neurones
responded with an almost regular frequency through out the duration of the current
injected. The spike-frequency adaptation curve (f - I curve) was linear (Fig. 3.4.1.5).
By contrast, Type B MVN neurones fired at a higher frequency for the first few
spikes of the train and then the firing frequency decayed to steady-state value (Fig.
3.4.1.6). As a result, in type B neurones, the response to current steps scaled
linearly except during the initial portion of the response, thus the spike frequency
adaptation curves show a secondary range (Fig 3.4.1.7, Serafin et al., 1991; du Lac
and Lisberger, 1995).
A further 18 MVN neurones were recorded and characterised in slices
prepared from animals that had undergone a sham-operation 4 hrs previously. Of
these 4/18 neurones (22%) were identified as Type A neurones and the remaining
14/18 (78%) neurones were Type B. The comparison of basic electrophysiological
properties of Type A and Type B in normal and sham-operated animals are
summarised in table 3.4.2. There were no significant differences found in the RMP,
membrane input resistance (Rm), action potential characteristics and spontaneous
resting discharge rates recorded from Type A and Type B of normal and sham-
operated animals. As shown in the graph in Fig. 3.4.1.8, the spike frequency
adaptation index (SFA index; ISI14 - ISI-, for the largest current step) plotted against
resting discharge of Type A and Type B MVN neurones for both groups also
showed a linear relationship. The steady-state gain of Type A and Type B in both
groups was also no different (Fig. 3.4.1.9). Therefore, the data from normal and




Electrophysiological properties of MVN neurones after UL.
A total of 48 spontaneously active MVN neurones were obtained in slices
prepared from adult rats that had undergone left unilateral labyrinthectomy 4 hours
earlier. Whole cell patch clamp recordings were made from the neurones that were
located in the rostral and the caudal regions of the MVN ipsilateral to the lesioned
side. Of these, 34 MVN neurones were recorded in the rostral region of the
ipsilateral nucleus, while the remaining 14 neurones were recorded in the caudal
region of the ipsilateral nucleus. In this study, neurones located in the contralateral
MVN were not examined.
The identification of neuronal types in both rostral and caudal regions of the
ipsilateral MVN was similar to those in control. It was found that the relative
proportions of Type A and Type B neurones recorded 4 hours after UL were similar
to controls. Hence 6/34 (17.6%) neurones recorded in the rostral part and 4/14
neurones recorded in the caudal part were Type A neurones, while the remaining
28/34 (82.3%) rostral neurones and the remaining 10/14 (71.4%) caudal neurones
were Type B.
As shown in histogram in Figure 3.4.2, there were no statistically significant
differences in RMP (-45.4 ± 0.8 mV, n = 34, Type A and B neurones together) and
Rin (153.6 ± 12.0 MQ, Fig 3.4.2.1) in the ipsilateral rostral MVN neurones recorded 4
hours after UL compared to rostral neurones in control slices (normal and sham-
operated neurones; RMP: -46.3 ± 0.6, n =28; Rm: 126.8 ± 8.8 MQ, n = 28). Similarly,
overall mean values for RMP (-45.1 ±1.7 mV, n = 14) and Rin (153.5 ± 17.0 MQ) did
not significantly differ between neurones in the ipsilateral caudal MVN after UL and
neurones in control caudal slices (RMP: -45.5 ± 0.5 mV, n = 15; Rm: 117 ± 8.0 MQ).
However, it was observed that the overall mean resting discharge rate
between the ipsilateral rostral MVN neurones after UL was significantly higher than
that of the rostral neurones in normal and sham-operated animals (21.9 ± 1.2
spikes/sec, n = 34 neurones in UL slices vs 13.6 ± 0.9 spikes/sec, n = 28 neurones
in control slices, p < 0.05, Student f-test; Fig 3.4.2.2). There was no difference in the
mean resting discharge rate in the ipsilateral caudal MVN neurones after UL (14.7 ±
1.3 spike/sec, n = 14 neurones) from those of caudal MVN neurones in control
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slices (14.8 ± 1.8 spikes/sec, n = 16 neurones). Hence, this result confirms the
earlier report of a significant increase in intrinsic excitability of ipsilateral rostral MVN
neurones within 4 hours following UL in the rat (Cameron and Dutia, 1997).
Interestingly, as shown in Fig. 3.4.2.3, comparison of the mean in vitro
resting discharge rates of the two sub-types of MVN neurones from the population
of the ipsilateral rostral MVN neurones after UL revealed that the resting discharge
rate of Type A neurones (15.0 ± 1.5 spikes/sec, n = 6 neurones) was not different
from that of rostral Type A neurones in pooled control (normal and sham) slices
(10.9 + 1.4 spikes/sec, n = 7 neurones). By contrast, the mean resting discharge
rate of rostral Type B neurones (23.4 ± 1.2 spikes/sec, n = 28 neurones) was
significant higher compared to control rostral Type B neurones (14.5 ± 1.1
spikes/sec, n = 21 neurones, p < 0.05, Student's f-test).
As indicated in figure 3.4.2.4, an analysis of the SFA index and resting
discharge rate relationship showed that rostral Type B MVN neurones after UL did
not form a homogenous group. Instead the SFA index values of 14/28 (50%) of the
ipsilateral rostral Type B MVN neurones overlapped with those of control rostral
Type B MVN neurones, and fell within the ± 99% prediction interval around the
mean control regression slope. The resting discharge rate, SFA index and steady-
state gains of these ipsilateral rostral Type B neurones were not different from those
of control rostral Type B MVN neurones. However, the remaining 14/28 (50%) of the
ipsilateral rostral Type B MVN neurones were distributed outside the + 99%
prediction interval of control regression slope, with resting discharge rates (Fig.
3.4.2.5) and SFA index that were significantly different from those of control and the
other group Type B neurones. Thus of the Type B neurones in the ipsilateral rostral
MVN a sub-population, which for the purpose of this thesis will be called "Type B+
neurones", showed a marked lesion-induced plasticity and adaptation in their
intrinsic membrane properties during the early stage of vestibular compensation
following UL, while the other group of rostral Type B neurones after UL did not show
any change in their intrinsic membrane properties ("Type B" neurones"). Figure
3.4.2.6 to 3.4.2.9 illustrate examples of voltage traces and SFA curves of Type B+
and Type B" MVN neurones in response to constant depolarising current pulses.
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Further analysis showed that the changes in the resting discharge rate and
SFA index in of these ipsilateral rostral Type B+ neurones were accompanied by
marked changes in the parameters of their spontaneous action potentials, as seen
in their averaged action potential shapes. The mean values of the spontaneous
action potential parameters of the two groups of ipsilateral rostral Type B neurones
after UL are shown in table 3.4.3. Following UL, the duration of the averaged
spontaneous action potentials of Type B+ MVN neurones measured at spike
threshold and at half-height (WT: 1.27 ± 0.05 ms; WH; 0.6 ± 0.03 ms, n = 14) were
significantly wider than that of Type B" neurones after UL (WT: 0.79 ± 0.05 ms; WH:
0.4 ± 0.03 ms, n = 14) and rostral Type B neurones in control slices (WT: 0.86 ±
0.05 ms; WH: 0.4 ± 0.02 ms, n = 21, Fig 3.4.3.1A and B). Moreover, in line with the
wider action potentials, both the mean rates of rise (93.8 ± 6.67 V/sec) and fall (88.5
± 5.54 V/sec) of the action potential of Type B+ neurones were also significantly
slower than the mean rate of rise and fall of the Type B" neurones (rise: 145.5 ±
11.91 V/sec; fall: 166 ± 14.30 V/sec) and control Type B neurones (rise: 141.5 +
9.47 V/sec; fall : 158.9 ± 11.87 V/sec, p < 0.05, one way, Fig 3.4.2.8C and D). By
contrast, the action potential parameters of the Type B" neurones showed no
significant changes (p > 0.05, one way ANOVA) in their averaged action potential
shapes after UL compared to control Type B neurones.
Furthermore, it were also observed that the early fast AFIP that is mediated
by TEA-sensitive K+ in Type B neurones (Johnston et al., 1994) became smaller in
Type B+ neurones, while the slower, delayed AHP that is mediated by apamin-
sensitive Ca2+-activated K+ conductance (Johnston et al., 1994) was not affected.
Figure 3.4.3.2, illustrates examples of averaged action potentials superimposed of
Type B MVN neurones in control slices and slices prepared from animals 4 hours
after UL. There were no change in the early fast and slow, delayed AHP in Type B-
MVN neurones.
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Figure 3.4.1.1 : Averaged action potential shapes of MVN
neurones
Action potential averaging showing two subtype of MVN
neurones, Type A and Type B. Note the single deep after
hyperpolarisation in the Type A (solid arrow) and the early fast
(solid arrow) followed by slow delayed (open arrow) after
hyperpolarisation in the Type B neurone.
TABLE3.4.1
COMPARISONOFELECTROPHYSIOLOG CALPROPERTIEOFNOR LTY EANDB MVNNEURONES. TypeATypeBP Parameters(n=9)(n 16) APwidthathreshold,ms1.18±0 090.8005<0. 01 APwidthahalf-heig t,ms0.56±050.3802<0. 1 Rateofris ,V/sec93.9±5.52152 80.1< 001 Rateoffall,V/sec92.9±7.16154.39. 7<0 001 RMP,mV-46.1±0.9-45.5±0.ns Rin,MQ140.2±3.31114.8±13.03ns Restingdischargerate,Hz13.4±2.2714.3.70n
Valuesrmean±S.E.M.;AP,actiopot ntial;RMPrestingmembra epoten i l;n,membranein uresist c ;,significa ce.Th Pvalueswerobtainedfr mStudent'st-tes ,(n=25)
Legend 3.4.1.2 : Response of Type A MVN neurone to current
pulses
(A) Example of voltage-current relationship (l-V; raw data) of Type A
MVN neurone to series of constant depolarising and hyperpolarising
current pulses. (B) l-V curve obtained from (A). Input resistance of
the neurone was measured from the slope of l-V curve. Arrow
indicates where the measurements were made. The resting
membrane potential of the neurone was held at -20 mV below firing
threshold.
Figure 3.4.1.2 : Response of Type A neurone to current pulses.
Legend 3.4.1.3 : Response of Type B MVN neurone to current
pulses
(A) Example of voltage-current relationship (l-V; raw data) of Type B
MVN neurone to series of constant depolarising and hyperpolarising
current pulses. (B) l-V curve obtained from (A). Input resistance of the
neurone was measured from the slope of l-V curve. Arrow indicates
where the measurements were made. The resting membrane
potential of the neurone was held at -20 mV below firing threshold.
(A)












Figure 3.4.1.4 : Voltage traces of a normal Type A MVN
neurone in response to depolarising current pulses of
different amplitudes for duration of 200ms. The neurone
displayed a regular firing frequency throughout the duration
of the current injected. RMP was held at -20 mV below firing
threshold.
Current injection (nA)
Figure 3.4.1.5 : Spike-frequency adaptation curve of normal Type A
MVN neurone
Spike-frequency adaptation curve of the Type A neurone illustrated
in figure 3.4.1.4, measured at different intervals showing linear
relationship to the amplitude of currents injected.
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Figure 3.4.1.6 : Voltage traces of a normal Type B MVN
neurone in response to depolarising current pulses of different
amplitudes. The neurone displayed a higher frequency for the
initial part of the spike train and then decayed to steady-state
value.
) interval
0.1 0.6 1.1 1.6 2.1 2.6 3.1
Current injection (nA)
3.6
Figure 3.4.1.7 : Spike-frequency adaptation curve of normal Type B
MVN neurone
Spike-frequency adaptation curve of the Type B neurone illustrated
in figure 3.4.1.6, measured at different intervals showing non-linear
relationship in the first interval. Notice the presence of a secondary
range for the first and second intervals.
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Figure 3.4.1.8 : Relationship between SFA index and resting discharge
rate
Scatter graphs showing the relationship between SFA index and resting
frequency of Type A and Type B MVN neurones from slices of normal
and sham animals
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Figure 3.4.1.9 : Relationship between steady-state l-F gain and resting
discharge rate
Scatter graphs showing the relationship between steady-state l-F gain
and resting frequency of Type A and Type B MVN neurones from slices
of normal and sham animals
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Figure 3.4.2 : Resting membrane potential of MVN neurones 4h post-
UL
Histogram showing the overall mean (± S.E.M) RMP of ipsilateral
rostral (open column) and ipsilateral caudal (solid column) MVN
neurones in control (rostral: n=28; caudal: n=15) and 4h post-UL
(rostral: n=34; caudal: n=14). There is no significant difference within
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Figure 3.4.2.1 : Membrane input resistance of MVN neurones 4h
post-UL
Histogram showing the overall mean (± S.E.M) membrane input
resistance of ipsilateral rostral (open column) and ipsilateral caudal
(solid column) MVN neurones in control (rostral: n=28; caudal: n=15)
and 4h post-UL (rostral: n=34; caudal: n=14). There is no significant
difference within groups. P>0.05, assessed by Student's t-test.
Discharge rate
control 4h post-UL
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Figure 3.4.2.2 : Spontaneous discharge rate of MVN neurones 4h
post-UL
Histogram illustrating the overall mean (± S.E.M) resting discharge
rate of ipsilateral rostral (open column) and ipsilateral caudal (solid
column) MVN neurones in control (rostral: n=28; caudal: n=15) and
4h post-UL slices (rostral: n=34; caudal: n=14). There is a
significant increase in the mean resting discharge rate of MVN
neurones in the ipsilateral rostral region 4h post-UL compared with





Figure 3.4.2.3 : Resting discharge rate of ipsilateral rostral Type A and
Type B MVN neurones 4h after UL
Histogram illustrating the mean (± S.E.M) resting discharge rate of
ipsilateral rostral Type A (open column) and ipsilateral rostral Type B (solid
column) MVN neurones in control (Type A: n=7; Type B: n=21) and 4h
post-UL slices (Type A: n=6; Type B: n=28). There is a significant increase
in the mean resting discharge rate of Type B MVN neurones in the
ipsilateral rostral region 4h post-UL compared with control Type B in the
ipsilateral rostral region. * P<0.05, assessed by student's f-test.
Legend 3.4.2.4 : Relationship between SFA index, steady-state l-F gain
and resting discharge rate of ipsilateral rostral Type B MVN neurones 4h
after UL
(A) Scatter plots illustrating the relationship between SFA index and resting
discharge rate of Type B MVN neurones in control ( t ) and ipsilateral
rostral Type B MVN neurones ) 4h post-UL. Figure shows the
regression slope of control Type B neurones and its 99% prediction
interval. Notice that there are two distinct populations of Type B neurones
4h post-UL, with 50% of Type B neurones falling within (Type B-), while the
remaining 50% fall outside the 99% prediction interval of control regression
slope. (B) The relationship between steady-state gain and discharge rate
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Figure 3.4.2.4 : Relationship between SFA index, steady-state l-F
gain and resting discharge rate of ipsilateral rostral Type B MVN




















Figure 3.4.2.5 : Spontaneous resting discharge rate of rostral Type B
MVN neurones in slices of control and 4h post-UL animals.
Histogram illustrating the mean (± S.E.M) of spontaneous discharge rate
of rostral Type B MVN neurones in control and post-UL (Type B+ and B )
animals. The spontaneous discharge rate of Type B+ neurones is
significantly higher than Type B" neurones post-UL and Type B in control
animals. * P< 0.05 compared with Type B-, # P<0.05 compared with
control Type B, assessed by one way ANOVA.
Figure 3.4.2.6 : Voltage traces of a Type B+ MVN neurone in
response to depolarising current pulses of different amplitudes.
The neurone displayed a higher frequency for the initial part of
the firing trains which then decayed to steady-state value (high
spike-frequency adaptation).
Figure 3.4.2.7 : Spike-frequency adaptation curve of Type B+ MVN
neurone
Spike-frequency adaptation curve of Type B+ neurone illustrated in
figure 3.4.2.6, measured at different intervals showing non-linear
relationship in the first interval. Notice the presence of a secondary
range for the first three and last three intervals, which gives higher
Value for SFA index.
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Figure 3.4.2.8 : Voltage traces of a Type B" MVN neurone in
response to depolarising current pulses of different amplitudes.
The neurone displayed a higher frequency for the initial part of




























Figure 3.4.2.9 : Spike-frequency adaptation curve of Type B- MVN
neurone
Spike-frequency adaptation curve of Type B- obtained from
Fig.3.4.2.8, measured at different intervals showing non-linear
relationship in the first interval. Notice the presence of a secondary
range for the first and the second intervals.
TABLE3.4.3



























Legend3.4.3.1:Spontan ousactionpotentialcharacteristicsfc n r la d4hft rULrostralTyBMVNneuro s.
(AandB)Histogramhowingthemean(±S.E.M)acti npo enti ldur ioofTypBMVNneur s,m ur dawidth threshold(Wt)andwidthhalf-heigh(W ).Th reissignif cantincrea etactionpot t aldur tiooTypB+MVN neuronesiULa imalscomparedt ntra dTypeB-neurones.(CandD)Meofr trepolarisation(r s )a d depolarisation(f ll)hasefact onpotentialTypeBMVNn uro sicontrola dft rULa imals.Throfepolarisa ion anddepolarisationhasefTypeB+asignificantlyl werthcont ola dTy eB-MVNneurones.#p<0.05com arwit control.*p<0.05comparedwithB-gr up,testedbyoneayANOVA
Figure3.4.3.1:Spontaneousactionpotentialchar cteristicsfTypBi n la d4post-ULimals.
Legend 3.4.3.2 : Averaged action potential shapes superimposed
from Type B MVN neurones in control and post-UL animals.
(A and B). Examples of averaged action potential shapes
superimposed from Type B MVN neurone in control and 4 hrs after
UL animals. Notice that absent of fast AHP in Type B+ neurones
(solid arrows), while the delayed slow AHP (open arrows) remain
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Figure 3.4.3.2 : Average action potentials superimposed from Type B MVN
neurones in control and post-UL animals.
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3.5 DISCUSSION
This study provides the first in vitro intracellular analysis of intrinsic
membrane properties of vestibular neurones in the rat MVN after unilateral
labyrinthectomy. The results of the study demonstrate that pronounced adaptive
changes take place in the intrinsic membrane properties of a specific subpopulation
of vestibular neurones in the rostral region of the MVN ipsilateral to the lesioned
side. Following 4 hours after a lesion of the peripheral vestibular receptors of the left
inner ear, 50% (14/28 of the sampled neurones) of the identified Type B neurones in
the ipsilateral rostral MVN developed a significant increase in their intrinsically-
generated in vitro resting discharge rate and exhibited a significant change in their
spontaneous firing behaviour in response to depolarising current injection, indicated
by a near two-fold increase in spike frequency adaptation index (SFA index). By
contrast, the resting discharge rate and the SFA index of the remaining ipsilateral
rostral Type B and ipsilateral rostral Type A as well as caudal MVN neurones were
not changed after unilateral labyrinthectomy. Thus, this result indicates that the
significant increase in the intrinsically-generated in vitro resting discharge rates of
the ipsilateral rostral MVN neurones observed in the previous study by Cameron
and Dutia (1997) using extracellular recordings, is attributable to a selective plastic
change and adaptation in the intrinsic excitability of this sub-population of ipsilateral
rostral Type B MVN neurones, which we have termed as Type B+ neurones, while
the intrinsic excitability of the remaining MVN neurones remains unchanged during
the early period of vestibular compensation following UL.
There were no changes in the resting membrane potentials, apparent
membrane input resistance or steady-state gain of the Type B+ neurones after UL.
However, it was observed that the increase in the intrinsic resting discharge rate and
the SFA index of these Type B neurones is accompanied by a marked change in
their averaged action potentials parameters. Thus, the duration of averaged
spontaneous action potentials measured at spike threshold and at half-height of
Type B+ neurones were longer than those of Type B" and control rostral Type B
neurones. The rate of action potential repolarisation and depolarisation phases of
Type B+ neurones were also slower than Type B" and control Type B neurones.
Furthermore, it was also observed that the early fast AHP of Type B+ neurones
became smaller or almost invisible. The changes in all of these averaged action
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potentials parameters, together with the loss of early fast AHP in Type B+
suggesting that there is a functional down-regulation of membrane potassium
conductances that are involved in the repolarisation of the action potential (Johnston
et al., 1994). Studies have shown that modulation of potassium current plays a
major role in controlling neuronal excitability (for reviews see, Hille, 1992; Jonas and
Kaczmarek, 1996; Bovill, 1997). Recent studies have indicated that potassium
conductances were subjected to modulation in synaptic plasticity (Nelson and Alkon,
1991; Janigro et al., 1997; Sobko et al., 1998). Although, K+ conductances in MVN
neurones are not well characterised, the present findings indicate that such
modulatory mechanisms may bring about the compensatory increase in the
excitability of MVN neurones. However, other ionic conductances than the
aforementioned K+ conductance of MVN neurones which underlies their
spontaneous action potentials may contribute to the increase resting discharge rate
and SFA index as well.
Yamanaka et al., (1998) showed that there was marked functional down-
regulation of GABAa and GABAb receptors efficacy in the rostral ipsilateral MVN
neurones within 4hrs following UL. While in the contralateral side, there was
significant up-regulation of the functional efficacy of GABAa receptors. However, the
selective adaptation of the electrophysiological properties of the Type B+ neurones
in the rostral MVN is in contrast to the functional down-regulation of GABA receptors
which appears to occur in all rostral MVN neurones tested. It has been suggested
that the down-regulation in GABAergic inhibition in the ipsilateral MVN is a key
process in bringing about the restoration of the resting discharge rate of ipsilateral
neurones after UL, by overcoming the disfacilitation and excessive commissural
inhibition to which these neurones were subjected after the lesion (Yamanaka et al.,
1998). By contrast, the increase in the discharge rate and SFA index in the rostral
ipsilateral Type B+ MVN neurones after UL are more appropriate to modify the
"signal processing" characteristics of these neurones during vestibular
compensation. For example, the initial high frequency discharge of Type B+
neurones during a depolarising pulse may be useful in generating spike firing in
these neurones after UL. Therefore, GABA receptors down-regulation and the
changes in intrinsic properties of Type B+ neurones would therefore appear to be
parallel compensatory process initiated by the vestibular deafferentation, which
together result in the recovery of resting discharge in the ipsilateral MVN neurones.
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There is no information at present as to the synaptic connectivity of Type A
and Type B neurones in the MVN, and their roles in processing vestibular and eye-
movement signals. This is a major limitation at present in understanding the
significance of the changes in the properties of Type B+ neurones seen in the
present study. However, now that it is known that Type B+ neurones show lesion-
induced plasticity after UL, it should be possible to apply modern microanatomical
and immunohistochemical techniques to study their characteristics and synaptic
connectivity. For example, morphological reconstruction studies of identified Type A
and Type B neurones after labelling with an intracellular marker (e.g. HRP) in slices
could reveal whether there are differences in their size or extent of their dendritic
arbors.
Nonetheless, from the location of the Type B+ neurones in the rostral region
of the ipsilateral MVN, and their frequency as observed (29%, 14/48 of total MVN
neurones post-UL sampled) it is possible that these neurones may be equivalent to
the flocculus target neurones (FTNs) recorded in monkeys undergoing motor
learning under conditions of visual modification (Lisberger et at., 1994). Projections
from the cerebelar flocculus to MVN neurones have been demonstrated in the
monkey (Lisberger et at., 1994), cat (Sato et at., 1988, Cheron 1996) and rabbit
(Stahl 1991, Stahl and Simpson 1992). Lisberger et at., (1994) showed that when
monkey were made to wear goggles that magnified their visual field, their VOR
showed an increase in gain so that a given head movement evoked a larger than
normal reflex eye movement. They also showed that, in parallel with this change in
the gain of the VOR, FTNs in the rostral MVN showed significant modifications in
their response to visual and vestibular stimulation. It is possible that, in parallel with
the recovery of resting discharge in the ipsilateral vestibular neurones after UL due
to down-regulation of GABAergic inhibitory function, the large visual-vestibular
mismatch that arises in the UL animals due to the imbalance in vestibular input
rather than an alteration in visual feedback, may give rise to equivalent adaptive
modifications in the FTNs in an effort to generate a normal VOR with the highly
abnormal vestibular input. While further experiments are necessary to directly test
this proposal, present findings suggest that the changes in responsiveness of FTNs
observed during motor learning in vivo may involve not only alteration in the efficacy
of cerebellar synapses but may also involve significant changes in the properties of
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the postsynaptic MVN neurones as observed in this study. Direct experimental
evidence for the proposal that Type B+ neurones correspond to FTNs, may come
from experiments on animals where HRP or another anterograde marker is injected
into the cerebellar flocculus, some days prior to the slice experiment. In the slice
experiment the identified Type B+ neurones will be filled with another marker and the
tissue would then be processed to visualise both labels. If Type B+ neurones are
FTNs, they should receive synaptic connections from the labelled cerebellar axons.
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In conclusion, this thesis presented the results of in vitro electrophysiological
experiments using the horizontal slices of dorsal brainstem containing the medial
vestibular nucleus. These slices used are viable for periods of up to 6h or more in
appropriate environments, and provide a very useful preparation in which to study
the effects of neurotransmitter and neuromodulators on the tonically active neurones
of the MVN. This preparation also extremely useful in studying the neuronal activity
and cellular mechanisms involved in the early stages of vestibular compensation in
the MVN following unilateral labyrinthectomy.
In the first chapter, it was demonstrated using extracellular and intracellular
whole-cell patch clamp recording techniques that large majority of spontaneously
active rat MVN neurones in vitro, were inhibited in a dose dependent manner by the
5-opioid receptor agonist, [D-Ala2, D-Leu5]-enkephalin (DADLE) and highly selective
5-opioid receptor agonist, DPLPE. This inhibition was effectively antagonised by the
selective 5-opioid receptor antagonist, naltrindole and also persisted in the presence
of modified low Ca2+, high Mg2+ medium, suggesting that the effects of DADLE are
likely to be mediated through its direct action on the postsynaptic receptors. These
results confirm the presence of 5-opioid receptors on MVN neurones, consistent with
the reported immunohistochemical and in situ hybridisation studies. By contrast,
agonists for p- and K-opioid receptors failed to elicit response in any of the MVN
neurones tested, although in situ hybridisation studies have demonstrated the
presence of low p- and k-opioid receptor mRNA in the MVN. It was suggested that
p- and k-receptor mediated effects within the MVN may be entirely presynaptic.
Future investigations should aim to determine the p- and k-receptor mediated
effects within this nucleus. For example, presynaptic modulatory effects of p- and k-
opioid agonists on the monosynaptic excitatory postsynaptic potential (e.p.s.p)
recorded with VIIIth nerve stimulation in vitro (Kinney et al., 1994) need to be
investigated. In whole cell patch clamp experiments experiments, it was shown that
the inhibitory effects of DADLE were mediated by membrane hyperpolarisation
associated with increased in outward K+ conductance in the cell membrane. This
finding was confirmed pharmacologically using the K+ channel blocker, TEA.
However, more selective K+ channel blockers, and further voltage-clamp analyses
are needed to characterise the K+ conductances more fully. It was also observed
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that the degree of DADLE-induced inhibition was dependent on post-natal age, in
that the responses to DADLE were smaller in younger animals and increase
significantly with age. It was suggested that this could be due to continuing post¬
natal growth and maturation of the MVN and their dendritic arbors or it could reflect
changes in the overall density of 5-opioid receptors on MVN neurones. Further
investigations are necessary to determine the morphological characteristics of the
MVN neurones or expression binding studies of 5-opioid receptors at different
postnatal age may provide information for the development of 5-opioid receptor in
the MVN. The importance of opioid innervation on the post-natal development of
MVN neurones can be investigated.
In the second chapter, the effect of N/OFQ on the spontaneously active
MVN neurones was examined using extracellular and intracellular whole cell patch
clamp recording techniques. It was demonstrated that N/OFQ profoundly inhibited
spontaneous discharge of MVN neurones. This inhibition was dose-dependent,
persisted in low Ca2+, Co medium and was resistant to pharmacological blockade of
naloxone, but was effectively antagonised by the selective ORL1 receptor
antagonist. In addition, both N/OFQ and DADLE inhibited the spontaneous
discharge of the majority of MVN neurones, while a minority of neurones was
selectively responsive either to N/OFQ or to DADLE but not both. Co-administration
of N/OFQ and DADLE to neurones that were responsive to both agonists resulted in
occlusion rather than summation. In whole cell patch clamp experiments, it was
shown that N/OFQ caused membrane hyperpolarisation and decrease in input
resistance in the MVN neurones. Thus, these results indicate that N/OFQ inhibited
the spontaneously active MVN neurones through its direct action via ORL1
receptors and that this inhibitory action was mediated by increased in K+
conductances. However, further voltage clamp experiments using specific ion
channel blockers are necessary to systematically determine and confirm the ionic
mechanisms underlying the effects of N/OFQ on Type A and Type B neurones.
In the final chapter, using whole cell patch clamp recording techniques the
changes in the electrophysiological properties of identified Type A and Type B MVN
neurones in the rostral region of the MVN during the early stage of vestibular
compensation (4h after UL) were studied. It was demonstrated that the
electrophysiological properties of Type A MVN neurones were unchanged following
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UL. In contrast, marked changes occurred in the membrane excitability and action
potential firing characteristics of specific sub-population of rostral Type B MVN
neurones, indicating that the changes in the intrinsic membrane properties of this
sub-population of MVN neurones may be an important cellular mechanism during
the behavioural recovery after vestibular lesions. Based on the location of this sub-
population of Type B neurones, It was suggested that they might be equivalent to
the flocculus target neurones (FTNs) recorded in monkey undergoing motor learning
under visual modification. Further investigations are therefore required in order to
explore the connectivity of this particular Type B neurones as well as voltage clamp
experiments to pharmacologically isolate the ionic conductances that responsible for
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